[["saturated fatty acids", "PD", "INFLUENCE"], ["Lactiplantibacillus plantarum SG5", "PD", "INFLUENCE"], ["major depression", "serious mental illnesses", "IS A"], ["HC", "multi-omics analysis", "USED BY"], ["Disordered gut microbiota", "stress-vulnerable mice", "LOCATED IN"], ["H<sub>2</sub>S", "inflammation", "INFLUENCE"], ["gut microbiota dysbiosis", "Parkinson's disease", "AFFECT"], ["dysbiosis", "gut flora", "CHANGE ABUNDANCE"], ["Cognitive impairment", "bipolar disorder", "AFFECT"], ["gut microbiota", "mental health problems", "IS LINKED TO"], ["incidental dementia", "Alzheimer's disease (AD) patients", "TARGET"], ["BEVs", "Parkinson's", "INFLUENCE"], ["Gut microbiota dysbiosis", "Alzheimer's disease", "AFFECT"], ["melatonin", "AD", "INFLUENCE"], ["Serotonergic dysfunction", "Parkinson's disease", "AFFECT"], ["behavioural issues", "animals", "TARGET"], ["GLP-1 (Glucagon-like Peptide-1) analogs", "Parkinson's disease", "INFLUENCE"], ["Gut microbiota dysbiosis", "anxiety", "AFFECT"], ["gut microbiota", "gut dyspiosis", "IS LINKED TO"], ["Gut Microbiota", "Metagenomic Analysis", "USED BY"], ["short-chain fatty acids", "ND pathogenesis", "INFLUENCE"], ["sphingolipids", "MDD", "INFLUENCE"], ["microgliosis", "dentate gyrus region", "STRIKE"], ["reduced intestinal iron absorption", "blood loss", "AFFECT"], ["antibiotics", "disorders", "CHANGE EFFECT"], ["Gut Microbial Alteration", "Parkinson Disease", "AFFECT"], ["defects in the gut function", "Parkinson's disease", "AFFECT"], ["cardiovascular diseases", "individuals", "TARGET"], ["diseases", "patients", "TARGET"], ["SCFAs", "Dysbiosis", "INFLUENCE"], ["motor symptoms", "gastrointestinal dysfunction", "AFFECT"], ["dextran sulfate sodium salt", "mice", "ADMINISTERED"], ["Rapid eye movement sleep behavior disorder", "prodromal PD", "AFFECT"], ["oxidative stress", "neurodegenerative disease pathologies", "AFFECT"], ["Cognitive impairment", "serious mental illnesses", "AFFECT"], ["gut microbiota dysbiosis", "mice", "TARGET"], ["Bacterial Butyrate", "Parkinson's Disease", "INFLUENCE"], ["fruits", "depressive symptoms", "INFLUENCE"], ["gut microbiome", "male C57BL/6J mice", "LOCATED IN"], ["valeric acid", "Parkinson's", "INFLUENCE"], ["gut microbiome", "fecal 16S rRNA analysis", "USED BY"], ["PD", "constipation", "AFFECT"], ["synbiotic product", "PD patients", "ADMINISTERED"], ["gut microbiota", "RBD", "IS LINKED TO"], ["intestinal flora", "\u03b1-syn transgenic C57BL/6 mice", "LOCATED IN"], ["Serious infections", "Parkinson's disease", "AFFECT"], ["Bile acids", "neurological disease", "INFLUENCE"], ["gut bacteria metabolites", "brain disorders", "INFLUENCE"], ["pathogenic microbes", "systemic inflammation", "INFLUENCE"], ["Gut dysbiosis", "PD", "AFFECT"], ["Aging", "mental health disorders", "AFFECT"], ["Postpartum depression", "women", "TARGET"], ["Parkinson's disease", "Colombian participants", "TARGET"], ["Gut microbiota-associated taurine metabolism dysregulation", "mouse model", "TARGET"], ["gut microflora", "dementia", "IS LINKED TO"], ["Gut microbiota", "depression", "IS LINKED TO"], ["low mood", "women", "TARGET"], ["Gastrointestinal Issues", "Neurodegenerative Diseases", "AFFECT"], ["Parasutterella", "PD", "INFLUENCE"], ["PD", "females", "TARGET"], ["eating disorders", "NCGS individuals", "TARGET"], ["cognitive decline", "learning and memory deficits", "AFFECT"], ["Central inflammation", "multiple sclerosis", "AFFECT"], ["dyskinesia", "PD mice", "TARGET"], ["alpha-synuclein", "systemic inflammation", "INFLUENCE"], ["Parkinson's disease", "A53T transgenic mice", "TARGET"], ["Firmicutes phyla", "gut microbiota", "PART OF"], ["pain", "antibiotics-treated mice", "TARGET"], ["patients", "mass spectrometry approach", "USED BY"], ["gut microbiota", "16S rRNA gene amplicon sequencing", "USED BY"], ["neuronal loss", "DLB", "AFFECT"], ["peripheral biological fluids", "Parkinson's disease", "INFLUENCE"], ["intestinal microbiota", "psychiatric diseases", "IS LINKED TO"], ["Dietary polysaccharides", "CNS disorders", "INFLUENCE"], ["agmatine", "prefrontal cortex", "LOCATED IN"], ["reactive astrocytosis", "neurodegenerative diseases", "AFFECT"], ["microbiota of the newborn", "pregnant and lactating women", "LOCATED IN"], ["MUD", "male subjects", "TARGET"], ["ADHD", "medication-na\u00efve adults", "TARGET"], ["Parkinson's disease", "PD-like mice", "TARGET"], ["non-celiac gluten/wheat sensitivity", "individuals", "TARGET"], ["Arketamine", "psychiatric disorders", "CHANGE EFFECT"], ["Cu", "MCI", "INFLUENCE"], ["neuroendocrine", "PD", "INFLUENCE"], ["murine protist Tritrichomonas musculus", "healthy and B-cell-deficient mice", "LOCATED IN"], ["Parkinson's disease", "neurodevelopmental disorders", "IS A"], ["Inflammation", "Parkinson's Disease", "AFFECT"], ["Autophagic dysfunction", "chronic immune activation", "AFFECT"], ["Crohn's disease", "ulcerative colitis patients", "TARGET"], ["KBs", "cerebral ischemia", "INFLUENCE"], ["agmatine", "depression-like behavior", "INFLUENCE"], ["microbiota", "bacterial imbalance", "AFFECT"], ["dysregulation of", "gut dysbiosis", "AFFECT"], ["fruits", "neurodegenerative diseases", "INFLUENCE"], ["nootropic herbs", "fecal microbiota", "IMPACT"], ["gut microbiota", "high-performance liquid chromatography-mass spectrometry", "USED BY"], ["psychotic syndromes", "METH users", "TARGET"], ["depression", "neuropsychiatric disorders", "IS A"], ["inflammation", "dysbiosis", "AFFECT"], ["aggregates", "neurodegenerative diseases", "AFFECT"], ["behavioural deficits", "GF-mice", "TARGET"], ["CUMS", "gut microbiome", "CHANGE ABUNDANCE"], ["major depression", "people", "TARGET"], ["intestinal microflora", "Parkinson's disease", "IS LINKED TO"], ["bipolar disorder", "individuals", "TARGET"], ["CRC", "UC", "AFFECT"], ["chronic constipation", "patients", "TARGET"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "intestinal inflammation", "INFLUENCE"], ["CP2305", "sleep disturbance", "CHANGE EFFECT"], ["B.35624", "depressive-like behavior", "INFLUENCE"], ["NDs", "neurodegenerative diseases", "IS A"], ["gastrointestinal microbiome", "AD", "IS LINKED TO"], ["gut microbiota", "constipation", "IS LINKED TO"], ["rotenone-induced motor deficits", "healthy control mice", "TARGET"], ["neurodevelopmental impairment", "Amyotrophic Lateral Sclerosis", "AFFECT"], ["gut microbiome", "mood disorders", "IS LINKED TO"], ["Enterococcus faecalis", "Parkinson's disease (PD) mice", "LOCATED IN"], ["depression", "older populations", "TARGET"], ["\u03b1-Syn", "gut", "LOCATED IN"], ["intestinal microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["prefrontal cortex", "CRS-exposed mice", "LOCATED IN"], ["participants", "16S rRNA gene sequencing", "USED BY"], ["disrupted gut microbiota composition and function", "dysbiosis", "AFFECT"], ["PD", "multifactorial neurodegenerative disorder", "IS A"], ["succinic acid", "OCD-colonized mice", "LOCATED IN"], ["LcS", "non-motor symptoms", "INFLUENCE"], ["Gut microbiota-derived short chain fatty acids", "cognitive decline", "INFLUENCE"], ["antimicrobial resistance", "healthy individuals", "TARGET"], ["COVID-19", "individuals", "TARGET"], ["ASD", "neurodevelopmental disorder", "IS A"], ["melatonin", "Dysbiosis", "INFLUENCE"], ["US participants", "16S rRNA gene sequencing", "USED BY"], ["depressive-like behavior", "female Sprague-Dawley rats", "TARGET"], ["iron", "intestinal microbiome", "IMPACT"], ["Huntington's disease", "HD", "AFFECT"], ["GABA", "autism spectrum disorder", "INFLUENCE"], ["PFC", "antibiotic-treated mice", "LOCATED IN"], ["intestinal microbiota dysbiosis", "Huntington's diseases", "AFFECT"], ["gut microbiota dysbiosis", "inflammation", "AFFECT"], ["Neuroinflammation", "nerve injury", "AFFECT"], ["proton-pump-inhibitors", "gut microbiota", "IMPACT"], ["Alzheimer's disease", "neurological and psychological disorders", "IS A"], ["gut microbiota", "autism spectrum disorder", "IS LINKED TO"], ["Fe-induced ferroptosis", "PD", "AFFECT"], ["Dysbiosis", "Alzheimer's disease", "AFFECT"], ["Short-chain fatty acids", "PD", "INFLUENCE"], ["emotional injury", "offspring", "TARGET"], ["food addiction", "addictive substance use disorders", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride", "female Sprague Dawley rats", "ADMINISTERED"], ["MitoPark mice", "Metabolomic gas chromatography-mass spectrometry", "USED BY"], ["IgA", "PD group", "LOCATED IN"], ["\u03b1-syn", "brain", "LOCATED IN"], ["hyperactivity", "SPF mice", "TARGET"], ["Microbiota", "Depressive Disorder", "IS LINKED TO"], ["Calprotectin", "gastrointestinal symptoms", "INFLUENCE"], ["gut bacteria", "PD", "INFLUENCE"], ["IBD", "neurodegenerative conditions", "AFFECT"], ["GM dysbiosis", "brain", "STRIKE"], ["gut microbiota dysbiosis", "systemic inflammatory processes", "AFFECT"], ["tablets", "sleep disturbance", "INFLUENCE"], ["depression-like phenotypes", "mice", "TARGET"], ["antibiotics", "Parkinson's disease", "CHANGE EFFECT"], ["H<sub>2</sub>S", "gut microbiota", "IMPACT"], ["prion proteins", "Parkinson's disease", "INFLUENCE"], ["Phytochemicals", "Huntington's disease", "INFLUENCE"], ["BPA", "gut microbiota", "IMPACT"], ["SCFAs", "age-related neurodegenerative disorders", "INFLUENCE"], ["ginsenoside Rh4", "depression-like behavior", "CHANGE EFFECT"], ["Firmicutes", "gut microbiota", "PART OF"], ["males", "resting-state functional magnetic resonance imaging", "USED BY"], ["Parkinson's-like symptoms", "mice", "TARGET"], ["depression", "neurodevelopmental disorders", "IS A"], ["Alzheimer's disease", "neurodegenerative disease", "IS A"], ["metals", "Lewy body dementia", "INFLUENCE"], ["gut microbiota", "intestinal microflora", "COMPARED TO"], ["Alzheimer's Disease", "autoimmune diseases", "IS A"], ["anxiety", "host brain disorders", "IS A"], ["Migraine", "women", "TARGET"], ["Clostridiales", "susceptible mice", "LOCATED IN"], ["\u03b1-synuclein", "dementia with Lewy bodies", "INFLUENCE"], ["gut microbiota", "frailty", "IS LINKED TO"], ["Fatigue", "cancer", "AFFECT"], ["reduced intestinal iron absorption", "iron deficiency", "AFFECT"], ["Epilepsy", "epilepsy patients", "TARGET"], ["AGP", "C. jejuni infection", "CHANGE EFFECT"], ["Akkermansia", "obesity", "INFLUENCE"], ["salt", "mental health concerns", "INFLUENCE"], ["indoles", "cognitive impairment", "INFLUENCE"], ["chemotherapy drugs", "gut microbiota", "IMPACT"], ["probiotics", "bifidobacteria", "IMPACT"], ["probiotics", "drug-resistant epilepsy", "INFLUENCE"], ["intestinal microbiota", "neurological and mental illnesses", "IS LINKED TO"], ["mood disorders", "Women", "TARGET"], ["FAE", "FA", "INTERACT"], ["viral infections", "critically ill patients", "TARGET"], ["gut barrier defects", "PD", "AFFECT"], ["arketamine", "depression-like behaviors", "CHANGE EFFECT"], ["B. infantis M-63", "participants", "ADMINISTERED"], ["gut microbes", "middle-aged group", "LOCATED IN"], ["gut eubiosis", "MDD", "AFFECT"], ["gut microbiota", "neurocognitive disorders", "IS LINKED TO"], ["fecal microbiome", "MPTP-induced Parkinson's disease mice", "LOCATED IN"], ["gut microbiota", "first-degree relatives", "LOCATED IN"], ["gut microbiome", "noncommunicable diseases", "IS LINKED TO"], ["Gastrointestinal dysfunction", "motor symptoms", "AFFECT"], ["psychiatric symptoms", "PD", "AFFECT"], ["PARK7/", "gut and brain diseases", "INFLUENCE"], ["gut microbiota", "brain diseases", "IS LINKED TO"], ["intestinal dysbiosis", "PD", "AFFECT"], ["GM", "hypertension", "IS LINKED TO"], ["bile acids", "gut microbiome", "IMPACT"], ["delirium-like behaviors", "mice", "TARGET"], ["BCAAs", "neurodegenerative diseases", "INFLUENCE"], ["gut microbiota", "Bipolar Disorder", "IS LINKED TO"], ["probiotics", "abdominal discomfort", "INFLUENCE"], ["Akkermansia muciniphila", "chronic stress-induced depressive-like behavior", "INFLUENCE"], ["cancer", "people", "TARGET"], ["Arketamine", "phencyclidine-induced cognitive deficits", "CHANGE EFFECT"], ["BAs", "gut", "LOCATED IN"], ["dysfunctional gut microbiota", "stress vulnerability", "IS LINKED TO"], ["phytochemicals", "gut flora", "IMPACT"], ["IMQ", "microbiota", "IMPACT"], ["gut microbiota", "Major depressive disorder", "IS LINKED TO"], ["neurotoxic metabolites", "neurodegenerative and inflammatory diseases", "INFLUENCE"], ["anhedonia", "Patients", "TARGET"], ["gut microbiome", "substance-induced mental disorders", "IS LINKED TO"], ["Pesticides", "dopaminergic neuron damage", "INFLUENCE"], ["Roseburia", "intestinal inflammation", "INFLUENCE"], ["motor and gastrointestinal dysfunctions", "Parkinson's disease", "AFFECT"], ["mild withdrawal symptoms", "Prevotella pallens", "CHANGE ABUNDANCE"], ["Gut microbiota", "psychiatric disorders", "IS LINKED TO"], ["Firmicutes phyla", "PD mice", "LOCATED IN"], ["PD", "protein malfunction", "AFFECT"], ["chronic constipation", "autonomic issues", "IS A"], ["GM", "neuropsychiatric/neurological diseases", "IS LINKED TO"], ["striatum", "PD-like mice", "LOCATED IN"], ["obesity", "psychiatric disorders", "AFFECT"], ["inflammatory bowel disease", "ischemic stroke", "AFFECT"], ["ginsenoside Rh4", "hypothalamic-pituitary-adrenal axis disorder", "CHANGE EFFECT"], ["fecal microbiota", "intestinal", "IS LINKED TO"], ["Intestinal microbiota", "Parkinson's Disease (PD) pathology", "IS LINKED TO"], ["gut microbiome", "psychiatric and neurodegenerative diseases", "IS LINKED TO"], ["LPHC diet", "dopaminergic neuronal death", "INFLUENCE"], ["PD", "Bifidobacterium", "CHANGE ABUNDANCE"], ["Gut-derived bacterial LPS", "methamphetamine craving", "INFLUENCE"], ["BD depression patients", "network-based functional connectivity (FC), grey matter volume (GMV) analyses", "USED BY"], ["probiotics", "obese individuals", "ADMINISTERED"], ["MUD", "Collinsella", "CHANGE ABUNDANCE"], ["loss of function", "Neurodegenerative diseases", "AFFECT"], ["schizophrenia", "serious mental illnesses", "IS A"], ["Clostridales", "gut microbiota", "PART OF"], ["PDD", "Fe", "INTERACT"], ["Clinical PD", "proinflammatory immune responses", "AFFECT"], ["GDM", "offspring", "TARGET"], ["Alzheimer's dementia", "SIBO", "AFFECT"], ["gastrointestinal microbiota", "functional bowel disease", "IS LINKED TO"], ["Gut microbiota", "honeybees", "LOCATED IN"], ["\u03b2-hydroxybutyrate", "glucose deficiency", "INFLUENCE"], ["Curcumin", "gastrointestinal and intestinal barrier dysfunctions", "INFLUENCE"], ["synbiotic product", "behavioral and cognitive symptoms", "INFLUENCE"], ["\u03b1-Synuclein", "Parkinson's disease", "INFLUENCE"], ["gut microbiota alterations", "PD", "AFFECT"], ["PUFA", "AN", "INFLUENCE"], ["inflammatory bowel disease", "chronic inflammatory diseases", "IS A"], ["Oxidative Stress", "Mice", "TARGET"], ["neurodegenerative or neuropsychiatric disease", "seniors", "TARGET"], ["Ketamine", "treatment-resistant depressed patients", "ADMINISTERED"], ["postbiotics", "mental health disorders", "INFLUENCE"], ["depression symptoms", "pregnant and lactating women", "TARGET"], ["copper", "AD", "INFLUENCE"], ["Gut Microbiota", "Preschool Children", "LOCATED IN"], ["gut microbiome", "schizophrenia", "IS LINKED TO"], ["gut microbiota", "HD", "IS LINKED TO"], ["gut microbiota dysbiosis", "inflammatory bowel diseases", "AFFECT"], ["microbiota disturbances", "feces metabolic disorders", "AFFECT"], ["gut microbiota community", "PD mice", "LOCATED IN"], ["SCFAs", "neuroinflammation", "INFLUENCE"], ["constipation", "gut frailty", "AFFECT"], ["Akkermansia", "metabolic disorders", "INFLUENCE"], ["SN", "mice", "LOCATED IN"], ["intestinal bacteria", "PD", "INFLUENCE"], ["genome", "psychiatric disorders", "IS LINKED TO"], ["compulsivity", "adults", "TARGET"], ["gut dysbacteria", "Patients", "TARGET"], ["phytoestrogens", "gut microbiota", "IMPACT"], ["breast cancer", "patients", "TARGET"], ["prebiotics", "neurodegenerative diseases", "INFLUENCE"], ["Probiotics", "Parkinson's disease", "INFLUENCE"], ["control individuals", "functional profiling", "USED BY"], ["gut microbiota", "neurological disorder", "IS LINKED TO"], ["neuroendocrine", "neurological diseases", "INFLUENCE"], ["broad beans", "PD", "INFLUENCE"], ["gut-residing bacteria", "brain diseases", "INFLUENCE"], ["Infant microbiota", "colic", "IS LINKED TO"], ["probiotics", "sample population", "ADMINISTERED"], ["gut microbiota", "KEGG enrichment analysis", "USED BY"], ["Polyphenols", "PD", "INFLUENCE"], ["OCD", "mental health disorder", "IS A"], ["COVID-19 clinical manifestations", "fatigue", "AFFECT"], ["inflammation", "A53T mice", "TARGET"], ["FC patients", "16S rRNA microbial genomics", "USED BY"], ["probiotic supplementation", "AD", "INFLUENCE"], ["Antibiotics", "depression", "CHANGE EFFECT"], ["gut microbiome", "MS", "IS LINKED TO"], ["Gut microbiota dysbiosis", "PD patients", "TARGET"], ["terpenoids", "neurological disorders", "INFLUENCE"], ["dietary polysaccharides", "exercise-induced fatigue", "INFLUENCE"], ["C57BL/6 mice", "open-field", "USED BY"], ["Parkinson's disease", "neurological and psychological disorders", "IS A"], ["curcumin", "psychiatric disorders", "INFLUENCE"], ["dysbiosis", "neurodegenerative and neurodevelopmental diseases", "AFFECT"], ["gut microbiota", "AN", "IS LINKED TO"], ["Tryptophan Hydroxylase", "Depressive-Like Behavior", "INFLUENCE"], ["depression-like behaviors", "rodents", "TARGET"], ["prefrontal cortex", "ABX-treated mice", "LOCATED IN"], ["dietary polysaccharides", "gut microbiota", "IMPACT"], ["COVID-19 clinical manifestations", "dysgeusia", "AFFECT"], ["healthy subjects", ", placebo-controlled, double-blinded crossover design", "USED BY"], ["Firmicutes", "patients", "LOCATED IN"], ["CIP", "subdiaphragmatic vagus nerve", "STRIKE"], ["Schizophrenia", "morbidity", "AFFECT"], ["Bacteroidetes", "gut microbiota", "PART OF"], ["AD", "Prevotella pallens", "CHANGE ABUNDANCE"], ["Gut Microbiota", "Bipolar Depression", "IS LINKED TO"], ["fibers", "neurodegenerative diseases", "INFLUENCE"], ["chronic diarrhea", "HD subjects", "TARGET"], ["AD", "neurological disorders", "IS A"], ["inflammatory bowel disease", "patients", "TARGET"], ["PD", "microscopic colitis", "AFFECT"], ["6-Hydroxydopamin-Induced Parkinson's Disease Rats", "fecal 16S rRNA gene sequencing", "USED BY"], ["high fat and high sugar (HFHS) diets", "gut microbiota", "IMPACT"], ["Alzheimer's disease", "elderly population", "TARGET"], ["vitamin D", "neurological dysfunction", "INFLUENCE"], ["processes", "neuro-inflammation", "AFFECT"], ["and non-motor symptoms", "PD", "AFFECT"], ["gut microbiota", "Alzheimer's and Parkinson's disease", "IS LINKED TO"], ["VLCKD", "schizophrenia", "INFLUENCE"], ["Propionic acid", "MPTP + H-BCAA mice", "LOCATED IN"], ["Gastrointestinal symptoms", "motor symptoms", "AFFECT"], ["PD", "\u03b1-syn transgenic mice", "TARGET"], ["EC-12", "Male mice", "ADMINISTERED"], ["Oxidative stress", "PD", "AFFECT"], ["PD", "control subjects", "TARGET"], ["schizophrenia", "infections", "AFFECT"], ["Metformin", "body weight loss", "CHANGE EFFECT"], ["neurotransmitters", "psoriasis", "INFLUENCE"], ["PD idiopathic cases", "16S rRNA gene sequencing", "USED BY"], ["gut microbiota", "AD", "IS LINKED TO"], ["Parkinson's disease", "novel transgenic (Tg) mice", "TARGET"], ["naltrexone", "alcohol addiction", "CHANGE EFFECT"], ["Parkinson's disease", "Rubus chingii var. suavissimus (S.K.Lee) L.T.Lu", "CHANGE ABUNDANCE"], ["depressive disorders", "patients", "TARGET"], ["prodromal, nonmotor dysfunctions", "patients", "TARGET"], ["fermented foods", "anorexia nervosa", "INFLUENCE"], ["intestinal microbiota", "psychiatric symptomatology", "IS LINKED TO"], ["multiple sclerosis", "NDDs", "IS A"], ["depressive symptoms", "Japanese employees", "TARGET"], ["controls", "GC-MS", "USED BY"], ["intestinal microbiota", "NGS", "USED BY"], ["gut microbiome (GM) dysbiosis", "Parkinson's disease", "AFFECT"], ["anxiety-like behavior", "mice", "TARGET"], ["mental health difficulties", "patients", "TARGET"], ["Cardinal motor impairment", "PD", "AFFECT"], ["\u03b2-amyloid", "neurodegenerative disorders", "INFLUENCE"], ["gut microbiome", "Amyotrophic Lateral Sclerosis", "IS LINKED TO"], ["obesity", "individual", "TARGET"], ["AD", "neurodegenerative protein conformational diseases", "IS A"], ["Parkinson's disease", "neurodegenerative amyloid disorder", "IS A"], ["dietary polysaccharides", "stroke", "INFLUENCE"], ["PFC", "juvenile offspring", "LOCATED IN"], ["gastrointestinal function impairment", "PD mice", "TARGET"], ["Prevotella", "behavioural problems", "INFLUENCE"], ["Gut microbiome dysbiosis", "Parkinson's disease", "AFFECT"], ["Growth factors", "PD", "INFLUENCE"], ["microbiota", "obesity", "IS LINKED TO"], ["aging-related physiological changes", "gut microbiota", "CHANGE ABUNDANCE"], ["intestinal flora", "PD", "IS LINKED TO"], ["choline", "protein misfolding", "INFLUENCE"], ["Rapid eye movement (REM) sleep behavior disorder", "non-motor symptom", "AFFECT"], ["iron deficiency", "mental and physical fatigue", "AFFECT"], ["metabolic syndrome", "Schizophrenic patients", "TARGET"], ["Parkinson's Disease", "Mouse Model", "TARGET"], ["Severe iron deficiency", "anemia", "AFFECT"], ["MDD", "disability", "IS A"], ["AN", "females", "TARGET"], ["mental illnesses", "medical disorders", "IS A"], ["Cerebral Ischemia", "Neurodegenerative Diseases", "IS A"], ["Altered", "Parkinson's disease", "AFFECT"], ["malfunctioning of the internal clock", "sleep disturbances", "AFFECT"], ["Major depressive disorder", "MDD patients", "TARGET"], ["berberine", "gut microbiota", "IMPACT"], ["chronic stress-induced depressive-like behavior", "mice", "TARGET"], ["neurodevelopmental impairment", "PD", "AFFECT"], ["human fecal microbiomes", "deep metagenomic sequencing", "USED BY"], ["LPS", "gut microbiota", "IMPACT"], ["levodopa", "gut bacteria", "IMPACT"], ["control individuals", "metagenome-wide association studies", "USED BY"], ["polyphenols", "gut microbiota", "IMPACT"], ["HD", "psychiatric abnormalities", "AFFECT"], ["human synucleinopathies", "gut microbiota", "CHANGE ABUNDANCE"], ["Rifaximin", "TRH", "INTERACT"], ["gut dysbiosis-induced neurodegeneration", "Huntington's disease", "AFFECT"], ["placebo", "sleep disturbance", "CHANGE EFFECT"], ["multi-probiotic supplementation", "SD-related mental health disorders", "INFLUENCE"], ["gut microbiota", "AIS patients", "LOCATED IN"], ["Nootropic Medicinal Herbs", "Parkinson's Disease Gut Microbiota", "IMPACT"], ["AD", "Firmicutes", "CHANGE ABUNDANCE"], ["\u03b2-lactamase inhibitors", "pro-inflammatory", "INTERACT"], ["neurodegeneration", "FD patients", "TARGET"], ["Parkinson's disease", "PD", "IS A"], ["irritable bowel syndrome", "patients", "TARGET"], ["gut microbiome", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["Inflammation", "oxidative stress", "AFFECT"], ["Gut microbiome", "mild cognitive impairment", "IS LINKED TO"], ["Bifidobacterium", "depression", "INFLUENCE"], ["microbiota dysregulation", "Huntington's", "AFFECT"], ["HD", "intestines", "STRIKE"], ["cytokines", "Gut microbiota", "IMPACT"], ["Commensal Gut Microbiota", "Alzheimer's Disease", "IS LINKED TO"], ["probiotic", "neurobehavioural deficits", "INFLUENCE"], ["TMAO", "PD", "INFLUENCE"], ["DSS", "mice", "ADMINISTERED"], ["alpha-synuclein", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "neurological and psychological problems", "IS LINKED TO"], ["Reduced glucose metabolism", "cerebral ischemia", "AFFECT"], ["whole grains", "mood disorders", "INFLUENCE"], ["Se (selenium) nanoparticles", "neurological diseases", "INFLUENCE"], ["gut microbiome-derived exosomes", "neurodegenerative diseases", "INFLUENCE"], ["microbial metabolites", "systemic inflammation", "INFLUENCE"], ["legumes", "mood disorders", "INFLUENCE"], ["gut-derived short-chain fatty acids", "Parkinson's disease", "INFLUENCE"], ["sugar", "Gut Microbiota", "IMPACT"], ["Lactobacillus reuteri", "anhedonia-like phenotypes", "INFLUENCE"], ["probiotic", "PD", "INFLUENCE"], ["gut microbiota", "Parkinson Disease", "IS LINKED TO"], ["Rk3", "hippocampus", "LOCATED IN"], ["HIV", "people living with", "TARGET"], ["gut microbiota", "idiopathic Parkinson's disease", "IS LINKED TO"], ["Ru", "Rubus chingii var. suavissimus (S.K.Lee) L.T.Lu", "IMPACT"], ["mitochondrial disfunction", "gut dysbiosis", "AFFECT"], ["curcumin", "colitis", "INFLUENCE"], ["\u03b1-Syn", "PD", "INFLUENCE"], ["Alzheimer's disease", "psychiatric, neurodevelopmental, functional, and neurodegenerative diseases", "IS A"], ["PD", "Parkinson's disease", "AFFECT"], ["gut microbiota", "controls", "LOCATED IN"], ["beneficial microbial metabolites", "bacterial imbalance", "INFLUENCE"], ["probiotics", "Lactobacillus family", "IMPACT"], ["gut microbiota", "individual", "LOCATED IN"], ["dysbiosis of the skin microbiome", "food allergies", "AFFECT"], ["human gut microbiome", "psychiatric conditions", "IS LINKED TO"], ["prebiotics", "PD symptoms", "INFLUENCE"], ["gut microbiota dysbiosis", "acute ischemic stroke patients", "TARGET"], ["Impaired circadian rhythms", "mental disorders", "AFFECT"], ["earthworm protein", "PD", "INFLUENCE"], ["microbiomes", "psoriasis", "IS LINKED TO"], ["motor neuron disease", "patients", "TARGET"], ["ASD", "subjects", "TARGET"], ["Altered stress responses", "adults", "TARGET"], ["proinflammatory cytokines", "gut", "LOCATED IN"], ["bacteria", "gut microbiota", "PART OF"], ["PD", "progressive neurodegenerative disease", "IS A"], ["HC", "16S-sequencing", "USED BY"], ["acetate", "neuroendocrine alterations", "INFLUENCE"], ["Manganese", "PD", "INFLUENCE"], ["fructo-oligosaccharides", "Female and male C57 BL/J mice", "ADMINISTERED"], ["Chronic gut inflammation", "neuro degeneration", "AFFECT"], ["edaravone", "depression", "INFLUENCE"], ["Psychological stress", "anxiety", "AFFECT"], ["gut microbiota alterations", "psychological disorders", "AFFECT"], ["<i>L. plantarum</i> CCFM405", "PD", "INFLUENCE"], ["bacteria", "psoriasis", "INFLUENCE"], ["RF", "gut microbiome", "IMPACT"], ["Neurodegenerative diseases", "behavioral changes", "AFFECT"], ["Probiotics", "neurophysiological anxiety", "INFLUENCE"], ["acute COVID-19", "Lachnospiraceae", "CHANGE ABUNDANCE"], ["gut microbiota", "alcohol addiction", "IS LINKED TO"], ["ketogenic", "apoptosis", "INFLUENCE"], ["PD", "gastrointestinal tract", "STRIKE"], ["Antipsychotics", "weight gain", "CHANGE EFFECT"], ["gut bacteria", "mental disorders", "INFLUENCE"], ["gut microbiota", "CCA", "IS LINKED TO"], ["constipation", "Parkinson's disease patients", "TARGET"], ["PD", "brain regions", "STRIKE"], ["GM", "depression", "IS LINKED TO"], ["hypomethylation of DNA", "epigenetic alterations", "AFFECT"], ["dopaminergic neuronal loss", "Parkinson's disease", "AFFECT"], ["Parkinson's disease", "chronic neurodegenerative disease", "IS A"], ["Orally Administered Ginkgolide C", "MPTP-Induced Neurodegeneration", "CHANGE EFFECT"], ["lung infections", "patients", "TARGET"], ["migraine", "women", "TARGET"], ["mild alcoholic hepatitis", "patients", "TARGET"], ["human microbiome", "disease", "IS LINKED TO"], ["environmental pollutants", "global diseases", "INFLUENCE"], ["galacto-oligosaccharides", "Female and male C57 BL/J mice", "ADMINISTERED"], ["human gut microbiota", "NCDs", "IS LINKED TO"], ["gut microbiota", "UPLC-MS", "USED BY"], ["Gut microbes", "central nervous system disorders", "IS LINKED TO"], ["wild-type mice", "site-mutations", "USED BY"], ["flavonoids", "gut flora", "IMPACT"], ["misfolding", "PD", "AFFECT"], ["inflammation", "MDD", "AFFECT"], ["depressive symptoms", "mouse models", "TARGET"], ["gut dysbiosis", "endometriosis", "AFFECT"], ["gut microbiome", "neurological and other diseases", "IS LINKED TO"], ["Impulsivity", "emotional and social maladjustment", "AFFECT"], ["constipation", "PD", "AFFECT"], ["pathological proteins", "gut dysbiosis", "INFLUENCE"], ["metabolic abnormalities", "insulin resistance", "AFFECT"], ["Alzheimer's disease", "Prevalent neurological disorders", "IS A"], ["Pharmabiotics", "neurodegenerative and viral diseases", "INFLUENCE"], ["psychedelics", "maladaptive chronic stress responses", "CHANGE EFFECT"], ["gastrointestinal (GI) disorders", "Parkinson's disease", "AFFECT"], ["probiotics", "healthy subjects", "ADMINISTERED"], ["gut microbiota", "psycho-physiological deficits", "IS LINKED TO"], ["PM2.5", "neurodegenerative diseases", "INFLUENCE"], ["PD", "anxiety", "AFFECT"], ["gut microbiota", "chronic social defeat stress", "IS LINKED TO"], ["memory impairment", "CIP", "AFFECT"], ["1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice", "16S rRNA gene sequencing", "USED BY"], ["TMAO", "protein misfolding", "INFLUENCE"], ["microbial chemicals", "gut microbiota", "IMPACT"], ["psychedelic compounds", "autoimmunity", "CHANGE EFFECT"], ["Gastrointestinal (GI) dysfunction", "Parkinson's disease", "AFFECT"], ["disabling motor alterations", "constipation", "AFFECT"], ["autism spectrum disorder", "brain-related diseases", "IS A"], ["Periodontitis", "systemic inflammation", "AFFECT"], ["gut microbiota", "mitochondrial dysfunction", "IS LINKED TO"], ["colitis", "mice", "TARGET"], ["Fecal microbiota", "Parkinson's disease", "IS LINKED TO"], ["sporadic form of Parkinson's disease", "gut microbiota", "CHANGE ABUNDANCE"], ["human gut microbiome", "PD", "IS LINKED TO"], ["EDCs", "anxiogenic behaviors", "INFLUENCE"], ["Paraquat", "PD", "INFLUENCE"], ["GM", "16S amplicon sequencing", "USED BY"], ["standardized ginger supplement", "gut microbiota", "IMPACT"], ["MDD", "individuals", "TARGET"], ["nasal microbiota", "nasal dysbiosis", "IS LINKED TO"], ["inflammation", "PD", "AFFECT"], ["chorea", "neurogenerative disorder", "IS A"], ["GI dysmotility", "PD", "AFFECT"], ["Calprotectin", "PD", "INFLUENCE"], ["polyphenolic compounds", "PD", "INFLUENCE"], ["SD", "rats", "TARGET"], ["WEG", "Lactobacillus", "IMPACT"], ["gut dysbiosis", "proteinopathies", "AFFECT"], ["chondroitin sulfate", "Bacteroides thetaiotaomicron", "IMPACT"], ["fecal microbiota", "resilient rats", "LOCATED IN"], ["gut microbes", "ulcers", "INFLUENCE"], ["Parkinson's disease", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "diabetes mellitus", "IS LINKED TO"], ["fruits", "oxidative stress", "INFLUENCE"], ["gut microbiota", "AD patients", "LOCATED IN"], ["(R)-ketamine", "Bacteroidales", "IMPACT"], ["Parkinson's Disease", "REM Sleep Behavior Disorder", "AFFECT"], ["gut microbiota", "C57BL/6 mice", "LOCATED IN"], ["Repeated (<i>S</i>)-ketamine administration", "spatial working memory impairment", "CHANGE EFFECT"], ["gut microbiota", "PPD patients", "LOCATED IN"], ["gut microbiota", "Dysbiosis of", "IS LINKED TO"], ["aggregates", "oxidative stress", "AFFECT"], ["chronic neuropathic pain", "Patients", "TARGET"], ["Parkinson's diseases", "neurodegenerative disorders", "IS A"], ["gut eubiosis", "mental disorders", "AFFECT"], ["gut microbiota", "human donors", "LOCATED IN"], ["healthy young", "compositional data analysis", "USED BY"], ["substantia nigra pars compacta", "PD mice", "LOCATED IN"], ["intestinal dysbiosis", "neurological diseases", "AFFECT"], ["MDD", "cholesterol esters", "INTERACT"], ["\u03b1-synuclein", "\u03b1-synucleinopathies", "INFLUENCE"], ["schizophrenia-like (SCZ-like) symptoms", "SPF mice", "TARGET"], ["thyroid disease", "endocrine system diseases", "IS A"], ["Trimethylamine N-Oxide", "Motor Dysfunction", "INFLUENCE"], ["psychedelics", "AiD", "CHANGE EFFECT"], ["gut microbiota", "chronic inflammation", "IS LINKED TO"], ["iron chelators", "gut microbiota", "IMPACT"], ["pharmacological", "gut microbiota", "IMPACT"], ["essential tremor", "HCs", "TARGET"], ["microbial metabolites", "cognitive decline", "INFLUENCE"], ["MA-exposed rats", "16S ribosomal RNA (rRNA) sequencing", "USED BY"], ["\u03b2-alanyl-3-methyl-L-histidine", "mice", "ADMINISTERED"], ["systemic inflammation", "small intestine", "STRIKE"], ["gut microbiota", "healthy groups", "LOCATED IN"], ["Huntington's disease", "cognitive deficits", "AFFECT"], ["dysbiosis of the skin microbiome", "asthma", "AFFECT"], ["Neuroinflammation", "autoimmunity", "AFFECT"], ["Ferulic acid", "neurodegenerative diseases", "INFLUENCE"], ["psychobiotics", "inflammatory bowel disease", "INFLUENCE"], ["gut microbiota", "Alzheimer's disease", "IS LINKED TO"], ["reactive oxygen species", "Inflammatory mechanisms", "INFLUENCE"], ["Gut Microbiota", "MPTP-Induced PD Model Mice", "LOCATED IN"], ["(R,S)-ketamine", "cognitive impairment", "CHANGE EFFECT"], ["probiotics", "obesity", "INFLUENCE"], ["patients", "small intestine breath hydrogen test", "USED BY"], ["PD mice", "Western blotting", "USED BY"], ["\u03b1-synuclein", "Synucleinopathies", "INFLUENCE"], ["gut microbiota", "susceptible mice", "LOCATED IN"], ["oxidative stress", "autism spectrum disorder", "AFFECT"], ["Neurodegenerative Microbially-Shaped Diseases", "Neuroinflammation", "AFFECT"], ["Amino Acids", "Gut Microbiota", "IMPACT"], ["spatial working memory impairment", "mice", "TARGET"], ["gut microbiota", "germ-free (GF) mice", "LOCATED IN"], ["frontotemporal dementia", "brain disorders", "IS A"], ["Melatonin", "Parkinson's disease", "INFLUENCE"], ["early-stage Parkinson's disease", "rotenone-induced mice", "TARGET"], ["PD", "inflammation", "AFFECT"], ["Gut Microbiota", "depression", "IS LINKED TO"], ["Parkinson's disease", "neurodegenerative disease", "IS A"], ["gut microbiota", "bipolar disorder", "IS LINKED TO"], ["metabolic dysfunction", "BD", "AFFECT"], ["endocannabinoids", "hypothalamus", "LOCATED IN"], ["Irritable bowel syndrome", "functional gastrointestinal disorder", "IS A"], ["Parkinson's disease", "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice", "TARGET"], ["probiotics", "gut frailty", "INFLUENCE"], ["acetate", "epilepsy", "INFLUENCE"], ["infant gut microbiota", "allergic disease", "IS LINKED TO"], ["leaky gut", "neurological disorders", "AFFECT"], ["vitamin D", "psychiatric disorders", "INFLUENCE"], ["Gegen-Qinlian decoction", "intestinal inflammation", "INFLUENCE"], ["mice", "nanopore sequencing", "USED BY"], ["metabolic dysfunction", "dyslipidemia", "AFFECT"], ["biofilm-associated proteins", "synucleinopathies", "INFLUENCE"], ["Gut Microbiota", "Patients", "LOCATED IN"], ["PD", "PrP-A53T mice", "TARGET"], ["gut microbiome", "major depressive disorder", "IS LINKED TO"], ["Rk3", "gut microbiota", "IMPACT"], ["CD", "UC", "AFFECT"], ["antibiotic rifaximin", "gut microbiome", "IMPACT"], ["PD", "dorsal vagal nucleus", "STRIKE"], ["neuroinflammation", "striatum", "STRIKE"], ["gut microbiome", "early-stage PD mice", "LOCATED IN"], ["PD", "Fusicatenibacter", "CHANGE ABUNDANCE"], ["gut microbiome dysbiosis", "neurodegenerative disorders", "AFFECT"], ["Synucleinopathies", "DLB", "AFFECT"], ["Intestinal inflammation", "patients", "TARGET"], ["AD", "Bacteroidetes", "CHANGE ABUNDANCE"], ["gut microbiome", "women", "LOCATED IN"], ["motor issues", "PD", "AFFECT"], ["Parkinson's disease", "neurological diseases", "IS A"], ["gut microbiome", "endocrine system diseases", "IS LINKED TO"], ["HIV infection", "gut microbiota", "CHANGE ABUNDANCE"], ["Cognitive impairment", "major depressive disorder", "AFFECT"], ["GEP", "motor dysfunction", "INFLUENCE"], ["gut microbiome dysbiosis", "ASD", "AFFECT"], ["Heat-killed Enterococcus fecalis", "anxiety-like behavior", "INFLUENCE"], ["Parkinson's disease", "disease", "IS A"], ["essential bacteria", "hepatic cancer", "INFLUENCE"], ["Parkinson's disease", "intestinal flora", "CHANGE ABUNDANCE"], ["Microbiota", "Parkinson's Disease", "IS LINKED TO"], ["Gut dysbiosis", "altered immune responses", "AFFECT"], ["Short-chain fatty acids", "gut microbiota", "IMPACT"], ["anxiety", "neurological disorders", "IS A"], ["pentanoic (valeric) acid", "epilepsy", "INFLUENCE"], ["gut microbial metabolites", "PD", "INFLUENCE"], ["schizophrenia", "psychiatric disorders", "IS A"], ["dysregulated gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["medium-chain triglyceride KD", "oxidative stress", "INFLUENCE"], ["Oral [60]fullerene", "gut microbiome", "IMPACT"], ["late-life depression", "patients", "TARGET"], ["ubiquitin-binding proteins", "inflammatory response", "INFLUENCE"], ["dysbiosis", "depression", "AFFECT"], ["Manganese", "central nervous system damage", "INFLUENCE"], ["systemic inflammation", "Parkinson's disease", "AFFECT"], ["neurodegenerative disorder", "PD patients", "TARGET"], ["imbalance in gut microbiota composition", "depression", "AFFECT"], ["gut microbes", "autism spectrum disorder", "IS LINKED TO"], ["A\u03b2", "hippocampus", "LOCATED IN"], ["COVID-19 clinical manifestations", "neurological manifestations", "AFFECT"], ["next-generation probiotics", "inflammatory processes", "INFLUENCE"], ["MPTP", "C57BL/6 mice", "ADMINISTERED"], ["gut microbiota", "dysregulated brain transcript response", "IS LINKED TO"], ["PD", "Coprococcus_2", "CHANGE ABUNDANCE"], ["gut microbiome", "PD", "IS LINKED TO"], ["microbiota", "Dysbiosis", "AFFECT"], ["Bifidobacterium animalis subsp. lactis XLTG11", "functional constipation", "INFLUENCE"], ["Ferulic acid", "oxidative stress", "INFLUENCE"], ["SCFA", "Ghanaian population", "LOCATED IN"], ["gut bacteria", "POD and non-POD mice", "LOCATED IN"], ["antibiotics", "depressive symptoms", "CHANGE EFFECT"], ["healthy young male university students", "TSST", "USED BY"], ["probiotics", "major depressive disorder", "INFLUENCE"], ["Alzheimer's and Parkinson's disease", "neurological diseases", "IS A"], ["NDDs", "multifactorial disorders", "IS A"], ["sugar", "gut", "LOCATED IN"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "motor symptoms", "INFLUENCE"], ["COVID-19", "Mitochondria", "INTERACT"], ["neuroinflammation", "brain", "STRIKE"], ["IBD", "IBD and non-IBD patients", "TARGET"], ["chronic alcohol overconsumption", "patients", "TARGET"], ["depression", "participants", "TARGET"], ["Huntington's disease", "Huntington's disease gene expansion carriers", "TARGET"], ["PD", "PD subjects", "TARGET"], ["gut microbiota", "resilient rats", "LOCATED IN"], ["KD", "motor dysfunction", "INFLUENCE"], ["E. coli", "metabolic syndrome", "INFLUENCE"], ["gut microbiota", "schizophrenia patients", "LOCATED IN"], ["Parkinson's disease", "chronic and progressive neurodegenerative disorder", "IS A"], ["GM", "household controls", "LOCATED IN"], ["dietary-derived SCFAs", "elderly individuals", "ADMINISTERED"], ["Parkinson's disease", "Prevalent neurological disorders", "IS A"], ["Fecal microbiota", "inflammation", "IS LINKED TO"], ["Mn", "Parkinson's disease", "INFLUENCE"], ["pentacyclic triterpene acid", "PD", "INFLUENCE"], ["probiotics", "NCDs", "INFLUENCE"], ["Gut Microbes", "Neuropathology", "USED BY"], ["early-stage PD mice", "mass spectrometry-based metabolomics", "USED BY"], ["dysregulation of", "CNS disorders", "AFFECT"], ["FLZ", "systemic inflammation", "CHANGE EFFECT"], ["microbial metabolites", "Parkinson's disease", "INFLUENCE"], ["microbiota dysregulation", "Parkinson's", "AFFECT"], ["gut microbes", "NDs", "IS LINKED TO"], ["sEH", "prefrontal cortex", "LOCATED IN"], ["GI dysfunction", "neurodegeneration", "AFFECT"], ["gut microbiota", "cognitive decline", "IS LINKED TO"], ["Autism Spectrum Disorder", "neurodevelopmental disorder", "IS A"], ["Microbiota-immune alterations", "adolescents", "TARGET"], ["Gut Microbiota", "neurological conditions", "IS LINKED TO"], ["neurodegeneration", "age-associated diseases", "IS A"], ["inflammatory cytokines", "colon tissue", "LOCATED IN"], ["Combined oral contraceptives", "females", "ADMINISTERED"], ["microbes", "MDMA + CRS group", "LOCATED IN"], ["inflammatory bowel diseases", "PD", "AFFECT"], ["gut microbiota", "Parkinson's disease patients", "LOCATED IN"], ["SCZ", "neurodevelopmental disorder", "IS A"], ["Parkinson's disease", "complex neurodegenerative disease", "IS A"], ["postbiotics", "gut microbiota", "IMPACT"], ["major depressive disorder", "patients", "TARGET"], ["patients", "post-mortem brain biopsy", "USED BY"], ["Neuroinflammation", "neurological disorders", "AFFECT"], ["intestinal microbiota", "autoimmune processes", "IS LINKED TO"], ["Semaglutide", "Anxious and Depressive-Like Behaviors", "CHANGE EFFECT"], ["Stress", "mania", "AFFECT"], ["baicalein", "neurodegenerative diseases", "INFLUENCE"], ["individuals", "amplicon sequencing", "USED BY"], ["skeletal muscle", "germ-free mice", "LOCATED IN"], ["compulsivity", "emotional and social maladjustment", "AFFECT"], ["neuropathic pain", "rodents", "TARGET"], ["gut microbiome", "substance-related disorders", "IS LINKED TO"], ["Pharmabiotics", "oxidative stress", "INFLUENCE"], ["bioactive food compounds", "mood disorders", "INFLUENCE"], ["gut dysbiosis", "HD", "AFFECT"], ["dysbiosis", "gut microbiota", "CHANGE ABUNDANCE"], ["iron", "brain", "LOCATED IN"], ["Short-chain Fatty Acids", "Parkinson's Disease", "INFLUENCE"], ["bodily pain", "M-63 per-protocol population", "TARGET"], ["propionate", "Parkinson's", "INFLUENCE"], ["\u03b1-synuclein fibrils", "brain", "LOCATED IN"], ["Parkinson's disease", "chronic inflammatory diseases", "IS A"], ["functional constipation", "children", "TARGET"], ["short chain fatty acids", "obesity", "INFLUENCE"], ["gut microbiota", "CNS disorders", "IS LINKED TO"], ["Changes", "Parkinson's Disease", "AFFECT"], ["therapeutic medications", "depression", "CHANGE EFFECT"], ["gut microbiome", "Parkinson's disease (PD) patients", "LOCATED IN"], ["fecal microbiota", "SPF mice", "LOCATED IN"], ["dysbiosis", "impaired cognitive functions", "AFFECT"], ["age-matched control group", "16S rRNA gene sequencing", "USED BY"], ["IBD", "psychiatric disorders", "AFFECT"], ["\u03b2-lactamase inhibitors", "severe infection-related pathologies", "CHANGE EFFECT"], ["Rubusoside", "Parkinson's disease", "INFLUENCE"], ["casein", "intestinal microbiota", "IMPACT"], ["fish", "mood disorders", "INFLUENCE"], ["Nichi Glucan", "gut microbiota", "IMPACT"], ["depressive symptoms", "PD patients", "TARGET"], ["microbes", "CNS illnesses", "IS LINKED TO"], ["depression", "neurological diseases", "IS A"], ["gut microbiota", "recipient animals", "LOCATED IN"], ["intestinal dysbiosis", "multiple sclerosis", "AFFECT"], ["Non-motor symptoms", "Parkinson's disease", "AFFECT"], ["Parkinson's", "neurodegenerative disorders", "IS A"], ["fecal microbiota", "first-episode, drug-naive OCD patients", "LOCATED IN"], ["PD", "Ruminococcus", "CHANGE ABUNDANCE"], ["gut microbiota", "neurological disorders", "IS LINKED TO"], ["bacitracin", "chicken gut microbiota", "IMPACT"], ["Neurodegenerative Disorders", "Patients", "TARGET"], ["Parkinson's disease", "age-associated neurodegenerative diseases", "IS A"], ["depression", "pregnant", "TARGET"], ["fecal microbiota", "anxiety- and depression-like behaviors", "IS LINKED TO"], ["PD", "Firmicutes", "CHANGE ABUNDANCE"], ["bacterial dysbiosis", "PD patients", "TARGET"], ["osteoporosis", "extra-intestinal diseases", "IS A"], ["PD", "bradykinesia", "AFFECT"], ["gut", "Parkinson's disease", "AFFECT"], ["Systemic inflammation", "IBDs", "AFFECT"], ["Huntington's disease", "NDDs", "IS A"], ["Puerarin", "oxidative stress", "INFLUENCE"], ["human GM", "pancreatic cancer", "IS LINKED TO"], ["Bifidobacterium", "wild-type mice", "LOCATED IN"], ["Parkinson's disease", "elderly population", "TARGET"], ["maternal infection", "offspring", "TARGET"], ["Microbiome", "Neurodegenerative and Psychiatric Disorders", "IS LINKED TO"], ["healthy controls", "Real-time quantitative PCR", "USED BY"], ["gut microbiota", "Multiple Sclerosis", "IS LINKED TO"], ["Bone fragility", "poor quality of life", "AFFECT"], ["SNI rats", "sucrose preference test", "USED BY"], ["copper", "Alzheimer's disease", "INFLUENCE"], ["Breast cancer", "patients", "TARGET"], ["PD", "seniors", "TARGET"], ["GABA", "attention deficit hyperactivity disorder", "INFLUENCE"], ["PDD", "iron", "INTERACT"], ["Gastrointestinal Dysbiosis", "Parkinson's Disease", "AFFECT"], ["human GM", "MCI", "IS LINKED TO"], ["metals", "cognitive decline", "INFLUENCE"], ["Probiotics", "Endocrine-Disrupting Chemical-Induced Health Risks", "INFLUENCE"], ["probiotics", "mental disorders", "INFLUENCE"], ["human microbiota", "neuropsychiatric disorders", "IS LINKED TO"], ["NDDs", "Huntington's disease", "AFFECT"], ["NPDs", "elderly people", "TARGET"], ["B-vitamins", "bipolar disorder", "INFLUENCE"], ["dioscin", "MPTP-induced gut dysbiosis", "INFLUENCE"], ["ALS", "gut microbiota", "CHANGE ABUNDANCE"], ["MPTP-induced dopaminergic neurotoxicity", "brain", "STRIKE"], ["diet", "mood disorders", "INFLUENCE"], ["Human microbiota", "neuroinflammation", "IS LINKED TO"], ["Gut microbiota-derived propionate", "Parkinson's disease", "INFLUENCE"], ["violence", "schizophrenia patients", "TARGET"], ["(R)-ketamine", "Ruminococcaceae", "IMPACT"], ["SCFAs", "neuropsychiatric disorders", "INFLUENCE"], ["Multidrug-resistant (MDR) superbugs", "severe infection-related pathologies", "INFLUENCE"], ["gut dysbiosis", "IBS", "AFFECT"], ["controls", "DNA methylation analysis", "USED BY"], ["ketamine", "MDD", "CHANGE EFFECT"], ["diabetes", "HD subjects", "TARGET"], ["midgut microbiota", "8-9 days old Pink1<sup>B9</sup> mutant flies", "LOCATED IN"], ["chronic social defeat stress", "mice", "TARGET"], ["autism spectrum disorder", "children", "TARGET"], ["mild AD", "participants", "TARGET"], ["gut microbiota", "ADHD", "IS LINKED TO"], ["Altered Gut-Brain Talk", "Parkinson's Disease", "AFFECT"], ["gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["healthy controls", "network-based functional connectivity (FC), grey matter volume (GMV) analyses", "USED BY"], ["gut microbiome", "neurotoxicity", "IS LINKED TO"], ["impulsive and violent behavior", "humans", "TARGET"], ["3,4-methylenedioxymethamphetamine", "chronic social defeat stress", "CHANGE EFFECT"], ["gut microbiome", "16S rRNA gene-sequencing analysis", "USED BY"], ["VD supplementation", "gut microbiota", "IMPACT"], ["gut biotics", "mental health disorders", "INFLUENCE"], ["cognitive impairment", "people living with", "TARGET"], ["TRH and TRH-like peptides", "brain", "LOCATED IN"], ["alterations in gut microbiota composition", "AD", "AFFECT"], ["ROS", "neurotoxicity", "INFLUENCE"], ["initial dysregulation", "Parkinson's disease", "AFFECT"], ["saline", "mice", "ADMINISTERED"], ["cafestol", "intestinal inflammation", "INFLUENCE"], ["Psychobiotics", "commensal gut bacteria", "IMPACT"], ["sucrose", "Mice", "ADMINISTERED"], ["colorectal cancer", "primary tumor locations", "STRIKE"], ["dysbiosis", "Alzheimer's", "AFFECT"], ["PD", "recipient mice", "TARGET"], ["acetoacetate", "glucose deficiency", "INFLUENCE"], ["depressive disorders", "disability", "AFFECT"], ["Probiotic Therapy", "Post-Infectious Fatigue", "INFLUENCE"], ["schizophrenia", "brain-related diseases", "IS A"], ["Huntington's disease", "cognitive and motor deficits", "IS A"], ["LPS endotoxins", "gut", "LOCATED IN"], ["intestinal microbiota", "Alzheimer's", "IS LINKED TO"], ["gut microbiome", "side effects", "IS LINKED TO"], ["IF-elevated sarcosine", "cognitive decline", "INFLUENCE"], ["Sodium", "Parkinson's disease", "INFLUENCE"], ["chronic stress", "depression", "AFFECT"], ["carnitine", "protein misfolding", "INFLUENCE"], ["Gut Microbiota", "Coronavirus Disease 2019", "IS LINKED TO"], ["intestinal microbiota", "directDIA", "USED BY"], ["inflammatory gastrointestinal diseases", "patients", "TARGET"], ["fermented foods", "gut", "IMPACT"], ["intestinal lesions", "human patients", "TARGET"], ["dysbiosis", "PD patients", "TARGET"], ["A1", "psychological distress", "INFLUENCE"], ["skin", "IMQ-treated mice", "LOCATED IN"], ["microbiomes", "IBD", "IS LINKED TO"], ["MDD", "treatment-resistant patients", "TARGET"], ["Fecal Microbiota", "Methamphetamine Use Disorder", "IS LINKED TO"], ["Gut microbiota", "vascular dementia", "IS LINKED TO"], ["Migraine", "complex, chronic, and debilitating multifactorial disorder", "IS A"], ["pro- and anti-inflammatory cytokines", "behavioral symptoms", "INFLUENCE"], ["MPTP-Induced Parkinson's Disease", "Mice", "TARGET"], ["healthy subjects", "Voxel-based morphometry", "USED BY"], ["metabolites", "PD", "IS LINKED TO"], ["probiotics", "PD", "INFLUENCE"], ["ACEs", "gut microbiota", "CHANGE ABUNDANCE"], ["dioscin", "oxidative stress", "INFLUENCE"], ["Internalizing behaviors", "isobutyrate", "INTERACT"], ["healthy control", "16S rRNA sequencing", "USED BY"], ["inflammatory bowel disease", "inflammatory diseases", "IS A"], ["gut microbiome dysregulation", "depression", "AFFECT"], ["FAE-producing gut microbiota", "Alzheimer's", "IS LINKED TO"], ["ADHD", "Gracilibacter", "CHANGE ABUNDANCE"], ["PD", "non-motor symptoms", "AFFECT"], ["GLP-1 (Glucagon-like Peptide-1) analogs", "neurological diseases", "INFLUENCE"], ["probiotics", "OCD", "INFLUENCE"], ["AD", "vulnerable persons", "TARGET"], ["(R)-ketamine", "humans", "ADMINISTERED"], ["arketamine", "phencyclidine-induced cognitive deficits", "CHANGE EFFECT"], ["motor and gastrointestinal dysfunctions", "PD", "AFFECT"], ["MCT-KD", "MPTP-induced damage", "INFLUENCE"], ["human-targeted drugs", "gut microbiome", "IMPACT"], ["gut microbiota", "drug addiction", "IS LINKED TO"], ["gut microbiota", "Autism Spectrum Disorder", "IS LINKED TO"], ["BAPs", "gut microbiota", "IMPACT"], ["\u03b1-Synuclein pathology", "GI tract", "STRIKE"], ["gastrointestinal microbiota", "PD", "IS LINKED TO"], ["MCT-KD", "antioxidant stress", "INFLUENCE"], ["Cu", "mild cognitive impairment", "INFLUENCE"], ["HI/R injury", "Mice", "TARGET"], ["Rubusoside", "Rubus chingii var. suavissimus (S.K.Lee) L.T.Lu", "IMPACT"], ["ADHD", "Children", "TARGET"], ["gut-brain axis microbiome", "mental disorders", "IS LINKED TO"], ["PD", "complex neurodegenerative disorder", "IS A"], ["polyunsaturated fatty acids", "gut microbiome", "IMPACT"], ["gut microbiota", "mood disorders", "IS LINKED TO"], ["Dysbiosis", "obesity", "AFFECT"], ["<i>P. mirabilis</i> urease", "PD", "INFLUENCE"], ["supplementation", "gut microbiome", "IMPACT"], ["mood disorders", "dyslipidemia", "AFFECT"], ["MPTP", "mice", "ADMINISTERED"], ["gut microbiota", "shotgun metagenomics", "USED BY"], ["gut microbiota", "violence", "IS LINKED TO"], ["Parkinson's disease", "individuals", "TARGET"], ["Akkermansia</i>", "inflammatory bowel disease", "INFLUENCE"], ["probiotics", "gastro-intestinal disorders", "INFLUENCE"], ["gut microbiota", "mouse model", "LOCATED IN"], ["Dysbiosis", "neurodegeneration", "AFFECT"], ["gut microbiota", "central nervous system disorders", "IS LINKED TO"], ["Parkinson's disease", "psychiatric, neurodevelopmental, functional, and neurodegenerative diseases", "IS A"], ["impulsive and/or violent behavior", "adults", "TARGET"], ["neurodegeneration", "A53T mice", "TARGET"], ["intestinal tissues", "PD mice", "LOCATED IN"], ["mice", "low-temperature extraction", "USED BY"], ["Oral berberine", "Parkinson's disease", "INFLUENCE"], ["Purified proteins", "mice", "LOCATED IN"], ["PD", "Escherichia/Shigella", "CHANGE ABUNDANCE"], ["(<i>S</i>)-ketamine", "CCI mice", "ADMINISTERED"], ["Inflammatory Bowel Disease", "People", "TARGET"], ["IBD", "neurodegeneration", "AFFECT"], ["gut microbes", "inflammatory and autoimmune diseases", "INFLUENCE"], ["PDD", "Mn", "INTERACT"], ["aluminium", "frontotemporal dementia", "INFLUENCE"], ["microbiome dysbiosis", "PD", "AFFECT"], ["gut microbiota", "THP withdrawal", "IS LINKED TO"], ["Gut microbiome", "subjective cognitive decline", "IS LINKED TO"], ["gut dysbiosis", "Parkinson's disease", "TARGET"], ["VAP", "neurobehavioral deficits", "INFLUENCE"], ["WEG", "intestinal disorders", "INFLUENCE"], ["casein", "intestinal inflammation", "INFLUENCE"], ["Idiopathic Rapid Eye Movement Sleep Behavior Disorder", "PD", "AFFECT"], ["gut microbiome", "NCDs", "IS LINKED TO"], ["gut microbiota", "16S rRNA gene sequencing", "USED BY"], ["gut microbiome dysbiosis", "PD", "AFFECT"], ["Beta 1,3-1,6 Glucans", "Neurodegenerative Diseases", "INFLUENCE"], ["dysbiosis", "CNS illnesses", "AFFECT"], ["Gut Microbiota", "Bipolar Disorder", "IS LINKED TO"], ["Parkinson's disease", "progressive neurological disorder", "IS A"], ["phylum Actinobacteria", "extrahepatic CCA", "INFLUENCE"], ["antibiotics", "gut microbiota", "IMPACT"], ["stress-induced anxiety-like behavior", "female", "TARGET"], ["calprotectin", "depression", "INFLUENCE"], ["PTSD", "mental health disorder", "IS A"], ["12-year-old children", "quantitative PCR", "USED BY"], ["PD", "dopaminergic neuron loss", "AFFECT"], ["Alzheimer's disease", "brain disorders", "IS A"], ["IL-6", "saline-treated mice", "LOCATED IN"], ["organophosphates", "PD", "INFLUENCE"], ["prebiotic", "patients", "ADMINISTERED"], ["Bacteroidota", "acute mice", "LOCATED IN"], ["inflammation", "depressed patients", "TARGET"], ["cognitive and physical disabilities", "people", "TARGET"], ["dietary polysaccharides", "neurological dysfunctions", "INFLUENCE"], ["gut microbiota", "schizophrenia-like behaviors", "IS LINKED TO"], ["SA", "OCD-colonized mice", "LOCATED IN"], ["microbiota disturbances", "anxiety", "AFFECT"], ["Dysbiosis", "small intestine bacterial overgrowth", "AFFECT"], ["modern therapeutic drugs", "psychosis", "CHANGE EFFECT"], ["HFD", "type 2 diabetes", "INFLUENCE"], ["\u03b1-Synuclein pathology", "vagus nerve", "STRIKE"], ["PQ", "PD", "INFLUENCE"], ["involuntary muscle contractions", "Dystonia", "AFFECT"], ["HAND", "people living with", "TARGET"], ["Gut microbiota", "opioid use disorders", "IS LINKED TO"], ["antipsychotics", "gut microbiota", "IMPACT"], ["neurodegeneration", "Familial Dysautonomia", "AFFECT"], ["postbiotics", "neurodegenerative diseases", "INFLUENCE"], ["gut microbiota", "body", "LOCATED IN"], ["gut microbial dysbiosis", "Parkinson's disease rats", "TARGET"], ["OPs", "PD", "INFLUENCE"], ["High Fat Diet", "type 2 diabetes", "INFLUENCE"], ["VLCKD", "heart failure", "INFLUENCE"], ["sarecycline", "infections", "CHANGE EFFECT"], ["PD", "nigrostriatal and gastrointestinal tracts", "STRIKE"], ["neuronal loss", "Parkinson's disease", "AFFECT"], ["Gut Dysbiosis", "Parkinson's Disease", "AFFECT"], ["immune dysregulation", "gut", "STRIKE"], ["Altered Gut Microbiota", "Neurological Diseases", "IS LINKED TO"], ["gut microbiota", "postoperative delirium", "IS LINKED TO"], ["vancomycin", "pro-inflammatory", "INTERACT"], ["gut microbiota", "non-motor symptoms", "IS LINKED TO"], ["Alzheimer's", "neurological disorders", "IS A"], ["Alzheimer's disease", "older adults", "TARGET"], ["Huntington's diseases", "neurodegenerative disorders", "IS A"], ["gut microbiota", "Alzheimer's and Parkinson's diseases", "IS LINKED TO"], ["fluoroquinolones", "psychotic episodes", "CHANGE EFFECT"], ["Parkinson's Disease", "progressive neurodegenerative disorder", "IS A"], ["Environmental neurotoxicants", "Parkinson's disease", "INFLUENCE"], ["PD patients", "metagenomic sequencing", "USED BY"], ["PD patients", "two-stage metagenome-wide association strategy", "USED BY"], ["females", "fMRI", "USED BY"], ["Alzheimer's disease", "neurological conditions", "IS A"], ["bacteria", "GBA disorders", "INFLUENCE"], ["Gastrointestinal Issues", "Anxiety", "AFFECT"], ["GI symptoms", "neurodegenerative diseases", "AFFECT"], ["brain-gut-axis (BGA) dysregulation", "PD", "AFFECT"], ["synbiotics", "gut microbiota", "IMPACT"], ["Al", "frontotemporal dementia", "INFLUENCE"], ["nutraceuticals", "gut microbiota", "IMPACT"], ["gut microbiota", "geriatric syndrome-associated illnesses", "IS LINKED TO"], ["melatonin", "Mn-induced neurogenesis impairment", "INFLUENCE"], ["patients", "double-blind, placebo-controlled trial", "USED BY"], ["trimethylamine N-oxide", "Parkinson's disease", "INFLUENCE"], ["dysbiosis", "pro-inflammatory conditions", "AFFECT"], ["gut microbiota dysbiosis", "neurodegenerative disease", "AFFECT"], ["Inflammatory Bowel Diseases", "Neurodegenerative Diseases", "AFFECT"], ["Casein", "Dopaminergic Nerve Injury", "INFLUENCE"], ["gut microbiota dysbiosis", "mental disorders", "AFFECT"], ["CRS", "mice", "TARGET"], ["N-acetyl-L-leucine", "neuroinflammation", "INFLUENCE"], ["GR 125487", "MPTP-induced motor bradykinesia", "CHANGE EFFECT"], ["PD", "early-stage PD mice", "TARGET"], ["Inflammation", "Autism Spectrum Disorders", "AFFECT"], ["Parkinson's", "inflammatory bowel", "AFFECT"], ["gastrointestinal microbiome", "functional bowel disease", "IS LINKED TO"], ["intestine", "mice", "LOCATED IN"], ["Astragalus polysaccharide", "intestinal inflammation", "INFLUENCE"], ["fecal microbiota", "inflammation and neurodegeneration", "IS LINKED TO"], ["\u03b1-Synuclein pathology", "gut", "STRIKE"], ["culprit proteins", "Huntington's", "INFLUENCE"], ["Fecal microbiota", "na\u00efve animals", "LOCATED IN"], ["autism", "host brain disorders", "IS A"], ["intestinal bacterial imbalance", "Alzheimer's and Parkinson's diseases", "AFFECT"], ["METH", "mental disorders", "CHANGE EFFECT"], ["acetate", "neuroinflammation", "INFLUENCE"], ["Gemmiger", "lipids", "INTERACT"], ["Dietary fiber", "Japanese workers", "ADMINISTERED"], ["Synbiotics", "inflammation", "INFLUENCE"], ["antibiotic rifaximin", "hepatic encephalopathy", "CHANGE EFFECT"], ["thermal hyperalgesia", "healthy naive mice", "TARGET"], ["gut microbes", "mood disorders", "IS LINKED TO"], ["calprotectin", "gut barrier injury", "INFLUENCE"], ["Gut Microbiota", "Neurodegenerative Diseases", "IS LINKED TO"], ["gut microbiota", "gut-brain", "LOCATED IN"], ["polyphenols", "GM", "IMPACT"], ["mitochondrial dysfunction", "PD patients", "TARGET"], ["abnormal", "Inflammatory bowel diseases", "AFFECT"], ["spatial working memory impairment", "subdiaphragmatic vagus nerve", "STRIKE"], ["PD", "RBD patients", "TARGET"], ["IBD", "patients", "TARGET"], ["Allantoin", "inflammation", "INFLUENCE"], ["Mn", "serum metabolic disorder", "AFFECT"], ["PD", "rigidity", "AFFECT"], ["nutrients", "mood disorders", "INFLUENCE"], ["Manganese", "gastrointestinal dysfunction", "INFLUENCE"], ["Constipation", "Parkinson's Disease", "AFFECT"], ["MedDiet", "age-related diseases", "INFLUENCE"], ["Allium sativum", "ulcerative colitis", "INFLUENCE"], ["Fecal microbiota", "12-year-old children", "LOCATED IN"], ["human microbiome", "neurodegenerative diseases", "IS LINKED TO"], ["gut microbes", "neurological disorders", "IS LINKED TO"], ["iRBD", "MSA", "AFFECT"], ["Parkinson's disease", "Parkinson's disease rats", "TARGET"], ["VAP", "cell damage", "INFLUENCE"], ["vitamin D deficiency", "obesity", "AFFECT"], ["Rh4", "hippocampal neuronal apoptosis", "CHANGE EFFECT"], ["microbiome", "neurodegenerative diseases", "IS LINKED TO"], ["PD", "progressive neurodegenerative disorder", "IS A"], ["Intestinal Microenvironment", "Depressive-Like Behavior", "IS LINKED TO"], ["COVID-19 infection", "patients", "TARGET"], ["PD", "\u03b1-syn", "INTERACT"], ["gut microbiota", "Mental disorders", "IS LINKED TO"], ["spatial working memory impairment", "complete Freund's adjuvant mice", "TARGET"], ["MDMA", "depression", "CHANGE EFFECT"], ["LcS-fermented milk", "Patients", "ADMINISTERED"], ["levodopa", "Parkinson's disease", "CHANGE EFFECT"], ["FGF21", "behavioral impairment", "INFLUENCE"], ["gut microbes", "neural developmental disorders", "IS LINKED TO"], ["motor dysfunction", "Parkinson's disease", "AFFECT"], ["mitochondrial dysfunction", "neuronal death", "AFFECT"], ["indoles", "anxiety", "INFLUENCE"], ["PDD", "zinc", "INTERACT"], ["psychobiotics", "irritable bowel syndrome", "INFLUENCE"], ["gut microbiome", "neurological diseases", "IS LINKED TO"], ["antibiotics", "neurological diseases", "CHANGE EFFECT"], ["unintentional weight loss", "patients", "TARGET"], ["gut microbes", "Parkinson's disease pathogenesis", "IS LINKED TO"], ["PD", "GI disorders", "AFFECT"], ["VD", "depression", "INFLUENCE"], ["Bacteroides eggerthii", "ADHD", "INFLUENCE"], ["butyrate triglyceride", "motor symptoms", "INFLUENCE"], ["gut microbiome", "disease", "IS LINKED TO"], ["butyric acid", "MPTP + H-BCAA mice", "LOCATED IN"], ["probiotic", "stress", "INFLUENCE"], ["Bifidobacterium", "chronic social defeat stress", "INFLUENCE"], ["PD", "population", "TARGET"], ["PD", "Parkinson's disease mice models", "TARGET"], ["Parkinson's disease dementia", "Fe", "INTERACT"], ["epigallocatechin-3-gallate", "PD", "INFLUENCE"], ["Cognitive decline", "physiological decline", "AFFECT"], ["K. pastoris KM71H", "antibiotic-treated mice", "ADMINISTERED"], ["anxiety", "people", "TARGET"], ["anorexia nervosa", "adolescents", "TARGET"], ["intestinal and oral microbiota", "16S rRNA gene sequencing", "USED BY"], ["3,4-Methylenedioxymethamphetamine", "MDMA", "INTERACT"], ["trimethylamine N-oxide", "neuroinflammation", "INFLUENCE"], ["alterations in the enteric nervous system", "PD", "AFFECT"], ["cheese", "PD", "INFLUENCE"], ["liver disease", "Individuals", "TARGET"], ["MS", "Butyricicoccus", "CHANGE ABUNDANCE"], ["GM", "controls", "LOCATED IN"], ["gastrointestinal symptoms", "gut microbiome", "CHANGE ABUNDANCE"], ["\u03b1-syn transgenic mice", "fecal metabolomics", "USED BY"], ["IBS", "endometriosis patients", "TARGET"], ["polycyclic aromatic hydrocarbons", "Parkinson's disease", "INFLUENCE"], ["oxidative stress", "Alzheimer's disease", "AFFECT"], ["beneficial microbial metabolites", "Dysbiosis", "INFLUENCE"], ["Parkinson's disease", "MPTP-induced Parkinson's disease mice", "TARGET"], ["psychedelics", "autoimmunity", "CHANGE EFFECT"], ["Gut microbiota", "inflammation status", "IS LINKED TO"], ["psychobiotic supplementation", "neurodegenerative diseases", "INFLUENCE"], ["MS", "patients", "TARGET"], ["Central inflammation", "anxiety", "AFFECT"], ["psycho-physiological deficits", "young survivors", "TARGET"], ["Gut microbiota-derived vitamins", "disease", "INFLUENCE"], ["Parkinson's disease", "patients", "TARGET"], ["fiber supplementation", "depression", "INFLUENCE"], ["participants", "Real-time quantitative PCR", "USED BY"], ["disorder of", "PD", "AFFECT"], ["post-infectious fatigue", "patients", "TARGET"], ["Parkinson's Disease", "PD mice", "TARGET"], ["Rubusoside", "gut microbiota", "IMPACT"], ["Schizophrenia", "neurodevelopmental disorder", "IS A"], ["homovanillic acid", "Roseburia intestinalis", "IMPACT"], ["gut microbiota", "autism spectrum disorders", "IS LINKED TO"], ["probiotics", "neurological diseases", "INFLUENCE"], ["intestinal dysbiosis", "Parkinson's patients", "TARGET"], ["protein", "gut microbiota", "IMPACT"], ["prebiotics", "gut microbiome", "IMPACT"], ["gut microbiota", "\u03b1-synuclein-related pathology", "IS LINKED TO"], ["Gut dysbiosis", "AD", "AFFECT"], ["gut microbiota dysbiosis", "dementia", "AFFECT"], ["gut microbiota", "inflammatory bowel diseases", "IS LINKED TO"], ["Dietary fibers", "anxiety", "INFLUENCE"], ["HCs", "metagenomic sequencing", "USED BY"], ["Nichi Glucan", "Lactobacillus", "IMPACT"], ["White matter injury", "neurological disorders", "AFFECT"], ["probiotic", "neurodegenerative processes", "INFLUENCE"], ["antidepressants", "Coprococcus spp.", "IMPACT"], ["low molecular weight compounds", "depression", "INFLUENCE"], ["natural compounds", "NDDs", "INFLUENCE"], ["Gut Microbiota Alterations", "Rapid Eye Movement Sleep Behavior Disorder", "AFFECT"], ["KBs", "extrahepatic tissues", "LOCATED IN"], ["NDDs", "multiple sclerosis", "AFFECT"], ["VD", "psychiatric disorders", "INFLUENCE"], ["gut dysbiosis", "neurological dysfunction", "AFFECT"], ["Nutraceuticals", "Gut Microbiota", "IMPACT"], ["acute stress", "Young adults", "TARGET"], ["IBD", "human subjects", "TARGET"], ["aggregated proteins", "pathological changes", "INFLUENCE"], ["gut microbiota", "neurodevelopmental disorders", "IS LINKED TO"], ["levodopa", "gut bacterial antibiotic resistance", "CHANGE EFFECT"], ["endometriosis", "gut microbiota", "CHANGE ABUNDANCE"], ["dairy products", "gut microbiota", "IMPACT"], ["HD", "gastrointestinal dysfunction", "AFFECT"], ["microbiota abundance", "Parkinson's disease", "IS LINKED TO"], ["Pesticides", "Parkinson's Disease", "INFLUENCE"], ["alpha-lactalbumin", "mental disorders", "INFLUENCE"], ["COVID-19 infection", "AIS patients", "TARGET"], ["metabolites", "mental disorders", "INFLUENCE"], ["suicide thoughts", "U.S. adults", "TARGET"], ["dietary fiber", "neuroinflammation", "INFLUENCE"], ["psychiatric disorders", "Individuals", "TARGET"], ["ELS", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbes", "Alzheimer's disease", "IS LINKED TO"], ["Casein", "Intestinal Inflammation", "INFLUENCE"], ["mental health problems", "preschool children", "TARGET"], ["gut microbiome", "males", "LOCATED IN"], ["oral microbiome", "depression", "IS LINKED TO"], ["GABA", "depression", "INFLUENCE"], ["gut microbiota", "preschool-aged children", "LOCATED IN"], ["Rk3", "intestinal barrier damage", "INFLUENCE"], ["GI microbiota", "mood disorders", "IS LINKED TO"], ["alpha-synuclein", "Parkinson's Disease", "INFLUENCE"], ["diet", "Male mice", "ADMINISTERED"], ["Parkinson's Disease", "Mice", "TARGET"], ["dysbiosis", "psychiatric disorders", "AFFECT"], ["gastrointestinal symptoms", "Parkinson's disease", "AFFECT"], ["neuroendocrine", "AD", "INFLUENCE"], ["proteins", "PD", "INFLUENCE"], ["fecal microbiota", "SCZ patients", "LOCATED IN"], ["impaired immune functions", "gut microbiota", "CHANGE ABUNDANCE"], ["sugar", "inflammatory diseases", "INFLUENCE"], ["healthy young", "shotgun sequencing", "USED BY"], ["Alcohol use disorder", "individuals", "TARGET"], ["Methamphetamine", "depression", "CHANGE EFFECT"], ["gut microbiome (GM) dysbiosis", "neurodegenerative disorders", "AFFECT"], ["Melatonin", "manganese-induced neural damage", "INFLUENCE"], ["EC-12 supplementation", "Male mice", "ADMINISTERED"], ["psychiatric subjects", "Quantitative PCR", "USED BY"], ["AKK", "depressive-like behavior", "INFLUENCE"], ["PD", "PD mice", "TARGET"], ["Impulsivity", "psychiatric disorders", "AFFECT"], ["AD", "older population", "TARGET"], ["Human Gut Microbiota", "Depression", "IS LINKED TO"], ["BPSD", "MCI", "AFFECT"], ["Intestinal dysbiosis", "neurodevelopmental and neurological disorders", "AFFECT"], ["dysbiosis", "neuro-inflammatory processes", "AFFECT"], ["bipolar patients", "Real-time quantitative PCR", "USED BY"], ["Parkinson's disease", "neurodegenerative diseases", "IS A"], ["indoles", "depression", "INFLUENCE"], ["BEVs", "neuropathological conditions", "INFLUENCE"], ["prebiotics", "CRS-induced depression", "INFLUENCE"], ["PD", "striatal region", "STRIKE"], ["Cu", "Alzheimer's disease", "INFLUENCE"], ["V. parvula", "neurodegeneration", "INFLUENCE"], ["THP", "heightened anxiety", "CHANGE EFFECT"], ["adult patients", "anthropometrics", "USED BY"], ["neuropsychiatric disorders", "patients", "TARGET"], ["curcumin", "Parkinson's disease", "INFLUENCE"], ["MPTP", "TLR2 deficiency", "INFLUENCE"], ["stable PD", "patients", "TARGET"], ["microbiomes", "Parkinson's disease", "IS LINKED TO"], ["Gut Microbiota", "Parkinson Disease", "IS LINKED TO"], ["gut microbiota-derived metabolites", "Alzheimer's disease", "INFLUENCE"], ["AD", "neurodegenerative disorders", "IS A"], ["mitochondrial dysfunction", "cerebral ischemia", "AFFECT"], ["MPTP", "dopaminergic (DA) neuron death", "INFLUENCE"], ["gut microbiota", "motor complications", "IS LINKED TO"], ["Immune-related alterations", "PD", "AFFECT"], ["patients", "16S rRNA gene-sequencing analysis", "USED BY"], ["constipation", "people", "TARGET"], ["Gut microbiota-derived short-chain fatty acids", "methamphetamine-induced depression", "INFLUENCE"], ["Bacteroidales", "susceptible mice", "LOCATED IN"], ["neuronal degeneration", "Parkinson's disease", "AFFECT"], ["gut microbiome", "cytokine storm", "IS LINKED TO"], ["FLZ", "neuroinflammation", "CHANGE EFFECT"], ["amino acids", "toxic metabolites", "INTERACT"], ["antiepileptic drugs", "gut microbiota", "IMPACT"], ["gut microbiota", "circadian disruption", "IS LINKED TO"], ["infant gut microbiota", "IgE-mediated food allergy", "IS LINKED TO"], ["infections", "birds", "TARGET"], ["Fecal Short-Chain Fatty Acid Alterations", "Multiple System Atrophy", "INFLUENCE"], ["<sup>14</sup>C-Tyr", "brain", "LOCATED IN"], ["Gut microbiota", "16S rRNA tag sequencing", "USED BY"], ["Blautia", "PD", "INFLUENCE"], ["astrogliosis", "dentate gyrus region", "STRIKE"], ["Gut microbiome alterations", "Parkinson's diseases", "AFFECT"], ["particle matter", "gut microbiota", "IMPACT"], ["Autism spectrum disorder", "neurodevelopmental disorder", "IS A"], ["Gut Microbiome", "General Anxiety Disorder", "IS LINKED TO"], ["Indole", "autoimmune response", "INFLUENCE"], ["intestinal flora", "gut", "LOCATED IN"], ["PD non-motor symptoms", "PD group", "TARGET"], ["phencyclidine-induced cognitive deficits", "mice", "TARGET"], ["Bacterial extracellular vesicles", "depression/anxiety", "INFLUENCE"], ["PD", "gastrointestinal (GI) dysfunction", "IS A"], ["Neurodegenerative diseases", "multifactorial disorders", "IS A"], ["gastrointestinal system", "PD patients", "LOCATED IN"], ["exam-related stress", "Young adults", "TARGET"], ["rotenone-induced PD", "mice", "TARGET"], ["intestinal microflora", "healthy individuals", "LOCATED IN"], ["PD patient", "two-stage metagenome-wide association strategy", "USED BY"], ["HD", "depression", "AFFECT"], ["gut microbiota", "Fecal metabolomics", "USED BY"], ["Dysbiosis", "mental health disorders", "AFFECT"], ["gut microbes", "MS", "IS LINKED TO"], ["gut dysbiosis", "gut microbiome", "CHANGE ABUNDANCE"], ["gastrointestinal microbiome", "PD", "IS LINKED TO"], ["dysbiosis of", "PD", "AFFECT"], ["KBs", "brain damage", "INFLUENCE"], ["resveratrol-shaped microbiota", "resveratrol-treated PD mice", "LOCATED IN"], ["<i>L. plantarum</i> CCFM405", "BCAAs", "INTERACT"], ["diarrhea", "High-ACE individuals", "TARGET"], ["gut microbiota", "amyotrophic lateral sclerosis", "IS LINKED TO"], ["butyrate triglyceride", "PD", "INFLUENCE"], ["long sleepers", "Gut microbial composition analysis", "USED BY"], ["Gut Microbiota", "Impending Mental Health Issues", "IS LINKED TO"], ["semaglutide", "DM2-induced impairments", "CHANGE EFFECT"], ["primary immunodeficiency", "patients", "TARGET"], ["Central inflammation", "Alzheimer's disease", "AFFECT"], ["MPP<sup>+</sup>", "cell damage", "INFLUENCE"], ["gut microbiota", "gut frailty", "IS LINKED TO"], ["anxiety", "Central nervous system (CNS) disorders", "IS A"], ["Infections", "schizophrenia", "AFFECT"], ["inflammation", "rotenone-induced Parkinson's disease mice", "TARGET"], ["Berberine", "intestinal inflammation", "INFLUENCE"], ["circadian disruptions", "Mental illness", "AFFECT"], ["gut microbiome", "multiple sclerosis", "IS LINKED TO"], ["neuro-inflammation", "Parkinson's Disease", "AFFECT"], ["chronic pain", "mice", "TARGET"], ["prednisolone", "Male Wistar rats", "ADMINISTERED"], ["Prebiotics", "gut frailty", "INFLUENCE"], ["microbiota", "intestine", "LOCATED IN"], ["anxiety-like behavior", "Socially isolated mice", "TARGET"], ["\u03b2-lactamase inhibitors", "brain abscess", "CHANGE EFFECT"], ["GMn", "MPTP", "INTERACT"], ["Klebsiella", "LH susceptible rats", "LOCATED IN"], ["cytokines", "gut microbiota", "IMPACT"], ["microbiota", "elderly population", "LOCATED IN"], ["B-vitamins", "schizophrenia", "INFLUENCE"], ["PD", "wild-type mice", "TARGET"], ["Metabolic Perturbations", "Familial Dysautonomia Patients", "TARGET"], ["Alzheimer's disease", "Parkinson's disease", "AFFECT"], ["depression", "mental health problems", "IS A"], ["metabolites", "pain", "INFLUENCE"], ["psychological distress", "adults", "TARGET"], ["Oral berberine", "gut microbiota", "IMPACT"], ["MDD", "Sutterella", "CHANGE ABUNDANCE"], ["dysbiosis", "ED", "AFFECT"], ["synbiotics", "impulsivity", "INFLUENCE"], ["Lactobacillus reuteri", "depression", "INFLUENCE"], ["(R,S)-ketamine", "BD", "CHANGE EFFECT"], ["amyotrophic lateral sclerosis", "neurological diseases", "IS A"], ["microbiota", "stress", "IS LINKED TO"], ["neurotransmitters", "CNS disorders", "INFLUENCE"], ["Ru", "PD", "INFLUENCE"], ["taurine supplement", "MPTP-induced motor deficits", "INFLUENCE"], ["gut dysfunction", "gut wall", "STRIKE"], ["dysbiosis of maternal microflora", "affective behavioral syndromes", "AFFECT"], ["Neurodegenerative diseases", "neurological conditions", "IS A"], ["gut dysbiosis", "psychiatric disorders", "AFFECT"], ["SCFAs", "PD", "INFLUENCE"], ["Vitamin D deficiency", "poor mental health", "AFFECT"], ["Depression", "chronic liver disease", "AFFECT"], ["intestine", "G93A mice", "LOCATED IN"], ["metabolites", "health disorders", "INFLUENCE"], ["imbalance in gut microbiota composition", "Dysbiosis", "AFFECT"], ["deficits in sociability", "SPF mice", "TARGET"], ["striatum", "juvenile offspring", "LOCATED IN"], ["TNF-\u03b1", "substantia nigra", "LOCATED IN"], ["Gut microbiota-derived short-chain fatty acids", "depression", "INFLUENCE"], ["prebiotics", "depression", "INFLUENCE"], ["Resveratrol", "resveratrol-shaped microbiota", "IMPACT"], ["Alzheimer's disease", "mice", "TARGET"], ["cognitive decline", "5XFAD mice", "TARGET"], ["Gut microbiota", "dysbiosis", "IS LINKED TO"], ["\u03b1-syn", "Parkinson's disease", "INFLUENCE"], ["GMs", "inflammatory bowel disease", "INFLUENCE"], ["culprit proteins", "Parkinson's", "INFLUENCE"], ["gut microbes", "CNS disorders", "IS LINKED TO"], ["Parkinson's", "neurological diseases", "IS A"], ["White matter injury", "intracerebral hemorrhage (ICH) patients", "TARGET"], ["gut microbiota", "cognitive disturbances", "IS LINKED TO"], ["broad-spectrum or species-specific antibiotics", "severe infection-related pathologies", "CHANGE EFFECT"], ["probiotics", "multiple sclerosis", "INFLUENCE"], ["patients", "shotgun metagenomics sequencing", "USED BY"], ["motor deficits", "rotenone-induced mice", "TARGET"], ["gut microbiota", "recipient mice", "LOCATED IN"], ["dysbiosis", "autoimmune diseases", "AFFECT"], ["psychiatric symptoms", "AD", "AFFECT"], ["Major Depressive Disorder", "Patients", "TARGET"], ["bacterial overgrowth", "Parkinson's disease", "AFFECT"], ["Hepatocellular carcinoma", "liver cancers", "IS A"], ["synbiotics", "psychiatric diseases", "INFLUENCE"], ["chronic restrain stress", "mice", "TARGET"], ["PUFA", "gastrointestinal problems", "INFLUENCE"], ["emotional, psychological and neurological imbalances", "population", "TARGET"], ["intestinal microbiota", "irritable bowel syndrome", "IS LINKED TO"], ["L. plantarum SG5", "neuroinflammation", "INFLUENCE"], ["A\u03b2", "C57BL/6 mice", "LOCATED IN"], ["Endocrine-Disrupting Chemical-Induced Health Risks", "Pregnant Women", "TARGET"], ["Parkinson's disease", "\u03b1-syn transgenic mice", "TARGET"], ["PD", "people aged over 65 years", "TARGET"], ["gut bacteria", "Parkinson disease", "INFLUENCE"], ["intestinal microbial alteration", "underweight", "AFFECT"], ["probiotic mixture", "Lactiplantibacillus plantarum", "IMPACT"], ["PD patients", "shotgun metagenomic sequencing", "USED BY"], ["Pharmabiotics", "inflammatory processes", "INFLUENCE"], ["Gut", "PPD", "INFLUENCE"], ["neurotransmitters", "schizophrenia", "INFLUENCE"], ["dysbiosis", "neurodegeneration", "AFFECT"], ["Parkinson's disease", "control subjects", "TARGET"], ["Cytokines", "Gut microbiota", "IMPACT"], ["vegetables", "gut microbiota", "IMPACT"], ["semaglutide", "astrogliosis", "CHANGE EFFECT"], ["autism spectrum disorder", "offspring", "TARGET"], ["microbiotas", "PD patients", "LOCATED IN"], ["proteobiotics", "mental health disorders", "INFLUENCE"], ["sham, non-POD, and POD mice", "16S ribosomal RNA gene sequencing", "USED BY"], ["neurodegenerative diseases", "patients", "TARGET"], ["Gut microbiota", "healthy controls", "LOCATED IN"], ["AA-MF", "PKU patients", "ADMINISTERED"], ["PS128", "motor deficits", "INFLUENCE"], ["Coriobacteriales Incertae Sedis", "PD patients", "LOCATED IN"], ["Peripheral extracellular vesicles", "neurodegeneration", "INFLUENCE"], ["pesticides", "gut bacteria", "IMPACT"], ["motor dysfunction", "PD mice", "TARGET"], ["Anorexia nervosa", "psychiatric disorder", "IS A"], ["unhealthy diets", "death", "INFLUENCE"], ["Altered", "PD", "AFFECT"], ["BD", "depressed patients", "TARGET"], ["Inflammatory Bowel Disease", "IBD", "AFFECT"], ["healthy controls", "ELISA method", "USED BY"], ["gut microbiota", "mood and depressive disorders", "IS LINKED TO"], ["gut microbiota", "first-degree relatives of RBD", "LOCATED IN"], ["Obesity", "SCFA synthesizing bacteria", "CHANGE ABUNDANCE"], ["gut dysbiosis", "neurologic", "AFFECT"], ["depression", "patients", "TARGET"], ["coffee extracts", "cancer", "INFLUENCE"], ["irritable bowel syndrome", "victims", "TARGET"], ["HIV-associated neurocognitive disorder", "PLWH", "TARGET"], ["intestinal microbiota glucagon-like peptide 1", "cognitive disorders", "INFLUENCE"], ["gut microbiota", "ASD", "IS LINKED TO"], ["microbial dysbiosis", "intestinal inflammation", "AFFECT"], ["AD", "neurological and psychological disorders", "IS A"], ["deficits", "Autism Spectrum Disorder", "AFFECT"], ["nasal microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["Gastrointestinal disorders", "Lewy body diseases", "IS A"], ["Mn", "neurotoxicity", "INFLUENCE"], ["lactic acid", "gut microbiota", "PRODUCED BY"], ["Mn", "PD", "INFLUENCE"], ["neurotoxin", "gut microbiome", "IMPACT"], ["propionate", "dopaminergic neuronal loss", "INFLUENCE"], ["alterations in gut microbiota composition", "anxiety", "AFFECT"], ["PD-like gut dysbiosis", "PD", "AFFECT"], ["Crohn's disease", "patients", "TARGET"], ["gut microbiota", "ICH", "IS LINKED TO"], ["Parkinson's disease", "neurological disorders", "AFFECT"], ["healthy older", "shotgun sequencing", "USED BY"], ["AD-associated gut microbiota dysbiosis", "wild-type mice", "TARGET"], ["intestinal microbiota dysbiosis", "Parkinson's", "AFFECT"], ["gut microbiota", "epilepsy", "IS LINKED TO"], ["amyloid curli", "Gram-negative enteric bacteria", "IMPACT"], ["emotion-related diseases", "people", "TARGET"], ["gastrointestinal microbiota", "cognitive impairment", "IS LINKED TO"], ["Misfolded protein aggregates", "neurodegenerative proteinopathies", "INFLUENCE"], ["butyrate-producing bacterium B. producta", "dopaminergic neuronal death", "INFLUENCE"], ["esophageal and gastric inflammation", "HD subjects", "TARGET"], ["Fiber intake", "depression", "INFLUENCE"], ["gut dysbiosis", "Alzheimer's", "AFFECT"], ["probiotic strains", "PD", "INFLUENCE"], ["ADHD", "Anaerotaenia", "CHANGE ABUNDANCE"], ["MS", "Akkermansia", "CHANGE ABUNDANCE"], ["gut microbiota", "MPTP/MPP<sup>+</sup> -induced Parkinson's disease", "IS LINKED TO"], ["Parkinson's disease", "Akkermansia", "CHANGE ABUNDANCE"], ["depression symptoms", "patients", "TARGET"], ["Gut Microbiome", "Inflammation", "IS LINKED TO"], ["male subjects", "enzyme-linked immunosorbent assay", "USED BY"], ["sarecycline", "pro-inflammatory", "INTERACT"], ["\u03b1-synuclein", "motor dysfunction", "INFLUENCE"], ["Beta 1,3-1,6 Glucans", "Autism Spectrum Disorder", "INFLUENCE"], ["Stress", "gastrointestinal", "STRIKE"], ["arketamine", "arketamine", "INTERACT"], ["agmatine", "antibiotic-induced dysbiosis", "INFLUENCE"], ["nutritional supplementation", "gut microbiome", "IMPACT"], ["mouse gut microbiota", "transcriptomics", "USED BY"], ["acute COVID-19", "gut dysbiosis", "AFFECT"], ["intestinal inflammation", "PD patients", "TARGET"], ["probiotics", "gut microbiota", "IMPACT"], ["drugs", "brain diseases", "CHANGE EFFECT"], ["lipopolysaccharide (LPS) endotoxins", "Parkinson's disease", "INFLUENCE"], ["Nutraceuticals", "gut microbiota", "IMPACT"], ["prebiotic inulin", "various diseases", "INFLUENCE"], ["chronic gastrointestinal inflammation", "IBDs", "AFFECT"], ["neuronal impairment", "Neurodegenerative diseases", "AFFECT"], ["motor symptoms", "PD patients", "TARGET"], ["gut microbiome", "CNS", "IS LINKED TO"], ["gut dysbiosis", "PD patients", "TARGET"], ["Methamphetamine Use Disorder", "Male Subjects", "TARGET"], ["gut microbiota-derived metabolites", "Parkinson's disease", "INFLUENCE"], ["myasthenia gravis", "neurological diseases", "IS A"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "gastrointestinal dysfunction", "INFLUENCE"], ["butyrate", "chronic cerebral hypoperfusion", "INFLUENCE"], ["tryptophan", "gut microbiota", "IMPACT"], ["moderate-to-severe MDD", "adults", "TARGET"], ["Acupuncture", "Parkinson's disease-related constipation", "CHANGE EFFECT"], ["intestinal microbiota", "bipolar disorder", "IS LINKED TO"], ["GM", "DATs", "USED BY"], ["Dysbiosis of", "Gut Microbiota", "CHANGE ABUNDANCE"], ["iron", "AD", "INFLUENCE"], ["proinflammatory markers", "Parkinson disease pathogenesis", "INFLUENCE"], ["dysbiosis of gut microbiota", "neurological diseases", "AFFECT"], ["Komagataella pastoris KM71H", "Depressive-Like Phenotype", "INFLUENCE"], ["SCFAs supplementation", "colonic inflammation", "INFLUENCE"], ["prion proteins", "prion illnesses", "INFLUENCE"], ["AD", "elderly population", "TARGET"], ["Fe", "AD", "INFLUENCE"], ["disorder of gut microbiota", "Parkinson's disease", "AFFECT"], ["Parkinson's disease", "older adults", "TARGET"], ["dysbiosis", "hyperactivation of the neuronal immune", "AFFECT"], ["aged microbiota", "neuroinflammation", "IS LINKED TO"], ["adult nursing students", "16S rRNA sequencing", "USED BY"], ["polycyclic aromatic hydrocarbons", "gut microbiota", "IMPACT"], ["systemic inflammation", "Mice", "TARGET"], ["psychotic disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["Stress", "sleep problems", "AFFECT"], ["Curcumin", "DSS-Induced Anxiety-Like Behaviors", "INFLUENCE"], ["intestinal flora", "KEGG enrichment analysis", "USED BY"], ["probiotics", "ELS-induced psychological changes", "INFLUENCE"], ["HIV-associated neurocognitive disorder", "people living with", "TARGET"], ["short-chain fatty acids", "stress-vulnerable mice", "LOCATED IN"], ["gut bacterial metabolites", "CNS", "INFLUENCE"], ["prednisolone", "epilepsy", "CHANGE EFFECT"], ["Gut Microbiome", "A53T and A53T-L444P Mice", "LOCATED IN"], ["Non-motor symptoms", "PD", "AFFECT"], ["PD", "Faecalibacterium prausnitzii", "CHANGE ABUNDANCE"], ["ASD", "neurodevelopmental disorders", "IS A"], ["Alterations", "gut microbiota", "CHANGE ABUNDANCE"], ["phenotypes", "mice", "TARGET"], ["Paraquat", "gut microbiome", "IMPACT"], ["intestinal flora", "autistic spectrum disorder", "IS LINKED TO"], ["GM", "Parkinson's disease", "IS LINKED TO"], ["probiotic bacteria-derived metabolites", "gut microbiota", "IMPACT"], ["Desulfobacterota", "PD and vehicle mice", "LOCATED IN"], ["antibiotics", "stress", "CHANGE EFFECT"], ["Food insecurity", "despair", "AFFECT"], ["fecal microbiota", "recipient mice", "LOCATED IN"], ["Metformin", "diabetes", "CHANGE EFFECT"], ["sex- and age- matched healthy controls", "enzyme-linked immunosorbent assay", "USED BY"], ["histopathological changes", "human patients", "TARGET"], ["healthy controls", "16S-sequencing", "USED BY"], ["Post-infectious fatigue", "impaired quality of life", "AFFECT"], ["pain", "anhedonia susceptible rats", "TARGET"], ["semaglutide", "depression", "CHANGE EFFECT"], ["dementia", "elderly population", "TARGET"], ["gut microbiota", "major depressive disorder", "IS LINKED TO"], ["WMI", "intracerebral hemorrhage (ICH) patients", "TARGET"], ["gut microbiota", "culture-independent techniques", "USED BY"], ["impulsivity", "adults", "TARGET"], ["puerarin", "Parkinson's disease", "INFLUENCE"], ["multiple sclerosis", "people", "TARGET"], ["Gut Microbiome", "Parkinson's Disease", "IS LINKED TO"], ["neuropsychiatric disorders", "gastrointestinal issues", "AFFECT"], ["postbiotics", "oxidative stress", "INFLUENCE"], ["neuroinflammation", "neuronal damage", "AFFECT"], ["METH users", "16S rRNA gene sequencing", "USED BY"], ["gut microbiome", "dysbiosis", "IS LINKED TO"], ["anti-depressants", "gut microbiota", "IMPACT"], ["tablet", "sleep disturbance", "INFLUENCE"], ["AN", "faecal microbiota", "CHANGE ABUNDANCE"], ["Campylobacter jejuni", "food poisoning", "INFLUENCE"], ["multiple sclerosis", "neurological disorders", "IS A"], ["poor bone strength", "fracture", "AFFECT"], ["psychotic syndromes", "individuals", "TARGET"], ["Verrucomicrobiota", "subchronic MPTP mice", "LOCATED IN"], ["neuro-inflammation", "PD", "AFFECT"], ["inflammatory microbiome", "NDDs", "IS LINKED TO"], ["EC-12 supplementation", "Butyricicoccus", "IMPACT"], ["fecal microbiota", "A53T mice", "LOCATED IN"], ["\u03b1-synuclein", "Parkinson's disease", "INFLUENCE"], ["microbiota", "gut", "LOCATED IN"], ["metabolic dysfunction", "neurotransmitter disruptions", "AFFECT"], ["PD", "Desulfovibrio", "CHANGE ABUNDANCE"], ["fecal microbiota", "antibiotics-treated pseudo-germ-free mice", "LOCATED IN"], ["Sanguinarine", "intestinal inflammation", "INFLUENCE"], ["Gastrointestinal (GI) dysfunction", "PD", "AFFECT"], ["probiotics", "Clostridium perfringens", "IMPACT"], ["leaky gut", "neurodegenerative disorders", "AFFECT"], ["gut microbiota", "COVID-19 disease", "IS LINKED TO"], ["male C57BL/6 mice", "low-temperature extraction", "USED BY"], ["probiotics", "behavioral problems", "INFLUENCE"], ["Bacteroides thetaiotaomicron", "ADHD", "INFLUENCE"], ["probiotics", "stress", "INFLUENCE"], ["gut microbiota", "PD", "IS LINKED TO"], ["metabolic disarrangements", "mental illness", "AFFECT"], ["Dysfunction of the gut microbiome", "infectious diseases", "AFFECT"], ["Oral [60]fullerene", "Parkinson's disease", "INFLUENCE"], ["gut microbiome", "inflammatory bowel disease", "IS LINKED TO"], ["abnormal gut microbiota", "PD", "IS LINKED TO"], ["gut microbiota", "autism", "IS LINKED TO"], ["vegetables", "depressive symptoms", "INFLUENCE"], ["gut microbiota", "diet-induced obese (DIO) and lean mice", "LOCATED IN"], ["Mn", "neurodegenerative disorders", "INFLUENCE"], ["participants", "amyloid PET", "USED BY"], ["healthy controls", "Quantitative PCR", "USED BY"], ["p-Tau", "hippocampus", "LOCATED IN"], ["substantia nigra", "mice", "LOCATED IN"], ["PD groups", "compositional data analysis", "USED BY"], ["Rh4", "depression-like behavior", "CHANGE EFFECT"], ["gut microbiota", "gastrointestinal symptoms", "IS LINKED TO"], ["PD", "male PD patients", "TARGET"], ["gut microbiome", "gut", "LOCATED IN"], ["COVID-19", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["PD group", "shotgun metagenomics sequencing", "USED BY"], ["COVID-19 clinical manifestations", "muscle aches", "AFFECT"], ["ampicillin", "Depression-like behavior", "CHANGE EFFECT"], ["MPTP-induced Parkinson's disease", "mouse", "TARGET"], ["mood disorders", "metabolic dysfunction", "AFFECT"], ["entacapone", "Clostridium", "IMPACT"], ["gut microbial population imbalance", "gut dysbiosis", "AFFECT"], ["GLP-1 (Glucagon-like Peptide-1) analogs", "stroke", "INFLUENCE"], ["bile acids", "inflammatory bowel disease", "INFLUENCE"], ["biofilm-associated proteins", "gut microbiota", "IMPACT"], ["Inflammatory bowel diseases", "IBDs", "AFFECT"], ["nasal microbiota", "NDs", "IS LINKED TO"], ["OS", "neuronal damage", "AFFECT"], ["MDD", "healthy control subjects", "TARGET"], ["phytochemicals", "neurological and psychological conditions", "INFLUENCE"], ["Major depressive disorder", "neuro-immune disorder", "IS A"], ["PD", "vulnerable persons", "TARGET"], ["acetic acid", "MPTP + H-BCAA mice", "LOCATED IN"], ["PM2.5", "depression", "INFLUENCE"], ["human gut microbiome dysbiosis", "psychiatric and psychological disorders", "AFFECT"], ["vitamin D deficiency", "diabetes", "AFFECT"], ["Alzheimer's disease", "degenerative disease", "IS A"], ["gut microbes", "schizophrenia", "INFLUENCE"], ["Amyotrophic Lateral Sclerosis", "neurodegenerative disorders", "IS A"], ["short-chain fatty acids", "schizophrenia", "INFLUENCE"], ["obesity", "common health disorders", "IS A"], ["amyloid-\u03b2", "Alzheimer's disease", "INFLUENCE"], ["antibiotics", "alterations of behavior", "CHANGE EFFECT"], ["Parkinson's Disease", "de novo PD patients", "TARGET"], ["gut microbiota", "ET", "IS LINKED TO"], ["OCN", "motor deficits", "INFLUENCE"], ["gut bacteria", "Parkinson disease pathogenesis", "INFLUENCE"], ["SCFAs", "ND pathogenesis", "INFLUENCE"], ["motor deficits", "mouse model", "TARGET"], ["salt", "inflammatory diseases", "INFLUENCE"], ["clinical symptoms", "patients", "TARGET"], ["perimenopausal panic disorder", "patients", "TARGET"], ["dietary polysaccharides", "depression", "INFLUENCE"], ["gut microbiota dysbiosis", "cognitive impairment", "AFFECT"], ["probiotic combination", "patients", "ADMINISTERED"], ["IBD", "vascular dementia", "AFFECT"], ["prenatal chronic stress", "offspring", "TARGET"], ["Gut Microbiota", "ADHD", "IS LINKED TO"], ["PD", "PD", "AFFECT"], ["Parkinson's disease", "older people", "TARGET"], ["Oxymatrine", "intestinal barrier dysfunction", "INFLUENCE"], ["MCI", "gut microbiomes", "CHANGE ABUNDANCE"], ["L-dopa", "circulation", "LOCATED IN"], ["gut microbiota", "mental disorders", "IS LINKED TO"], ["spices", "mental disorders", "INFLUENCE"], ["Disordered gut microbiota", "inflammatory processes", "IS LINKED TO"], ["gut microbiota", "Parkinson's disease (PD) patients", "LOCATED IN"], ["depression symptoms", "older adults", "TARGET"], ["rotenone", "microbiome dysbiosis", "CHANGE EFFECT"], ["FLZ", "dopaminergic neuron death", "CHANGE EFFECT"], ["human gut microbiota", "autism spectrum disorder", "IS LINKED TO"], ["\u03b1-synuclein", "neuroinflammation", "INFLUENCE"], ["cytokines", "frontotemporal dementia", "INFLUENCE"], ["Ru", "microglia activation", "INFLUENCE"], ["memory impairment", "Chronic inflammatory pain", "AFFECT"], ["metabolites", "dysfunctions", "INFLUENCE"], ["Rh4", "hypothalamic-pituitary-adrenal axis disorder", "CHANGE EFFECT"], ["gut microbiota", "older populations", "LOCATED IN"], ["MDMA", "microbes", "IMPACT"], ["dementia", "individuals", "TARGET"], ["schizophrenia", "individuals", "TARGET"], ["probiotics", "depressive symptoms", "INFLUENCE"], ["FC", "children", "TARGET"], ["GM", "HTN", "IS LINKED TO"], ["dysbiosis", "age-related neurodegenerative disorders", "AFFECT"], ["IBD", "multiple sclerosis", "AFFECT"], ["dopaminergic neuronal loss", "PD", "AFFECT"], ["Water extract of ginseng", "parkinsonism", "INFLUENCE"], ["GABA", "Alzheimer's and Parkinson's disease", "INFLUENCE"], ["gut microbiota", "resveratrol-treated PD mice", "LOCATED IN"], ["GM", "depressive disorders", "IS LINKED TO"], ["dysbiosis", "Parkinson's disease", "AFFECT"], ["PARK7/DJ-1", "intestinal inflammation", "INFLUENCE"], ["GABA", "gut", "IMPACT"], ["probiotic", "depression symptoms", "INFLUENCE"], ["Parkinson's disease", "dorsal vagal nucleus", "STRIKE"], ["GI symptoms", "NDDs", "AFFECT"], ["alpha synuclein", "Parkinson's disease", "INFLUENCE"], ["Gut Microbiota", "Mental Disorders", "IS LINKED TO"], ["antipsychotics", "gastrointestinal microbiota", "IMPACT"], ["Parkinson's disease", "subjects", "TARGET"], ["intestinal microbiota", "Parkinson's disease", "IS LINKED TO"], ["o_Clostridiales", "gut microbiota", "PART OF"], ["Functional constipation", "gastrointestinal disorder", "IS A"], ["adult patients", "sociodemographic and health behavior questionnaires", "USED BY"], ["bipolar disorder", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["gut microbiota", "healthy people", "LOCATED IN"], ["muscle atrophy", "ALS", "AFFECT"], ["Insulin resistance", "T2D", "AFFECT"], ["microbiota dysbiosis", "amyotrophic lateral sclerosis", "AFFECT"], ["misfolding", "AD", "AFFECT"], ["gut microbiome", "Postpartum depression", "IS LINKED TO"], ["AD", "gut microbiota", "CHANGE ABUNDANCE"], ["Gut Microbiota", "Autism Spectrum Disorder", "IS LINKED TO"], ["behavioral changes", "elderly people", "TARGET"], ["bacteria", "human gut microbiome", "PART OF"], ["TRD", "Patients", "TARGET"], ["antimicrobial peptides defensin 5 alpha", "intestinal microbiome", "PRODUCED BY"], ["gut microbiota", "neurodegenerative disorders", "IS LINKED TO"], ["psychiatric and neurological diseases", "clinical subjects", "TARGET"], ["\u03b1-synuclein", "inflammation", "INFLUENCE"], ["Rubusoside", "cellular apoptosis", "INFLUENCE"], ["gut microbiota", "neuroinflammatory processes", "IS LINKED TO"], ["circadian misalignment", "psychiatric metabolic comorbidities", "AFFECT"], ["alcohol liver disease", "individuals", "TARGET"], ["parkinsonism", "MPTP-induced Parkinson's disease mice", "TARGET"], ["Parkinson's disease", "small intestine", "STRIKE"], ["prodromal, nonmotor dysfunctions", "PD", "AFFECT"], ["Parkinson's", "Neurodegenerative protein conformational diseases", "IS A"], ["probiotics", "neurodegenerative diseases", "INFLUENCE"], ["fecal microbiota", "PD", "IS LINKED TO"], ["Inflammation", "Alzheimer's disease", "AFFECT"], ["Levodopa", "gut microbiota", "IMPACT"], ["PUFA", "eating disorder psychopathology", "INFLUENCE"], ["intestinal bacterium Christensenella minuta DSM 32891", "cardiometabolic disease", "INFLUENCE"], ["autism", "neurological disorders", "IS A"], ["probiotics", "PTSD", "INFLUENCE"], ["substantia nigra", "water-treated mice", "LOCATED IN"], ["mental and GI disorders", "patients", "TARGET"], ["butyrate", "neuroendocrine alterations", "INFLUENCE"], ["PD", "neurodegenerative amyloid disorder", "IS A"], ["Huntington's disease", "age-related neurodegenerative disorders", "IS A"], ["metformin", "Parkinson's disease", "CHANGE EFFECT"], ["butyrate", "epilepsy", "INFLUENCE"], ["gut microbiota", "age-related neurodegenerative disorders", "IS LINKED TO"], ["prebiotic", "PD", "INFLUENCE"], ["Cognitive impairment", "MDD", "AFFECT"], ["A2 beta-casein", "psychological distress", "INFLUENCE"], ["propionate", "depression", "INFLUENCE"], ["Infections", "PD", "AFFECT"], ["Fermented Foods", "obesity", "INFLUENCE"], ["iron", "Alzheimer's disease", "INFLUENCE"], ["Melatonin", "neurological diseases", "INFLUENCE"], ["coffee", "PD", "INFLUENCE"], ["FTLD", "neurological diseases", "IS A"], ["gut microbiota", "Alzheimer's diseases", "IS LINKED TO"], ["Gastrointestinal dysmotility", "Parkinson's disease", "AFFECT"], ["dysbiosis", "Huntington's disease", "AFFECT"], ["PD-like neurotoxicity", "mice", "TARGET"], ["CRC patients", "double-blinded, randomized, parallel controlled clinical trial", "USED BY"], ["Alzheimer's and Parkinson's disease", "neurodegenerative conditions", "IS A"], ["Gut Microbiome", "Functional Constipation", "IS LINKED TO"], ["loss of movement coordination", "Parkinson's disease", "AFFECT"], ["PD-related constipation", "Proteobacteria", "CHANGE ABUNDANCE"], ["B-vitamins", "autism", "INFLUENCE"], ["intestinal microbiota", "anxiety", "IS LINKED TO"], ["a-syn misfolding", "enteric nerves", "STRIKE"], ["probiotics", "impulsivity", "INFLUENCE"], ["SeNPs", "neurological diseases", "INFLUENCE"], ["NaB", "gut dysfunction", "INFLUENCE"], ["sex- and age- matched healthy controls", "16S rRNA sequencing", "USED BY"], ["trehalose", "gut microbiota", "IMPACT"], ["probiotics", "MDD", "INFLUENCE"], ["Older persons", "targeted metabolomics platform", "USED BY"], ["polyphenols", "gut microbiota", "PRODUCED BY"], ["Gut microbiota changes", "Parkinson's Disease", "AFFECT"], ["probiotics", "inflammatory bowel disease", "INFLUENCE"], ["gut microbiota", "attention deficit/hyperactivity disorder", "IS LINKED TO"], ["THP", "parkinsonism", "CHANGE EFFECT"], ["systemic inflammation", "MUD", "AFFECT"], ["medications", "depressive disorders", "CHANGE EFFECT"], ["gut microbiome", "stroke", "IS LINKED TO"], ["Se", "Parkinson's disease", "INFLUENCE"], ["microbiota", "imiquimod-treated mice", "LOCATED IN"], ["intestinal flora", "PD", "AFFECT"], ["dysbiosis", "neuroinflammation", "AFFECT"], ["gut microbiota", "rats", "LOCATED IN"], ["anxiety", "neurological and psychological disorders", "IS A"], ["ASD-like behavioral abnormalities", "juvenile offspring", "TARGET"], ["iron deficiency", "anemia", "AFFECT"], ["tryptophan", "inflammatory bowel disease", "INFLUENCE"], ["attention-deficit hyperactivity disorder", "patients", "TARGET"], ["PD mice", "enzyme-linked immunosorbent assay", "USED BY"], ["coffee extracts", "inflammatory diseases", "INFLUENCE"], ["gut microbiota", "healthy mice", "LOCATED IN"], ["motor and sensory deficits", "PD", "AFFECT"], ["MCT-KD", "mitochondrial loss", "INFLUENCE"], ["gut dysbiosis", "neurodegeneration", "AFFECT"], ["prebiotics", "psychiatric symptoms", "INFLUENCE"], ["MDMA", "anhedonia-like behavior", "CHANGE EFFECT"], ["gastrointestinal (GI) dysfunction", "Individuals", "TARGET"], ["GM", "CUMS group", "LOCATED IN"], ["gastrointestinal disturbance", "Parkinson's disease", "AFFECT"], ["vitamin D deficiency", "non-alcoholic fatty liver disease", "AFFECT"], ["gut microbiome", "organ-specific autoimmune disease", "IS LINKED TO"], ["SA", "necrotic enteritis", "INFLUENCE"], ["Depression", "medical disorders", "IS A"], ["intestinal flora", "patients", "LOCATED IN"], ["gut microbiome", "age-related alterations", "IS LINKED TO"], ["non-absorbable antibiotics", "gut microbiome", "IMPACT"], ["multiple sclerosis", "neuropsychiatric disorders", "IS A"], ["gut and brain inflammation", "neurodegeneration", "AFFECT"], ["Probiotics", "dysbiosis", "INFLUENCE"], ["gut microbiota", "Huntington's disease", "IS LINKED TO"], ["GI tract", "patients", "LOCATED IN"], ["SIBO", "Alzheimer's patients", "TARGET"], ["anxiety", "mental disorders", "IS A"], ["MDD", "neurasthenic disease", "IS A"], ["constipation", "chronic kidney disease", "AFFECT"], ["Parkinson's", "patients", "TARGET"], ["Rk3", "neuronal damage", "INFLUENCE"], ["Parkinson's disease", "Male C57BL/6 mice", "TARGET"], ["attention deficit/hyperactivity disorder", "participants", "TARGET"], ["gut microbiota", "NCDs", "IS LINKED TO"], ["imbalance in gut microbiota composition", "autism spectrum disorders", "AFFECT"], ["food poisoning", "humans", "TARGET"], ["Gut microbiota dysbiosis", "autism spectrum disorder", "AFFECT"], ["healthy controls", "stool sample analysis", "USED BY"], ["gut dysbiosis", "pathological protein-related neurodegenerative diseases", "AFFECT"], ["respiratory paralysis", "patients", "TARGET"], ["immune system alterations", "Parkinson's disease", "AFFECT"], ["ASD", "males", "TARGET"], ["probiotics", "elderly", "ADMINISTERED"], ["Reduced glucose metabolism", "brain damage", "AFFECT"], ["rectum", "EphB6-deficient mice", "LOCATED IN"], ["antidepressant", "gut microbiota", "IMPACT"], ["microbial metabolites", "neurological diseases", "INFLUENCE"], ["Microbiome Metabolites", "Neurological Disorders", "INFLUENCE"], ["Parkinson's disease", "seniors", "TARGET"], ["BAs", "neurodegenerative diseases", "INFLUENCE"], ["gastro-intestinal disturbances", "PD patients", "TARGET"], ["anxiety", "COVID-19 patients", "TARGET"], ["amyloid-\u03b2", "Parkinson's disease", "INFLUENCE"], ["healthy control", "Metagenomics sequencing", "USED BY"], ["gut-microbiota", "individuals", "LOCATED IN"], ["depression- and anxiety-like behavior", "offspring", "TARGET"], ["dysbiosis", "inflammation", "AFFECT"], ["Gut microbiota", "frontotemporal dementia", "IS LINKED TO"], ["inescapable electric stress", "Adult male rats", "TARGET"], ["dietary polysaccharides", "neurodegenerative", "INFLUENCE"], ["ketamine", "depression", "CHANGE EFFECT"], ["intestinal microbiota", "inflammation", "IS LINKED TO"], ["probiotic/prebiotic supplementation", "gut microbiome", "IMPACT"], ["inflammation associated cytokines", "brain", "LOCATED IN"], ["the gut microbiome", "oxidative stress", "AFFECT"], ["metabolic disarrangements", "Schizophrenic patients", "TARGET"], ["probiotics", "commensal gut bacteria", "IMPACT"], ["neurological disease", "patients", "TARGET"], ["Curcumin", "depression", "INFLUENCE"], ["PD patients", "Sequencing", "USED BY"], ["coffee", "breast and colon cancer", "INFLUENCE"], ["Alzheimer's disease", "NDDs", "IS A"], ["\u03b1Syn proteins", "substantia nigra", "LOCATED IN"], ["FLZ", "PD", "CHANGE EFFECT"], ["anhedonia-like phenotypes", "antibiotic-treated mice", "TARGET"], ["depressive", "anxiety", "AFFECT"], ["antibiotic-induced microbiome depletion", "mouse brain", "STRIKE"], ["initial dysregulation", "PD", "AFFECT"], ["persistent infection", "Parkinson's disease", "AFFECT"], ["propionate", "motor deficits", "INFLUENCE"], ["arketamine", "mice", "ADMINISTERED"], ["phenolic compounds", "\u03b1S oligomer-induced cellular and synaptic toxicities", "INFLUENCE"], ["Depression", "Patients", "TARGET"], ["gut dysfunction", "Parkinson's disease", "AFFECT"], ["PD", "\u03b1-synuclein fibrils", "INTERACT"], ["MDD patients", "16S rRNA sequencing", "USED BY"], ["VAP", "dopaminergic neuron damage", "INFLUENCE"], ["gut barrier defects", "gastrointestinal tract", "STRIKE"], ["Fermented Foods", "mental health concerns", "INFLUENCE"], ["Probiotics", "host's gut microbiota", "IMPACT"], ["LPHC diet", "PD mice", "ADMINISTERED"], ["PD cases", "16S rRNA gene sequencing", "USED BY"], ["Akkermansia", "cardiovascular diseases", "INFLUENCE"], ["Sub-chronic inflammation", "brain", "STRIKE"], ["psychiatric diseases", "patients", "TARGET"], ["intestinal microbiota", "SCZ patients", "LOCATED IN"], ["Gut microbial dysbiosis", "mitochondrial dysfunction", "AFFECT"], ["\u03b1-Synuclein pathology", "brain", "STRIKE"], ["arketamine", "cognitive deficits", "CHANGE EFFECT"], ["gut microbiota", "PD dyskinesia", "IS LINKED TO"], ["Gut microbial dysbiosis", "Parkinson's disease", "AFFECT"], ["dietary flavonoids", "gut microbiome", "IMPACT"], ["Rk3", "depression-like behavior", "INFLUENCE"], ["Parkinson's disease", "recipient mice", "TARGET"], ["PD patients", "16S rRNA sequencing", "USED BY"], ["Dioscin", "PD", "INFLUENCE"], ["subjects", "Whole genome metagenome (WGM) sequencing", "USED BY"], ["gut microbiota", "PD motility", "IS LINKED TO"], ["Parkinson's", "neurodegenerative diseases", "IS A"], ["gut microbiota", "Male C57BL/6J mice", "LOCATED IN"], ["gut microbiota", "central nervous system-based disorders", "IS LINKED TO"], ["intestinal microbiota", "Alzheimer's disease", "IS LINKED TO"], ["obsessive-compulsive disorder", "drug-naive patients", "TARGET"], ["aged microbiota", "gut inflammation", "IS LINKED TO"], ["MS", "Dorea", "CHANGE ABUNDANCE"], ["specific gut microbiota", "PD", "IS LINKED TO"], ["Gut microbiota dysbiosis", "neuropsychiatric and neurological disorders", "AFFECT"], ["gastrointestinal symptoms", "PD", "AFFECT"], ["male C57BL/6 mice", "oral gavage", "USED BY"], ["ADHD", "gut microbiota", "CHANGE ABUNDANCE"], ["ICH", "gut dysbiosis", "AFFECT"], ["gut microbiota dysbiosis", "neurodegenerative diseases", "AFFECT"], ["gut microbiota alterations", "Parkinson's disease", "AFFECT"], ["Alzheimer's", "neurodegenerative disorders", "IS A"], ["microbiota", "PPD patients", "LOCATED IN"], ["gut microbiota", "primary neurodegenerative dementias", "IS LINKED TO"], ["AiD", "AiD patient population", "TARGET"], ["schizophrenia-like (SCZ-like) symptoms", "SCZ patients", "TARGET"], ["deficits", "ASD", "AFFECT"], ["motor and non-motor symptoms", "PD patients", "TARGET"], ["neuroinflammation", "MPTP-induced PD mice", "TARGET"], ["Trimethylamine N-Oxide", "Neuroinflammation", "INFLUENCE"], ["Mn", "central nervous system damage", "INFLUENCE"], ["essential tremor", "subjects", "TARGET"], ["Parkinson's disease", "A53T mice", "TARGET"], ["nalmefene", "alcohol addiction", "CHANGE EFFECT"], ["wild-type mice", "16S rRNA gene sequencing", "USED BY"], ["Bacterial Metabolites", "Depression", "INFLUENCE"], ["gut microbiota", "neurodegenerative disease", "IS LINKED TO"], ["chronic gastrointestinal inflammation", "Inflammatory bowel diseases", "AFFECT"], ["affective disorders", "patients", "TARGET"], ["Vitamin D3 deficiency", "Coronavirus Disease 2019", "AFFECT"], ["Acanthopanax senticosus", "PD", "INFLUENCE"], ["mood disorders", "patients", "TARGET"], ["PD", "autoimmune diseases", "IS A"], ["Melatonin", "multiple sclerosis", "INFLUENCE"], ["active metabolites", "Antrodia camphorata", "IMPACT"], ["Misfolded protein aggregates", "cellular toxicity", "INFLUENCE"], ["Parkinson's disease", "non-motor symptoms", "AFFECT"], ["3,4-Methylenedioxymethamphetamine", "saline-treated mice", "ADMINISTERED"], ["CSDS", "saline-treated mice", "TARGET"], ["microbiota-derived molecules", "depression", "INFLUENCE"], ["gut microbiota dysbiosis", "psychiatric and psychological disorders", "AFFECT"], ["42-healthy spouses", "16S rRNA amplicon-sequencing", "USED BY"], ["Fecal Metabolites", "Intestinal Inflammation", "INFLUENCE"], ["PD", "age-related neurodegenerative disorders", "IS A"], ["fibre supplementation", "gut microbiota", "IMPACT"], ["Inflammation", "Parkinson's disease", "AFFECT"], ["sodium chloride solution", "Male Wistar rats", "ADMINISTERED"], ["intestinal microbial flora", "autism spectrum disorders", "IS LINKED TO"], ["Inflammatory bowel diseases", "IBD patients", "TARGET"], ["Gastrointestinal dysfunction", "inflammation of the gut", "AFFECT"], ["SCFAs", "iRBD", "INFLUENCE"], ["Parkinson's disease", "complex neurodegenerative disorder", "IS A"], ["Neurodegeneration", "patients", "TARGET"], ["FLZ", "gut barrier destruction", "CHANGE EFFECT"], ["gut microbiome", "neurodegenerative diseases", "IS LINKED TO"], ["neuronal degeneration", "PD", "AFFECT"], ["polyphenols", "neurodegeneration", "INFLUENCE"], ["acetate", "Parkinson's", "INFLUENCE"], ["FLZ", "PD-related microbiota alterations", "CHANGE EFFECT"], ["puerarin", "Parkinson's disease", "CHANGE EFFECT"], ["stroke", "Prevalent neurological disorders", "IS A"], ["gut microbiota", "neurological diseases", "IS LINKED TO"], ["N-methylglutamate", "insomnia group", "LOCATED IN"], ["Huntington's disease", "peripheral symptoms", "AFFECT"], ["gut microbiome", "psychiatric conditions", "IS LINKED TO"], ["<i>Lactobacillus gasseri</i> CP2305", "clinical symptoms", "INFLUENCE"], ["BD depression patients", "metagenomic sequencing", "USED BY"], ["Aberrant Intestinal Microbiome", "mental health disorders", "IS LINKED TO"], ["Rk3", "depression", "INFLUENCE"], ["gut dysbiome", "Gut-first Parkinson's disease", "IS LINKED TO"], ["inflammatory bowel diseases", "Parkinson disease", "AFFECT"], ["riboflavin", "PD", "INFLUENCE"], ["gut microbiota", "Metagenomics", "USED BY"], ["gut microbiota", "memory decline", "IS LINKED TO"], ["conventional dairy", "psychological distress", "INFLUENCE"], ["L. plantarum SG5", "MPTP-induced motor deficits", "INFLUENCE"], ["RF", "traveler's diarrhea", "CHANGE EFFECT"], ["gut microbiota alterations", "Alzheimer's disease", "AFFECT"], ["VLCKD", "Parkinson's", "INFLUENCE"], ["\u03b1-synuclein fibrils", "Parkinson's disease", "INFLUENCE"], ["turmeric", "IBS symptoms", "INFLUENCE"], ["Orally Administered Ginkgolide C", "Oxidative Stress", "CHANGE EFFECT"], ["PD", "neurodegenerative disorder", "IS A"], ["age-dependent defects of", "PD", "AFFECT"], ["drugs", "SCN2A disease", "CHANGE EFFECT"], ["probiotics", "neurological conditions", "INFLUENCE"], ["Migraine", "men", "TARGET"], ["obesity", "adult cohort", "TARGET"], ["alpha-synuclein-mediated motor deficits", "mice", "TARGET"], ["Parkinson's disease", "honeybees", "TARGET"], ["gut microbiota alterations", "anxiety", "AFFECT"], ["gut microbiota", "young adults", "LOCATED IN"], ["dysbiosis", "MS", "AFFECT"], ["Lactobacillus) plantarum", "neurodegenerative disease", "INFLUENCE"], ["microbes", "vehicle + CRS group", "LOCATED IN"], ["Depressive-Like Behavior", "Mice", "TARGET"], ["Probiotics", "gut microbiota", "IMPACT"], ["autism spectrum disorders", "neurodevelopmental disorders", "IS A"], ["COVID-19 infection", "gut microbiota dysbiosis", "AFFECT"], ["Se", "Alzheimer's disease", "INFLUENCE"], ["Curcumin", "motor deficits", "INFLUENCE"], ["Idiopathic Rapid Eye Movement Sleep Behavior Disorder", "MSA", "AFFECT"], ["antibiotics", "psychiatric symptoms", "CHANGE EFFECT"], ["human gut microbiota", "anxiety", "IS LINKED TO"], ["Huntington's disease", "gastrointestinal dysfunction", "AFFECT"], ["Akk", "colon inflammation", "INFLUENCE"], ["gut microbes", "ASD", "IS LINKED TO"], ["Short-chain fatty acids", "depression", "INFLUENCE"], ["metabolomes", "anxiety disorders", "IS LINKED TO"], ["pentanoic (valeric) acid", "Parkinson's", "INFLUENCE"], ["cytokines", "dementia", "INFLUENCE"], ["PD", "age-matched household control participants", "TARGET"], ["Reduced anti-inflammatory gut microbiota", "depression", "IS LINKED TO"], ["Peptic ulceration", "PD", "AFFECT"], ["neuronal loss", "PD", "AFFECT"], ["GEP", "MPTP-induced mitochondrial apoptosis", "INFLUENCE"], ["ADHD", "neurological diseases", "IS A"], ["AG", "DSS-induced murine colitis", "INFLUENCE"], ["BAs", "NDs", "INFLUENCE"], ["striatum", "mice", "LOCATED IN"], ["(R)-ketamine", "rodents", "ADMINISTERED"], ["genus Coprococcus", "extrahepatic CCA", "INFLUENCE"], ["Vitamin D3 deficiency", "critically ill patients", "TARGET"], ["Inflammatory Bowel Disease", "Patients", "TARGET"], ["gut microbiota", "human being", "LOCATED IN"], ["biologically active polyphenols", "neurodegenerative diseases", "INFLUENCE"], ["Intestinal Microbiome", "Parkinson's Disease", "IS LINKED TO"], ["melatonin supplement", "mice", "ADMINISTERED"], ["Rk3", "gut microbiota", "PRODUCED BY"], ["gut microbiota", "metabolic syndrome", "IS LINKED TO"], ["Intestinal inflammation", "PD", "AFFECT"], ["toxic RNA and mutant protein", "brain", "LOCATED IN"], ["Gut Microbiota", "Disease", "IS LINKED TO"], ["ET", "patients", "TARGET"], ["Parkinson's disease", "nigrostriatal and gastrointestinal tracts", "STRIKE"], ["Gut microbiota-mediated ursodeoxycholic acids", "inflammation", "INFLUENCE"], ["erythrocyte-derived EVs", "synucleinopathies", "INFLUENCE"], ["gut microbiota", "alcohol-related diseases", "IS LINKED TO"], ["SCD", "patients", "TARGET"], ["major depressive disorder", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["fiber supplements", "depression", "INFLUENCE"], ["trimethylamine N-oxide", "PD", "INFLUENCE"], ["neurodegeneration", "ALS", "AFFECT"], ["Intestinal inflammation", "chronic gastrointestinal disorder", "IS A"], ["Probiotics", "negative affect", "INFLUENCE"], ["Gastrointestinal dysfunction", "Parkinson's disease", "AFFECT"], ["microbial metabolites", "multiple sclerosis", "INFLUENCE"], ["tobacco use disorder", "individuals", "TARGET"], ["SCFAs", "cardiovascular disease", "INFLUENCE"], ["plazomicin", "infections", "CHANGE EFFECT"], ["PD mice", "16S rRNA sequencing", "USED BY"], ["gut dysbacteriosis", "Parkinson's disease", "AFFECT"], ["Parkinson's disease", "male and female patients", "TARGET"], ["probiotic", "anxiety", "INFLUENCE"], ["intestinal microbial flora", "neurological and neurodevelopmental disorders", "IS LINKED TO"], ["PD", "middle-aged and elderly people", "TARGET"], ["fecal microbiota", "control (no CSDS) mice", "LOCATED IN"], ["gut microbiota", "case groups", "LOCATED IN"], ["bacterial", "Parkinson's disease", "INFLUENCE"], ["PD", "motor and non-motor symptoms", "IS A"], ["mice", "splenectomy", "USED BY"], ["gut microbiota", "opioid use disorders", "IS LINKED TO"], ["LPS", "\u03b1-synuclein pathology", "INFLUENCE"], ["Organophosphorus pesticides", "gut microbiota", "IMPACT"], ["IL-6", "systemic inflammation", "INFLUENCE"], ["microbiome", "schizophrenia", "IS LINKED TO"], ["NCDs", "gut microbiota", "CHANGE ABUNDANCE"], ["Chronic gut inflammation", "systemic inflammation", "AFFECT"], ["Small intestinal bacterial overgrowth", "patients", "TARGET"], ["Calprotectin", "beta defensin 2", "INTERACT"], ["postbiotics", "depression", "INFLUENCE"], ["intestinal flora", "Parkinson's disease", "IS LINKED TO"], ["AD transgenic mice", "site-mutations", "USED BY"], ["psychotic disorders", "patients", "TARGET"], ["neurodegeneration", "neurodevelopmental impairment", "AFFECT"], ["gut microbiota", "microbiology and enteric neurophysiology assays", "USED BY"], ["motor and non-motor symptoms", "patients", "TARGET"], ["sugar", "depression", "INFLUENCE"], ["minocycline", "recipients", "ADMINISTERED"], ["Olanzapine", "diet-induced obesity", "CHANGE EFFECT"], ["GBA disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["oxidative stress", "PD", "AFFECT"], ["dysbiosis of the skin microbiome", "cardiovascular diseases", "AFFECT"], ["intestinal bacteria", "healthy and B-cell-deficient mice", "LOCATED IN"], ["FOS", "stress-induced anxiety-like behavior", "INFLUENCE"], ["probiotic", "pregnant and lactating women", "ADMINISTERED"], ["inflammatory bowel diseases", "IBD", "AFFECT"], ["SARS-CoV-2", "COVID-19", "AFFECT"], ["metabolites", "neurodegenerative diseases", "INFLUENCE"], ["epigallocatechin-3-gallate", "neurodegenerative diseases", "INFLUENCE"], ["Bacteroidetes and Firmicutes phyla", "human gut microbiota", "PART OF"], ["neurological diseases", "brain", "STRIKE"], ["gut microbiota", "depressed patients", "LOCATED IN"], ["B. producta-derived butyrate", "PD", "INFLUENCE"], ["gut microbiota", "intestinal inflammation", "IS LINKED TO"], ["soybean meal", "intestinal pathologies", "INFLUENCE"], ["gut microbiota", "16S ribosomal RNA sequencing", "USED BY"], ["Gut dysbiosis", "females", "TARGET"], ["Parkinson's disease", "PD mice", "TARGET"], ["stroke", "patients", "TARGET"], ["cardiovascular diseases", "age-associated diseases", "IS A"], ["gut microbiota", "immune alterations", "IS LINKED TO"], ["gut-microbiome", "PD symptoms", "IS LINKED TO"], ["PD", "complex neurodegenerative disease", "IS A"], ["RBD", "PD", "AFFECT"], ["intestinal inflammation", "healthy control mice", "TARGET"], ["intestinal microbiota", "Multiple Sclerosis", "IS LINKED TO"], ["drugs", "NMDA receptor dysfunction", "CHANGE EFFECT"], ["fecal microbiota", "CSDS-susceptible mice", "LOCATED IN"], ["prefrontal cortex", "mice", "LOCATED IN"], ["gut microbiota", "stress-related conditions", "IS LINKED TO"], ["<i>Bacteroides fragilis</i> 839", "PD", "INFLUENCE"], ["ADHD", "Selenomonadaceae", "CHANGE ABUNDANCE"], ["Oxymatrine", "intracerebral hemorrhage", "INFLUENCE"], ["Gut microbial dysbiosis", "CNS disorders", "AFFECT"], ["Parkinson's disease", "progressive neurodegenerative disorder", "IS A"], ["macro- and micronutrients", "patients", "ADMINISTERED"], ["depression", "METH users", "TARGET"], ["rotenone", "intestinal inflammation", "CHANGE EFFECT"], ["gut microbiota", "CVD", "IS LINKED TO"], ["Sodium butyrate", "neuropsychiatric disorders", "INFLUENCE"], ["gut microbiome", "shotgun metagenomic sequencing", "USED BY"], ["motor deficits", "honeybees", "TARGET"], ["gut microbiota", "anxiety disorders", "IS LINKED TO"], ["metabolomes", "depression", "IS LINKED TO"], ["cyclophosphamide", "Barnesiella intestinihominis", "IMPACT"], ["mobility problems", "patients", "TARGET"], ["Acanthopanax senticosus", "Parkinson's disease", "INFLUENCE"], ["gut microbiome", "patients", "LOCATED IN"], ["Huntington's disease", "people", "TARGET"], ["gut microbiome", "NDs", "IS LINKED TO"], ["Gut microbiota alterations", "Parkinson's disease", "AFFECT"], ["oral and gut microbiota", "healthy controls", "LOCATED IN"], ["depression-like phenotypes", "adult mice", "TARGET"], ["dysbiosis", "ADHD", "AFFECT"], ["depression-like behavior", "mice", "TARGET"], ["major depressive disorder", "healthy people", "TARGET"], ["Gut microbiome alterations", "AD", "AFFECT"], ["tryptophan", "autoimmune response", "INFLUENCE"], ["PD", "disability", "IS A"], ["gut microbes", "PD", "IS LINKED TO"], ["Parkinson's disease", "population", "TARGET"], ["bacterial metabolites", "brain diseases", "INFLUENCE"], ["Excessive alcohol intake", "alcohol-related diseases", "AFFECT"], ["gut dysbacteriosis", "neuroinflammation", "AFFECT"], ["Neurodegenerative disorders", "cognitive and physical disabilities", "AFFECT"], ["gut microbes", "autism", "IS LINKED TO"], ["microbiota dysregulation", "neurodegenerative diseases", "AFFECT"], ["postbiotics", "inflammatory processes", "INFLUENCE"], ["individuals", "DBPC challenge test", "USED BY"], ["stress responsivity", "male rats", "TARGET"], ["3,4-Methylenedioxymethamphetamine", "U.S. adults", "ADMINISTERED"], ["sulforaphane", "memory and learning deficits", "INFLUENCE"], ["intestinal flora", "mood disorders", "IS LINKED TO"], ["12-month-old WT, KO and HET female mice", "V4 16S rRNA sequencing", "USED BY"], ["levodopa-induced side effects", "PD patients", "TARGET"], ["casein", "intestinal microbiota", "PRODUCED BY"], ["anxiety", "neurological diseases", "IS A"], ["amyotrophic lateral sclerosis", "neurological conditions", "IS A"], ["pre-, pro- and postbiotics", "gut microbiota", "IMPACT"], ["MPTP", "male C57BL/6J mice", "ADMINISTERED"], ["midgut microbiota", "mutant animals", "LOCATED IN"], ["depression", "neurological disorders", "IS A"], ["impulsive and/or violent behavior", "participants", "TARGET"], ["butyric", "ET", "INFLUENCE"], ["synbiotics", "gut microbiome", "IMPACT"], ["sulforaphane", "working memory impairment", "INFLUENCE"], ["Sleep disorders", "metabolic syndrome", "AFFECT"], ["Obsessive-compulsive disorder", "mental health disorder", "IS A"], ["Fecal Short-Chain Fatty Acid Alterations", "Parkinson's Disease", "INFLUENCE"], ["medications", "depressive symptoms", "CHANGE EFFECT"], ["propionate", "chronic cerebral hypoperfusion", "INFLUENCE"], ["gut microbiome", "asthma", "IS LINKED TO"], ["gut microbiota", "multiple sclerosis", "IS LINKED TO"], ["metals", "primary neurodegenerative dementias", "INFLUENCE"], ["gut microbiome", "inflammatory diseases", "IS LINKED TO"], ["mental illness", "Schizophrenic patients", "TARGET"], ["ligature-induced periodontitis", "microglial activation", "AFFECT"], ["ABX", "gut microbiota", "IMPACT"], ["Gastrointestinal Dysfunction", "Parkinsonian Syndromes", "AFFECT"], ["gut-microbiota-derived metabolite trimethylamine N-oxide", "Parkinson's disease", "INFLUENCE"], ["combined oral contraceptives", "gut microbiota", "IMPACT"], ["Human microbiota", "obsessive-compulsive disorder", "IS LINKED TO"], ["NaB", "neuropsychiatric disorders", "INFLUENCE"], ["autism spectrum disorder", "neurological and psychological disorders", "IS A"], ["Major depressive disorder", "disability", "AFFECT"], ["antibiotics", "Dysbiosis", "CHANGE EFFECT"], ["short-chain fatty acid", "cognitive decline", "INFLUENCE"], ["Bifidobacterium longum subsp. longum 35624", "stress responsivity", "INFLUENCE"], ["rotenone", "PD-like symptoms", "CHANGE EFFECT"], ["Antipsychotics", "schizophrenia", "CHANGE EFFECT"], ["saturated fat", "obesity", "INFLUENCE"], ["aged garlic", "DSS-induced murine colitis", "INFLUENCE"], ["\u03b1S", "dementia with Lewy bodies", "INFLUENCE"], ["mitochondrial dysfunction", "brain damage", "AFFECT"], ["Migraine", "nausea", "AFFECT"], ["Neuroinflammation", "neuronal degeneration", "AFFECT"], ["KBs", "apoptosis", "INFLUENCE"], ["striatum", "NSE-h\u03b1Syn Tg mice", "LOCATED IN"], ["intestinal microflora", "patients", "LOCATED IN"], ["fecal microbiota", "anhedonia susceptible rats", "LOCATED IN"], ["PD patients", "16S rRNA gene sequencing", "USED BY"], ["healthy crowd", "16S rRNA gene-sequencing analysis", "USED BY"], ["probiotic", "Alzheimer's disease", "INFLUENCE"], ["Amyotrophic lateral sclerosis", "neurodegenerative diseases", "IS A"], ["PD groups", "shotgun sequencing", "USED BY"], ["Oxymatrine", "gut microbiota", "IMPACT"], ["gut microbiome", "oxidative stress", "IS LINKED TO"], ["OCN", "Firmicutes phyla", "IMPACT"], ["gut microbiome", "COVID-19", "IS LINKED TO"], ["Microbiota", "Parkinson Disease", "IS LINKED TO"], ["gut microbiome dysbiosis", "autism spectrum disorder", "AFFECT"], ["chlorogenic acid", "intestinal inflammation", "INFLUENCE"], ["comorbidities", "individuals", "TARGET"], ["antibiotics", "Prevotella", "IMPACT"], ["Anti-inflammatory drugs", "inflammation", "CHANGE EFFECT"], ["striatal dopamine", "PD mice", "LOCATED IN"], ["CRC", "patients", "TARGET"], ["gut", "16S rRNA gene sequencing", "USED BY"], ["gut microbiota", "RT-PCR", "USED BY"], ["clindamycin", "mice", "ADMINISTERED"], ["ambient fine particulate matter", "Parkinson's disease", "INFLUENCE"], ["A53T transgenic mice", "Integrated multi-omics profiling", "USED BY"], ["stress", "depressed patients", "TARGET"], ["GM", "PD", "IS LINKED TO"], ["gut microbiota", "stress", "IS LINKED TO"], ["ASD", "neurological and psychological disorders", "IS A"], ["liver", "germ-free mice", "LOCATED IN"], ["(R)-ketamine", "monkeys", "ADMINISTERED"], ["MCI", "patients", "TARGET"], ["Neurodevelopmental toxicity", "Neurodegenerative and mental disorders", "AFFECT"], ["gut microbiome", "HD", "IS LINKED TO"], ["skin", "imiquimod-treated mice", "LOCATED IN"], ["gut", "PrP-A53T mice", "LOCATED IN"], ["human gut microbiome", "Parkinson's disease", "IS LINKED TO"], ["gut microbiomes", "mild and severe Graves' disease (GD) patients", "LOCATED IN"], ["PD", "functional and cognitive impairments", "IS A"], ["Meth", "anxiety", "CHANGE EFFECT"], ["Alzheimer's disease", "neurodevelopmental disorders", "IS A"], ["THC", "weight", "CHANGE EFFECT"], ["puerarin", "PD", "INFLUENCE"], ["gut microbiota", "psychiatric illness", "IS LINKED TO"], ["genus Bacteroides", "non-insomnia group", "LOCATED IN"], ["insulin resistance", "mice", "TARGET"], ["Parkinson's disease", "Flavobacteriaceae_noname", "CHANGE ABUNDANCE"], ["Probiotics", "neurodegenerative diseases", "INFLUENCE"], ["gut microbiota", "dementias", "IS LINKED TO"], ["chronic inflammation", "systemic physiological dysfunction", "IS A"], ["Cognitive impairment", "BD", "AFFECT"], ["ceftriaxone (CFX)-induced dysbiosis", "PD", "AFFECT"], ["Clozapine", "metabolic abnormalities", "CHANGE EFFECT"], ["gastrointestinal microbiome", "cognitive impairment", "IS LINKED TO"], ["Enterobacteriaceae", "patients", "LOCATED IN"], ["p-Tau", "C57BL/6 mice", "LOCATED IN"], ["depressive episodes", "pro-inflammatory genera", "CHANGE ABUNDANCE"], ["biotin", "PD", "INFLUENCE"], ["(R)-ketamine", "arketamine", "INTERACT"], ["IBS", "gut microbiota", "CHANGE ABUNDANCE"], ["gut dysbiosis", "Parkinson's disease", "AFFECT"], ["Crohn's disease", "ulcerative colitis", "AFFECT"], ["Parkinson's disease", "gut", "STRIKE"], ["gut microbiota", "CRC patients", "LOCATED IN"], ["B-vitamins", "dementia", "INFLUENCE"], ["oral microbiome", "anxiety", "IS LINKED TO"], ["Proteobacteria", "gut microbiota", "PART OF"], ["basal dysbiosis", "mutant animals", "TARGET"], ["short-chain fatty acids", "gut microbiota alterations", "INFLUENCE"], ["acute and remission schizophrenia", "patients", "TARGET"], ["Prebiotics", "short-chain fatty acid-producing bacteria", "IMPACT"], ["Major depressive disorder", "neurasthenic disease", "IS A"], ["gut microbiota", "gut inflammation", "IS LINKED TO"], ["polyphenols", "gut flora", "IMPACT"], ["Probiotic treatment", "stress responsivity", "INFLUENCE"], ["Parkinson's Disease", "people", "TARGET"], ["probiotics", "CNS conditions", "INFLUENCE"], ["prebiotics", "neurological disorders", "INFLUENCE"], ["antibiotics", "neurodegenerative and neuro-inflammatory processes", "CHANGE EFFECT"], ["chronic social defeat stress", "saline-treated mice", "TARGET"], ["spices", "gut microbiota", "IMPACT"], ["depression", "humans", "TARGET"], ["probiotics", "BD", "INFLUENCE"], ["inulin", "headache", "INFLUENCE"], ["dextran sulfate sodium", "gut microbiome alterations", "INFLUENCE"], ["GLP-1", "Parkinson's disease", "INFLUENCE"], ["SA participants", "16S rRNA gene sequencing", "USED BY"], ["gut microbiome", "physiological decline", "IS LINKED TO"], ["age-associated cognitive decline", "Alzheimer's and Parkinson's disease", "AFFECT"], ["CSDS", "splenomegaly", "AFFECT"], ["Bifidobacterium longum</i> R0175", "depression symptoms", "INFLUENCE"], ["prebiotics", "patients", "ADMINISTERED"], ["Gut dysbiosis", "metabolic, cardiovascular, reproductive, and neurobehavioral disorders", "AFFECT"], ["PD patients", "LC-MS/MS", "USED BY"], ["hUCB-derived plasma", "dopaminergic neuronal cell loss", "INFLUENCE"], ["Gut Microbiome", "Schizophrenia", "IS LINKED TO"], ["ASD", "neurological diseases", "IS A"], ["abnormal behaviour", "butyrate-producing bacteria", "CHANGE ABUNDANCE"], ["abnormal behaviour", "animals", "TARGET"], ["Fecal microbiome alterations", "treatment-naive de novo Parkinson's disease", "AFFECT"], ["gastrointestinal microbiota", "BD", "IS LINKED TO"], ["MedDiet", "Parkinson's disease", "INFLUENCE"], ["Parkinson's disease", "gastrointestinal (GI) dysfunction", "IS A"], ["PD pathogenesis", "gut microbiota", "CHANGE ABUNDANCE"], ["butyrate-producing bacterium B. producta", "neuroinflammation", "INFLUENCE"], ["inflammation", "Alzheimer's disease", "AFFECT"], ["alcohol dependence", "Patients", "TARGET"], ["metabolic dysfunction", "inflammation", "AFFECT"], ["sporadic Alzheimer's", "neurodegenerative disorders", "IS A"], ["PD", "individuals", "TARGET"], ["SeNPs", "altered microbiota", "IMPACT"], ["disruptions in cellular processes", "PD", "AFFECT"], ["PD", "ageing population", "TARGET"], ["MPTP", "male C57BL/6 mice", "ADMINISTERED"], ["Lactobacillus intestinalis", "depression", "INFLUENCE"], ["3,4-Methylenedioxymethamphetamine", "PTSD", "CHANGE EFFECT"], ["systemic inflammation", "chronic diseases", "AFFECT"], ["BD", "patients", "TARGET"], ["curcumin", "mental disorders", "INFLUENCE"], ["wild-type mice", "behavioral test", "USED BY"], ["Autism Spectrum Disorder", "Subjects", "TARGET"], ["pro- and anti-inflammatory cytokines", "neuroinflammation", "INFLUENCE"], ["depression", "Central nervous system (CNS) disorders", "IS A"], ["Very-Low-Calorie Ketogenic Diet", "Obesity", "INFLUENCE"], ["microbiota disturbances", "eating disorders", "AFFECT"], ["PD patients", "16S amplicon sequencing", "USED BY"], ["Gemmiger", "metabolic syndromes", "INFLUENCE"], ["major depressive disorder", "Mood disorders", "IS A"], ["gut microbiota", "elderly people", "LOCATED IN"], ["bile acids", "neurological diseases", "INFLUENCE"], ["chemokines", "gut", "LOCATED IN"], ["oxidative stress", "Huntington's disease", "AFFECT"], ["gut frailty", "chronic inflammation", "AFFECT"], ["autosomal dominant disease", "neurodegeneration", "AFFECT"], ["Rk3", "prefrontal cortex", "LOCATED IN"], ["gastrointestinal disturbance", "motor symptoms", "AFFECT"], ["prebiotics", "Parkinson's disease", "INFLUENCE"], ["PD mice", "16S rRNA gene sequencing", "USED BY"], ["Bile acids", "gut", "LOCATED IN"], ["iron", "mild cognitive impairment", "INFLUENCE"], ["motor issues", "Parkinson's disease", "AFFECT"], ["Gut Microbiota", "PD", "IS LINKED TO"], ["motor alterations", "Parkinson's disease", "AFFECT"], ["schizophrenia", "dysregulated brain transcript response", "AFFECT"], ["omega-3 fatty acids", "gut microbiome", "IMPACT"], ["NALL", "neuroinflammation", "INFLUENCE"], ["Parkinson's disease", "nonmotor symptom", "IS A"], ["<sup>14</sup>C-Tyr", "male weanling pigs", "ADMINISTERED"], ["aggregated proteins", "inflammatory responses", "INFLUENCE"], ["Levodopa", "Parkinson's", "CHANGE EFFECT"], ["gut microbiota", "AD symptoms", "IS LINKED TO"], ["Parkinson Disease", "brain", "STRIKE"], ["microbial metabolites", "brain", "LOCATED IN"], ["GAD", "Fusicatenibacter", "CHANGE ABUNDANCE"], ["culprit proteins", "gut microbiota", "IMPACT"], ["Gut Microbiota", "mental health concerns", "IS LINKED TO"], ["fecal microbiota", "novel transgenic (Tg) mice", "LOCATED IN"], ["Idiopathic rapid eye movement sleep behavior disorder", "synucleinopathies", "AFFECT"], ["Central nervous system (CNS) disorders", "patients", "TARGET"], ["cannabinoid CB1 receptor agonists", "hyperphagia", "CHANGE EFFECT"], ["environmental pollutants", "gut microbiota", "IMPACT"], ["alterations of behavior", "gut microbiota", "CHANGE ABUNDANCE"], ["AD", "neurodegenerative diseases", "IS A"], ["Autism", "ASD", "AFFECT"], ["probiotics", "IBS", "INFLUENCE"], ["major depressive disorder", "Actinobacteria", "CHANGE ABUNDANCE"], ["GM", "neurodegenerative disorders", "IS LINKED TO"], ["AN", "severe psychiatric disease", "IS A"], ["gut microbiota", "chronic inflammatory diseases", "IS LINKED TO"], ["Se", "epilepsy", "INFLUENCE"], ["PD", "rotenone-induced Parkinson's disease mice", "TARGET"], ["rheumatoid arthritis", "gut microbiome", "CHANGE ABUNDANCE"], ["Migraine", "photophobia", "AFFECT"], ["taurine supplement", "DA neuron loss", "INFLUENCE"], ["intestinal microbiota", "Amyotrophic Lateral Sclerosis", "IS LINKED TO"], ["gut microbiota", "preschool children", "LOCATED IN"], ["gut microbiome", "quantitative microbiome profiling", "USED BY"], ["intestinal barrier disorder", "mice", "TARGET"], ["clozapine", "schizophrenia", "CHANGE EFFECT"], ["immune dysfunction", "mental illness", "AFFECT"], ["gut microbiota", "metabolomics", "USED BY"], ["ALS", "cognitive and motor deficits", "IS A"], ["vitamin B6", "gut microbiota", "IMPACT"], ["indole", "healthy individuals", "LOCATED IN"], ["HI/R injury", "mice", "TARGET"], ["proteins", "AD", "INFLUENCE"], ["gastrointestinal dysfunction", "PD patients", "TARGET"], ["poor bone strength", "susceptibility", "AFFECT"], ["repurposed drugs", "NDDs", "CHANGE EFFECT"], ["unexplained fatigue", "people", "TARGET"], ["inflammatory cytokines", "epilepsy mice", "LOCATED IN"], ["inflammation", "MS", "AFFECT"], ["Probiotics", "Parkinson's Disease", "INFLUENCE"], ["skin-gut-microbiota", "IMQ-treated mice", "LOCATED IN"], ["gut bacterial metabolites", "diseases of the central nervous system", "INFLUENCE"], ["age-related dysbiosis", "PD", "AFFECT"], ["intestinal barrier", "patients", "LOCATED IN"], ["Pycnogenol", "elderly participants", "ADMINISTERED"], ["dysbiosis", "Parkinson's", "AFFECT"], ["patients", "hydrogen breath test", "USED BY"], ["Parkinson's disease", "people aged over 65 years", "TARGET"], ["n-butyric acid", "gut microbiota", "PRODUCED BY"], ["alcohol use disorder", "individuals", "TARGET"], ["LPHC diet", "1-methyl-4-phenyl-1,2,3,6-tetrathydropyridine (MPTP)-induced motor deficits", "INFLUENCE"], ["gut microbiota", "dysbiosis", "IS LINKED TO"], ["mHTT", "brain", "LOCATED IN"], ["gut microbiota dysbiosis", "anxiety", "AFFECT"], ["intestinal microbiota", "Parkinson's", "IS LINKED TO"], ["bacteria", "human gut microbiota", "PART OF"], ["Fecal Short-Chain Fatty Acid Alterations", "PD", "INFLUENCE"], ["PD", "complex multifactorial disease", "IS A"], ["neurodegeneration", "PD patients", "TARGET"], ["neurodegenerative disorders", "older population", "TARGET"], ["patients", "high-performance liquid chromatography-mass spectrometry", "USED BY"], ["Synucleinopathies", "multiple system atrophy", "AFFECT"], ["US participants", "Gut microbial composition analysis", "USED BY"], ["gut microbiota", "clinical symptoms", "IS LINKED TO"], ["GLP-1 (Glucagon-like Peptide-1) analogs", "Alzheimer's disease", "INFLUENCE"], ["gut microbiota", "sham-operated rats", "LOCATED IN"], ["gut microbiota", "GF-mice", "LOCATED IN"], ["dietary agents", "mental illness", "INFLUENCE"], ["gut microbiota", "neurodegenerative PCDs", "IS LINKED TO"], ["Valeric acid", "epilepsy", "INFLUENCE"], ["intestinal perforation", "gastrointestinal disorders", "AFFECT"], ["VD deficiency", "anxiety-related behavior", "AFFECT"], ["healthy gut microbiota", "PD", "IS LINKED TO"], ["TLR2 deficiency", "dopaminergic injury", "AFFECT"], ["Huntington's disease", "psychiatric abnormalities", "AFFECT"], ["Parkinson's disease", "primary chronic neurodegenerative disorder", "IS A"], ["resilient and susceptible mice", "16S rRNA analysis", "USED BY"], ["PD", "postural instability", "AFFECT"], ["PD patients", "multi-omics sequencing techniques", "USED BY"], ["gut microbiota", "prenatal chronic stress", "IS LINKED TO"], ["probiotics", "infant colic", "INFLUENCE"], ["exogenous melatonin", "Mn-induced neurogenesis impairment", "INFLUENCE"], ["anxiety", "individuals", "TARGET"], ["Parkinson's disease", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["Lactiplantibacillus", "neurodegenerative disease", "INFLUENCE"], ["gut microbiota", "inflammatory bowel disease", "IS LINKED TO"], ["Excessive alcohol intake", "gut microbiota", "CHANGE ABUNDANCE"], ["Probiotics", "Inflammatory Bowel Disease", "INFLUENCE"], ["ambient fine particulate matter", "Alzheimer's disease", "INFLUENCE"], ["dioscin", "Parkinson's disease", "INFLUENCE"], ["GI symptoms", "patients", "TARGET"], ["Stress", "COVID-19 patients", "TARGET"], ["FLZ", "gut microbiota", "IMPACT"], ["Vitamin D3 deficiency", "viral infections", "AFFECT"], ["alcohol use disorder", "Individuals", "TARGET"], ["FAE-producing gut microbiota", "Parkinson's", "IS LINKED TO"], ["gut microbiota", "gut", "LOCATED IN"], ["Parkinson's disease", "Propionivibrio", "CHANGE ABUNDANCE"], ["gut dysbiosis-induced neurodegeneration", "autism spectrum disorder", "AFFECT"], ["gut microbiome", "anxiety", "IS LINKED TO"], ["ET", "HCs", "TARGET"], ["gut microbiota", "loneliness", "IS LINKED TO"], ["HD", "cognitive and motor deficits", "IS A"], ["gut microbiota", "alcohol abuse", "IS LINKED TO"], ["multiple sclerosis", "neurodegenerative disorders", "IS A"], ["microbiota-derived extracellular vesicles", "psychiatric disorders", "INFLUENCE"], ["Gut Microbiome", "Mental Health Disparities", "IS LINKED TO"], ["Alzheimer's disease", "chronic age-related diseases", "IS A"], ["Nasal Microbiota", "Neurological Disorders", "IS LINKED TO"], ["acetylcholine", "olfactory dysfunction", "INFLUENCE"], ["\u03b2-amyloid", "prefrontal cortex", "LOCATED IN"], ["ginsenoside Rh4", "neuronal damage", "CHANGE EFFECT"], ["Gut Microbiome", "Patients", "LOCATED IN"], ["Gut Microbiota", "Parkinson's and Alzheimer's", "IS LINKED TO"], ["NAFLD", "patients", "TARGET"], ["feces", "mice", "LOCATED IN"], ["people", "16S V3 to V4 rRNA sequencing", "USED BY"], ["depressive disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["the gut microbiome", "inflammatory processes", "AFFECT"], ["WMI", "peri-hematoma region", "STRIKE"], ["gut microbiota", "hepatic encephalopathy", "IS LINKED TO"], ["medicinal herbs", "mental disorders", "INFLUENCE"], ["Fibroblast growth", "behavior deficits", "INFLUENCE"], ["PD mice", "16S rDNA sequencing", "USED BY"], ["psychiatric disorders", "pathological protein-related neurodegenerative diseases", "AFFECT"], ["curcumin", "anxiety-like behaviors", "INFLUENCE"], ["bacterial changes", "PD", "AFFECT"], ["Phytochemicals", "autism spectrum disorder", "INFLUENCE"], ["A2", "psychological distress", "INFLUENCE"], ["PD", "SNCA-transgenic (A53T) mice", "TARGET"], ["<i>Lactobacillus gasseri</i> CP2305", "irritable bowel syndrome", "INFLUENCE"], ["gut microbiota", "non-POD and POD mice", "LOCATED IN"], ["HCs", "16S amplicon sequencing", "USED BY"], ["microbial", "PD", "INFLUENCE"], ["biologically active polyphenols", "NDs", "INFLUENCE"], ["ambient fine particulate matter", "schizophrenia", "INFLUENCE"], ["Arketamine", "cognitive impairment", "CHANGE EFFECT"], ["HD", "cognitive deficits", "AFFECT"], ["Prevotellaceae", "PD mice", "LOCATED IN"], ["behavioral", "NW mothers", "TARGET"], ["Bacterial Butyrate", "Depressive Symptoms", "INFLUENCE"], ["Helicobacter pylori", "rigidity", "INFLUENCE"], ["intestinal flora", "Fecal metabolomics", "USED BY"], ["TMAO", "Alzheimer's", "INFLUENCE"], ["(R,S)-ketamine", "patients", "ADMINISTERED"], ["inflammation", "Multiple Sclerosis", "AFFECT"], ["probiotic mixture", "Lactobacillus helveticus", "IMPACT"], ["probiotics", "Salmonella enterica", "IMPACT"], ["MS", "PD", "AFFECT"], ["Idiopathic rapid eye movement sleep behavior disorder", "Parkinson's Disease", "AFFECT"], ["PD patients", "targeted bisulfite sequencing", "USED BY"], ["psychosis", "patients", "TARGET"], ["intestinal microflora", "Alzheimer's disease", "IS LINKED TO"], ["gut microbiome", "Graves' Disease", "IS LINKED TO"], ["neurotoxin 1-methyl-4-phenylpyridinium", "PD", "INFLUENCE"], ["SCFAs", "AD", "INFLUENCE"], ["\u03b1-syn", "PD", "INFLUENCE"], ["GI dysfunction", "gut microbiota", "CHANGE ABUNDANCE"], ["ketamine", "treatment-resistant patients", "ADMINISTERED"], ["probiotic supplementation", "gut microbiota", "IMPACT"], ["Sodium Butyrate", "Gut Microbiota", "IMPACT"], ["autism spectrum disorders", "neurological disorders", "IS A"], ["Gut microbiota", "motor deficits", "IS LINKED TO"], ["neurotrophins", "LBD", "INFLUENCE"], ["gastrointestinal disturbance", "PD", "AFFECT"], ["Fiber intake", "anxiety", "INFLUENCE"], ["metabolic dysfunction", "MDD", "AFFECT"], ["homovanillic acid", "Bifidobacterium longum", "IMPACT"], ["post-acute COVID-19 infection", "AIS patients", "TARGET"], ["oxidative stress", "multiple sclerosis", "AFFECT"], ["anxiety", "mental health problems", "IS A"], ["damaged intestinal system", "PD mice", "LOCATED IN"], ["LPS", "neuroinflammation", "INFLUENCE"], ["altered microbiomes", "neurodegeneration", "IS LINKED TO"], ["MSA", "neurological diseases", "IS A"], ["protein", "gut microbiota", "PRODUCED BY"], ["Gut microbiota", "brain", "LOCATED IN"], ["gut microbiota", "neurodegenerative diseases", "IS LINKED TO"], ["Alzheimer's disease", "dementia", "AFFECT"], ["Parkinson's disease", "Faecalibacterium prausnitzii", "CHANGE ABUNDANCE"], ["capsaicin", "mental disorders", "INFLUENCE"], ["bacterial", "persistent infection", "INFLUENCE"], ["dietary fiber", "human microbiome", "IMPACT"], ["Vitamin D deficiency", "dysmetabolism", "AFFECT"], ["gut microbiota", "cognitive impairment", "IS LINKED TO"], ["Dysbiosis", "inflammatory diseases", "AFFECT"], ["Oral pathogens", "Parkinson's disease", "INFLUENCE"], ["Intestinal dysbiosis", "PD", "AFFECT"], ["gut microbes", "Parkinson's disease", "INFLUENCE"], ["Parkinson's disease dementia", "manganese", "INTERACT"], ["propionate", "neuroinflammation", "INFLUENCE"], ["gut microbiota", "Alterations", "IS LINKED TO"], ["Gut Microbiota Alterations", "Parkinson's Disease", "AFFECT"], ["Gut Microbiota", "Mice", "LOCATED IN"], ["sodium butyrate", "\u03b1-Synuclein mRNA", "CHANGE EXPRESSION"], ["epigallocatechin-3-gallate", "NDs", "INFLUENCE"], ["neurodegenerative diseases", "human patients", "TARGET"], ["neurodegeneration", "patients", "TARGET"], ["mild Alzheimer's disease", "patients", "TARGET"], ["NaB", "\u03b1-Synuclein mRNA", "CHANGE EXPRESSION"], ["Gut Microbiome", "Neurotoxicity", "IS LINKED TO"], ["Gut microbiota dysbiosis", "attention deficit hyperactivity disorder", "AFFECT"], ["Parkinson's disease", "brain-related diseases", "IS A"], ["TMAO", "ischemic stroke", "INFLUENCE"], ["anti-Saccharomyces cerevisiae antibody", "IBD", "INFLUENCE"], ["probiotics", "brain-gut-microbiota axis associated disorders", "INFLUENCE"], ["gut microbiome", "C57BL/6 mice", "LOCATED IN"], ["Urinary Inflammatory Biomarkers", "Children", "TARGET"], ["coronavirus infection", "dysfunction of the RAAS", "AFFECT"], ["multispecies probiotics", "anxiety", "INFLUENCE"], ["COVID-19 clinical manifestations", "hyposmia", "AFFECT"], ["GM", "anxiety-like and depression-like behavior", "IS LINKED TO"], ["Manganese-induced sex-specific gut microbiome perturbations", "C57BL/6 mice", "TARGET"], ["Metformin", "insulin resistance", "CHANGE EFFECT"], ["patients", "16S rDNA sequencing", "USED BY"], ["gut microbiome", "ALS", "IS LINKED TO"], ["Coprococcus_2", "intestinal inflammation", "INFLUENCE"], ["controls", "metagenomic analysis", "USED BY"], ["gut microbiota", "older individuals", "LOCATED IN"], ["behavioral", "Children", "TARGET"], ["probiotics", "microbiota of the newborn", "IMPACT"], ["gut microbiota", "methamphetamine-associated alterations", "IS LINKED TO"], ["Multifunctional Selenium Nanoparticles", "Altered Gut Microbiota", "IMPACT"], ["polycystic ovary syndrome", "patients", "TARGET"], ["gut microbiota", "cerebrovascular diseases", "IS LINKED TO"], ["acetylcholine", "Alzheimer's Disease", "INFLUENCE"], ["fiber", "Japanese workers", "ADMINISTERED"], ["Altered gut microbiota", "idiopathic Parkinson's disease", "IS LINKED TO"], ["gut microbiota", "socially isolated mice", "LOCATED IN"], ["bipolar disorder", "Firmicutes", "CHANGE ABUNDANCE"], ["gut microbiota-derived SCFAs", "age-related neurodegenerative disorders", "INFLUENCE"], ["APs", "schizophrenia", "CHANGE EFFECT"], ["Inflammatory Bowel Syndromes", "neurodegenerative and neuropsychiatric diseases", "AFFECT"], ["<i>L. plantarum</i> CCFM405", "dopaminergic neuronal death", "INFLUENCE"], ["dysbiosis", "Parkinson's Disease", "AFFECT"], ["Anti-inflammatory drugs", "depressive symptoms", "CHANGE EFFECT"], ["Ketamine", "susceptible mice", "ADMINISTERED"], ["Parkinson's disease", "male PD patients", "TARGET"], ["GEP", "dysbiosis", "INFLUENCE"], ["Maslinic acid", "PD", "INFLUENCE"], ["ALS", "brain disorders", "IS A"], ["motor and cognitive dysfunction", "PD mice", "TARGET"], ["Probiotics", "Mental Health", "INFLUENCE"], ["Parkinson's Disease", "human midbrain", "STRIKE"], ["iron", "mental and physical fatigue", "INFLUENCE"], ["gut microbiota", "metagenomic sequencing", "USED BY"], ["intestinal immune alterations", "PD-related neurodegeneration", "AFFECT"], ["Bile acids", "liver", "LOCATED IN"], ["motor symptoms", "humans", "TARGET"], ["Mn", "microglia overactivation", "AFFECT"], ["Clostridium perfringens", "food poisoning", "INFLUENCE"], ["motor dysfunction", "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice", "TARGET"], ["gut microbiota", "behavioural deficits", "IS LINKED TO"], ["anxiety", "patients", "TARGET"], ["Parkinson's disease", "psychiatric and neurologic disorders", "IS A"], ["MDD", "disability", "AFFECT"], ["gut microbiota alterations", "autism", "AFFECT"], ["FC", "patients", "TARGET"], ["dimethylglycine", "glial overactivation", "INFLUENCE"], ["CMM", "gut dysbiosis", "CHANGE EFFECT"], ["indoles", "multiple sclerosis", "INFLUENCE"], ["iRBD", "Multiple System Atrophy", "AFFECT"], ["COVID-19", "acute ischemic stroke (AIS) patients", "TARGET"], ["short-chain fatty acids", "neuroinflammation", "INFLUENCE"], ["gut microbiota", "stroke", "IS LINKED TO"], ["Bacteroides eggerthii", "PTSD", "INFLUENCE"], ["Mn", "Parkinson's-like neurological disorders", "INFLUENCE"], ["toxic metals", "Gut Microbiota", "IMPACT"], ["MS", "CNS-affected autoimmune demyelination condition", "IS A"], ["functional constipation", "patients", "TARGET"], ["Microbiome", "schizophrenia", "IS LINKED TO"], ["KD", "dysbiosis", "INFLUENCE"], ["depression", "Faecalibacterium prausnitzii", "CHANGE ABUNDANCE"], ["gut microbiota", "psychotic syndrome", "IS LINKED TO"], ["ASD", "females", "TARGET"], ["pesticides", "PD", "INFLUENCE"], ["gut microbiota", "PD pathogenesis", "IS LINKED TO"], ["gut microbiota", "intestine", "LOCATED IN"], ["gut microbiota", "muscle wasting", "IS LINKED TO"], ["Parkinson's disease", "PD", "AFFECT"], ["terpenoids", "neurological and psychological conditions", "INFLUENCE"], ["Environmental toxicants", "cognitive impairment", "INFLUENCE"], ["Inflammation", "PD", "AFFECT"], ["inflammation of the gut", "Parkinson's disease", "AFFECT"], ["epilepsy", "neurological disorders", "IS A"], ["NaB", "PD", "INFLUENCE"], ["gut dysbiosis", "Huntington's disease transgenic mice", "TARGET"], ["Gut Microbiota", "Obesity", "IS LINKED TO"], ["IBS", "Individuals", "TARGET"], ["bipolar disorder", "serious mental illnesses", "IS A"], ["neuronal damage", "patients", "TARGET"], ["multisystem atrophy", "neurological diseases", "IS A"], ["Saturated fatty acids", "oxidative stress", "INFLUENCE"], ["Asaccharobacter", "LH susceptible rats", "LOCATED IN"], ["gut dysbiosis", "Huntington's", "AFFECT"], ["gut microbiota", "psychiatric conditions", "IS LINKED TO"], ["Bifidobacterium", "mice", "LOCATED IN"], ["Alzheimer's disease", "Neurodegenerative diseases", "IS A"], ["neuroinflammation", "Parkinson's disease", "AFFECT"], ["stress", "offspring", "TARGET"], ["patient-derived intestinal microbiota", "motor dysfunction", "IS LINKED TO"], ["disulfiram", "alcohol addiction", "CHANGE EFFECT"], ["medication-naive children and adolescents", "shotgun metagenomics", "USED BY"], ["fermented food", "depressive illness", "INFLUENCE"], ["SARS-CoV-2 infections", "Parkinson's disease patients", "TARGET"], ["amyotrophic lateral sclerosis", "neurological disorders", "IS A"], ["commensal microbiota", "Parkinson disease", "IS LINKED TO"], ["Cancer", "young adults", "TARGET"], ["Akk", "PD", "INFLUENCE"], ["PD", "human midbrain", "STRIKE"], ["inflammation", "overweight teens", "TARGET"], ["\u03b1-synuclein fibrils", "PD", "INFLUENCE"], ["Fecal microbiota", "patients", "LOCATED IN"], ["hippocampus", "mice", "LOCATED IN"], ["valeric acid", "epilepsy", "INFLUENCE"], ["neurodegeneration", "AD", "AFFECT"], ["depressive behaviors", "rats", "TARGET"], ["repurposed drugs", "NPDs", "CHANGE EFFECT"], ["PD patients", "metagenomics", "USED BY"], ["prebiotics", "gastrointestinal and neurological conditions", "INFLUENCE"], ["dysbiosis of the skin microbiome", "problems", "AFFECT"], ["gut microbiome", "human participants", "LOCATED IN"], ["AN", "individuals", "TARGET"], ["Serum and Fecal Metabolites", "Metabolic Perturbations", "INFLUENCE"], ["modern therapeutic drugs", "depression", "CHANGE EFFECT"], ["neuroinflammation", "mice", "TARGET"], ["salt", "obesity", "INFLUENCE"], ["short-chain fatty acids", "inflammation", "INFLUENCE"], ["fecal microbiota", "Meth-administrated mice", "LOCATED IN"], ["malfunctioning of the internal clock", "low-grade inflammation", "AFFECT"], ["\u03b1-synuclein", "PD", "INFLUENCE"], ["Psychobiotics", "GBA disorders", "INFLUENCE"], ["PD patients", ",", "USED BY"], ["Curcumin", "Irritable Bowel Syndrome", "INFLUENCE"], ["Rosmarinic acid", "intestinal inflammation", "INFLUENCE"], ["sarecycline", "severe infection-related pathologies", "CHANGE EFFECT"], ["MPTP", "acute PD model mice", "ADMINISTERED"], ["Ketamine", "schizophrenia-like symptoms", "CHANGE EFFECT"], ["gut microbiome", "brain", "LOCATED IN"], ["GM", "dementia", "IS LINKED TO"], ["autism spectrum disorder", "patients", "TARGET"], ["Fecal gut microbiota", "Phylogenetic Investigation", "USED BY"], ["PD patients", "resting-state functional magnetic resonance imaging", "USED BY"], ["motor and cognitive deficits", "MPTP-induced PD mice", "TARGET"], ["squamosamide derivative", "PD", "INFLUENCE"], ["medications", "gut microbiota", "IMPACT"], ["gut microbiota", "rapid-eye-movement sleep behavior disorder", "IS LINKED TO"], ["meropenem", "pro-inflammatory", "INTERACT"], ["splenomegaly", "saline-treated mice", "TARGET"], ["fecal microbiota", "specific pathogen-free (SPF) mice", "LOCATED IN"], ["Gut microbiota changes", "people", "TARGET"], ["Bacteroides", "PD", "INFLUENCE"], ["PD", "RBD", "AFFECT"], ["striatum", "PD mice", "LOCATED IN"], ["Intestinal inflammation", "people", "TARGET"], ["gut microbes", "multiple sclerosis", "IS LINKED TO"], ["semaglutide", "serotonin", "INTERACT"], ["probiotics", "AD and PD patients", "ADMINISTERED"], ["Human Fecal Microbiota", "MPTP-Induced Neurotoxicity", "IS LINKED TO"], ["MS", "Parabacteroides", "CHANGE ABUNDANCE"], ["gut microbiota", "person", "LOCATED IN"], ["underweight", "Parkinson's disease", "AFFECT"], ["bipolar disorder", "Faecalibacterium", "CHANGE ABUNDANCE"], ["APs", "psychiatric disorders", "CHANGE EFFECT"], [", high-sugar diets", "immune dysfunction", "INFLUENCE"], ["PD", "colonic diverticular disease", "AFFECT"], ["Dietary Components", "Mental Disorders", "INFLUENCE"], ["gut dysbacteriosis", "PD", "AFFECT"], ["schizophrenia", "neuropsychiatric and neurodegenerative disorders", "IS A"], ["anxiety", "IBD patients", "TARGET"], ["Amyotrophic lateral sclerosis", "Parkinson's disease", "AFFECT"], ["borderline personality disorder", "participants", "TARGET"], ["constipation", "patients", "TARGET"], ["fecal microbiota", "metabolomics analysis", "USED BY"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine", "acute PD model mice", "ADMINISTERED"], ["distress", "participants", "TARGET"], ["Phytochemicals", "Parkinson's disease", "INFLUENCE"], ["rotenone", "motor symptoms", "CHANGE EFFECT"], ["butyrate", "Parkinson's", "INFLUENCE"], ["esketamine", "phencyclidine-induced cognitive deficits", "CHANGE EFFECT"], ["active metabolites", "neurological symptoms", "INFLUENCE"], ["gut microbiota", "metabonomic analysis", "USED BY"], ["unilateral 6-hydroxydopamine (6-OHDA)-induced PD", "rats", "TARGET"], ["salivary microbiome", "depression", "IS LINKED TO"], ["AN", "adolescent patients aged 12 to", "TARGET"], ["reactive oxygen species", "imbalance of immune functions", "INFLUENCE"], ["ASD", "patients", "TARGET"], ["Gut microbiota dysbiosis", "depression", "AFFECT"], ["gut microbiome", "participants", "LOCATED IN"], ["Gut Microbiota", "fecal 16S rRNA gene sequencing", "USED BY"], ["IBDs", "neurodegeneration", "AFFECT"], ["intestinal and oral microbiota", "metagenomic sequencing", "USED BY"], ["neuroinflammation", "neurological disorders", "AFFECT"], ["psychobiotics", "Parkinson's disease", "INFLUENCE"], ["faecal microbiota", "AN", "IS LINKED TO"], ["Parkinson's disease", "rotenone-challenged mice", "TARGET"], ["Urine", "Patients", "LOCATED IN"], ["in", "gastrointestinal", "STRIKE"], ["microbiota", "Mild cognitive impairment", "IS LINKED TO"], ["toxic metabolites", "GBA dysregulation", "INFLUENCE"], ["C57BL/6 mice", "wire hanging tests", "USED BY"], ["psychiatric illness", "patients", "TARGET"], ["probiotics", "depression", "INFLUENCE"], ["Gut dysbiosis", "small intestine", "STRIKE"], ["Infectious Microorganisms", "Parkinson's Disease", "INFLUENCE"], ["gut microbiome", "NDDs", "IS LINKED TO"], ["Parkinson's disease", "MPTP-induced mouse model", "TARGET"], ["gut microbiome", "16S V3 to V4 rRNA sequencing", "USED BY"], ["pharmacological", "inflammation", "INFLUENCE"], ["fermented foods", "depression", "INFLUENCE"], ["gut microbial flora", "brain", "LOCATED IN"], ["Bacteroidota", "subchronic mice", "LOCATED IN"], ["schizophrenia", "schizophrenia-like behaviors", "AFFECT"], ["Synbiotic supplementation", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "individuals", "LOCATED IN"], ["bile acids", "cardiovascular disease", "INFLUENCE"], ["mild withdrawal symptoms", "gut microbiota", "CHANGE ABUNDANCE"], ["Alzheimer's disease", "age-related neurodegenerative disorders", "IS A"], ["gut microbiome", "psychiatric disorders", "IS LINKED TO"], ["f_Ruminococcaceae", "gut microbiota", "PART OF"], ["PD", "motor symptoms", "IS A"], ["Insulin resistance", "AD", "AFFECT"], ["NJ241", "MPTP-induced weight loss", "INFLUENCE"], ["Ruminococcaceae", "susceptible mice", "LOCATED IN"], ["peripheral tissues", "male rats", "LOCATED IN"], ["headache", "patients", "TARGET"], ["gut microbiota", "neurological or neuropsychiatric diseases", "IS LINKED TO"], ["Mental disorders", "neuroinflammatory processes", "AFFECT"], ["Toxin-like Peptides", "Gut Microbiome", "IMPACT"], ["gut microbiome (GM) dysbiosis", "Alzheimer's disease", "AFFECT"], ["trehalose", "Mice", "ADMINISTERED"], ["E. coli", "obesity", "INFLUENCE"], ["Parkinson's disease", "Clostridium", "CHANGE ABUNDANCE"], ["ambient fine particulate matter", "autism spectrum disorders", "INFLUENCE"], ["Cognitive impairment", "schizophrenia", "AFFECT"], ["microbiomes", "inflammatory bowel disease", "IS LINKED TO"], ["Gastrointestinal (GI) dysfunction", "parkinsonian syndromes", "AFFECT"], ["intestinal microbiome", "toxicity", "IS LINKED TO"], ["mental health impairment", "Individuals", "TARGET"], ["3-nitrophenylhydrazine", "GMs", "INTERACT"], ["Food insecurity", "loss of happiness", "AFFECT"], ["HAND", "cognitive impairment", "AFFECT"], ["PD", "irritable bowel syndrome", "AFFECT"], ["Bacterial Butyrate", "Changes", "INFLUENCE"], ["cytokines", "AD", "INFLUENCE"], ["Iron deficiency", "iron deficiency", "AFFECT"], ["inulin supplementation", "intestinal microbiota", "IMPACT"], ["TPPU", "ASD-like behaviors", "CHANGE EFFECT"], ["neurotrophins", "PD", "INFLUENCE"], ["gut microbiota", "juvenile offspring", "LOCATED IN"], ["Gut Dysbiosis", "Neurological Diseases", "IS A"], ["anti-neuroinflammatory fullerenes", "PD", "INFLUENCE"], ["Parkinson's disease", "mouse model", "TARGET"], ["motor deficits", "PD-like mice", "TARGET"], ["gut microbiota", "Parkinson 's disease", "IS LINKED TO"], ["Alzheimer's", "Neurodegenerative protein conformational diseases", "IS A"], ["GI microbiota", "adults", "LOCATED IN"], ["gut microbiome dysbiosis", "depression", "AFFECT"], ["dysbiosis", "PD", "AFFECT"], ["dysbiosis of gut microbiota", "neurological disorders", "AFFECT"], ["IF-elevated sarcosine", "glial overactivation", "INFLUENCE"], ["gut microbiota", "PD patients", "LOCATED IN"], ["PD", ", and progressive", "IS A"], ["intestinal bacterium Christensenella minuta DSM 32891", "cardiometabolic disturbances", "INFLUENCE"], ["NJ241", "behavioral deficits", "INFLUENCE"], ["Probiotic <", "MPTP-induced oxidative stress", "INFLUENCE"], ["intestinal microbiota", "PD", "IS LINKED TO"], ["PD-related constipation", "Bacteroidetes", "CHANGE ABUNDANCE"], ["ASD", "GM", "CHANGE ABUNDANCE"], ["Phytochemicals", "neurological disorders", "INFLUENCE"], ["dysbiosis", "OCD", "AFFECT"], ["major depressive disorder", "gut microbiota", "CHANGE ABUNDANCE"], ["neurological disorders", "participants", "TARGET"], ["healthy controls", "high-performance liquid chromatography-mass spectrometry", "USED BY"], ["PD patients", "full-length 16S rRNA analyses", "USED BY"], ["Alzheimer's disease", "Americans", "TARGET"], ["colon", "PD mice", "LOCATED IN"], ["colic", "infants", "TARGET"], ["gut inflammation", "PD", "AFFECT"], ["microbial metabolites", "NDs", "INFLUENCE"], ["host glycans", "PD", "INFLUENCE"], ["dysbiotic", "PD-related neurodegeneration", "IS LINKED TO"], ["Huntington's", "Neurodegenerative protein conformational diseases", "IS A"], ["IBS", "functional gastrointestinal disorder", "IS A"], ["Alzheimer's disease", "neurological diseases", "IS A"], ["RA", "gut microbiome", "CHANGE ABUNDANCE"], ["interleukin-6", "gut microbiota", "IMPACT"], ["bacterial microbiomes", "infectious disease", "IS LINKED TO"], ["mental illness", "individuals", "TARGET"], ["12-year-old children", "16S rRNA gene sequencing", "USED BY"], ["Gut microbiota dysbiosis", "\u03b1-synuclein-related pathology", "AFFECT"], ["Microbiota", "Huntington's Disease", "IS LINKED TO"], ["oxidative stress", "neurodegenerative diseases", "AFFECT"], ["saturated fat", "Gut Microbiota", "IMPACT"], ["Gut microbiome", "human gastrointestinal tract", "LOCATED IN"], ["IBD", "adults", "TARGET"], ["MUD", "Faecalibacterium", "CHANGE ABUNDANCE"], ["gut microbiome", "attentional deficits", "IS LINKED TO"], ["fruits", "mental disorders", "INFLUENCE"], ["non-motor symptoms of PD", "patients", "TARGET"], ["curcumin", "gut microbiome", "IMPACT"], ["Zanthoxylum bungeanum", "mental disorders", "INFLUENCE"], ["Lactobacillus", "socially isolated mice", "LOCATED IN"], ["PP treatment", "MPTP-induced motor deficits", "INFLUENCE"], ["serum bacterial metabolites", "gut microbiota", "IMPACT"], ["dysbiosis", "dementia", "AFFECT"], ["gut microbiota", "IBD", "IS LINKED TO"], ["MPTP", "PD-like neurotoxicity", "INFLUENCE"], ["behavioral and cognitive symptoms", "PD patients", "TARGET"], ["age-related neurological diseases", "females", "TARGET"], ["NJ241", "gastrointestinal dysfunction", "INFLUENCE"], ["HC", "neurological diseases", "IS A"], ["gut microbiota", "dopa-unresponsive symptoms", "IS LINKED TO"], ["Roseburia inulinivorans", "older group", "LOCATED IN"], ["Prebiotics", "Mental Health", "INFLUENCE"], ["antimicrobial peptides defensin 5 alpha", "ALS intestine", "LOCATED IN"], ["Dysbiosis", "hepatic cancer", "AFFECT"], ["synbiotics", "mental health disorders", "INFLUENCE"], ["short-chain fatty acids", "gut microbiota", "IMPACT"], ["alterations in gut microbiota composition", "dysbiosis", "AFFECT"], ["antidepressant drugs", "depressive symptoms", "CHANGE EFFECT"], ["gut microbiota", "irritable bowel syndrome", "IS LINKED TO"], ["AD", "degenerative disease", "IS A"], ["next-generation probiotics", "oxidative stress", "INFLUENCE"], ["Ginger Root Powder", "Fatigue", "INFLUENCE"], ["attention deficit hyperactivity disorder", "neuropsychiatric and neurological disorders", "IS A"], ["Postpartum depression", "PPD patients", "TARGET"], ["Neuroinflammation", "Parkinson's Disease", "AFFECT"], ["prion proteins", "neurological disorders", "INFLUENCE"], ["depressive episodes", "short-chain fatty acids-producing bacterial genera", "CHANGE ABUNDANCE"], ["Trimethylamine N-oxide", "Glial Reaction", "INFLUENCE"], ["Gut dysbiosis", "Huntington's disease", "AFFECT"], ["gut microbiome", "dysbiosis", "AFFECT"], ["Bifidobacterium breve Bif11", "oxidative stress", "INFLUENCE"], ["Reduced anti-inflammatory gut microbiota", "anhedonia", "IS LINKED TO"], ["microbiota", "epilepsy", "IS LINKED TO"], ["substantia nigra", "PrP-A53T mice", "LOCATED IN"], ["rotenone", "central nervous system (CNS) pathology", "CHANGE EFFECT"], ["intestinal microbiota", "GI and non-GI disorders", "IS LINKED TO"], ["gut microbiota", "psychotic disorders", "IS LINKED TO"], ["gut microbiota", "BD", "IS LINKED TO"], ["antibiotics", "psychotic episodes", "CHANGE EFFECT"], ["gut microbes", "intestinal perforation", "INFLUENCE"], ["ketamine", "mood disorders", "CHANGE EFFECT"], ["gut microbiota", "control, resilient, and susceptible mice", "LOCATED IN"], ["PD patient", "metagenomic analysis", "USED BY"], ["PD", "healthy individuals", "TARGET"], ["oral and gut microbiota", "AD patients", "LOCATED IN"], ["gut microbiome", "16S rRNA gene sequencing", "USED BY"], ["violence behaviors", "schizophrenia patients", "TARGET"], ["irritable bowel syndrome", "Individuals", "TARGET"], ["IBDs", "affective symptoms", "AFFECT"], ["mycobiota", "ITS2 sequencing", "USED BY"], ["chicken gut microbiome", "food poisoning", "IS LINKED TO"], ["gut dysbiosis-induced neurodegeneration", "Alzheimer's disease", "AFFECT"], ["gut microbiota", "host gut", "LOCATED IN"], ["Bifidobacterium", "stress", "INFLUENCE"], ["alterations in the enteric nervous system", "MS", "AFFECT"], ["fecal microbial alterations", "METH addictions", "AFFECT"], ["epilepsy", "rats", "TARGET"], ["curcumin", "gut microbiota", "IMPACT"], ["Alzheimer's", "patients", "TARGET"], [", high-sugar diets", "inflammation", "INFLUENCE"], ["mood disorders", "Females", "TARGET"], ["LPS", "permeability", "INFLUENCE"], ["inborn errors of metabolism", "patients", "TARGET"], ["vitamin D", "bariatric patients", "ADMINISTERED"], ["Depression", "Parkinson's disease", "AFFECT"], ["red wine", "PD", "INFLUENCE"], ["arketamine", "gut microbiota", "IMPACT"], ["prebiotics", "mental disorders", "INFLUENCE"], ["BCAAs", "PD", "INFLUENCE"], ["Parkinson's disease", "autoimmune diseases", "IS A"], ["Cognitive impairment", "psychiatric disorders", "AFFECT"], ["IBS", "healthy individuals", "TARGET"], ["polyphenols", "Antiparkinsonian effects", "INFLUENCE"], ["concomitant PD-associated gut dysbiosis", "PD", "AFFECT"], ["gut dysbiosis", "Parkinson's", "AFFECT"], ["psychobiotic combination", "Bifidobacterium longum</i> R0175", "IMPACT"], ["progressive neuron loss", "patients", "TARGET"], ["\u03b1-synuclein fibrils", "intestinal neural plexus", "LOCATED IN"], ["Phytochemicals", "Alzheimer's disease", "INFLUENCE"], ["Parkinson's disease", "age-related neurodegenerative disorders", "IS A"], ["synbiotics", "neurological disorders", "INFLUENCE"], ["Fecal propionic acid", "autonomic dysfunction", "INFLUENCE"], ["intractable epilepsy", "patients", "TARGET"], ["Intestinal inflammation", "animals", "TARGET"], ["vitamin D", "anxiety disorders", "INFLUENCE"], ["gut microbiota", "neurodevelopmental, neuropsychiatric, and neurological conditions", "IS LINKED TO"], ["dopaminergic neuron loss", "elderly population", "TARGET"], ["young microbiota", "neuroinflammation", "IS LINKED TO"], ["Parkinson's disease", "neurological degenerative condition", "IS A"], ["gut microbiota", "NAFLD patients", "LOCATED IN"], ["gut microbiota", "patients", "LOCATED IN"], ["ambient fine particulate matter", "neurodevelopmental disorders", "INFLUENCE"], ["gut microbiota", "NDs", "IS LINKED TO"], ["synbiotics", "patients", "ADMINISTERED"], ["Neurodegenerative diseases", "elderly people", "TARGET"], ["BD", "healthy control subjects", "TARGET"], ["gut dysbiosis", "mucosal inflammation", "AFFECT"], ["Buyang Huanwu decoction", "Parkinson's disease", "INFLUENCE"], ["neuropsychiatric diseases", "METH addictions", "AFFECT"], ["fecal microbiota", "PD patients", "LOCATED IN"], ["SCFAs", "Parkinson's disease", "INFLUENCE"], ["inflammation", "gut", "STRIKE"], ["oral cavity", "PD patients", "LOCATED IN"], ["Parkinson's disease", "neurodegenerative disorder", "IS A"], ["NAFLD", "subjects", "TARGET"], ["gut microbiota", "control (no stress) rats", "LOCATED IN"], ["FA", "neurodegenerative diseases", "INFLUENCE"], ["probiotics", "gut dysbiosis", "INFLUENCE"], ["Manganese", "neurodegenerative disorders", "INFLUENCE"], ["metformin", "gut microbiota", "IMPACT"], ["hepatic ischemia/reperfusion (HI/R) injury", "mice", "TARGET"], ["alterations in the enteric nervous system", "gut microbiome", "CHANGE ABUNDANCE"], ["microbiota-derived molecules", "anxiety", "INFLUENCE"], ["antimicrobial peptides defensin 5 alpha", "intestinal microbiome", "IMPACT"], ["\u03b1Syn proteins", "NSE-h\u03b1Syn Tg mice", "LOCATED IN"], ["glucuronomannan oligosaccharides", "Saccharina japonica", "IMPACT"], ["AD transgenic mice", "16S rRNA gene sequencing", "USED BY"], ["Trihexyphenidyl", "parkinsonism", "CHANGE EFFECT"], ["gut microbiota", "liver", "LOCATED IN"], ["GLP-1 1", "Lactobacillus", "IMPACT"], ["Gut Microbiota", "Neurological and Psychological Disorders", "IS LINKED TO"], ["oxidative stress", "Parkinson's Disease", "AFFECT"], ["PD", "gastrointestinal diseases", "AFFECT"], ["inflammatory lipopolysaccharide", "gut microbiota", "IMPACT"], ["microbiota-mediated UDCA", "ischemic stroke", "INFLUENCE"], ["butyrate", "motor symptoms", "INFLUENCE"], ["mice", "next generation sequencing", "USED BY"], ["MUD", "individuals", "TARGET"], ["MDD", "adults", "TARGET"], ["MUD", "Odoribacter", "CHANGE ABUNDANCE"], ["patients", "16S rRNA sequencing", "USED BY"], ["neuronal loss", "MSA", "AFFECT"], ["Alzheimer's", "neurodegenerative diseases", "IS A"], ["placebo", "patients", "ADMINISTERED"], ["synbiotics", "Parkinson's disease", "INFLUENCE"], ["nutraceuticals", "Parkinson's disease", "INFLUENCE"], ["PD", "neurodegenerative diseases", "IS A"], ["Mental Health Disparities", "Hispanics", "TARGET"], ["Fermented Foods", "inflammatory diseases", "INFLUENCE"], ["RHSD", "cognitive impairment", "INFLUENCE"], ["Rh4", "synaptic structural damage", "CHANGE EFFECT"], ["prebiotics", "PD", "INFLUENCE"], ["gut microbiome", "Alzheimer's Disease", "IS LINKED TO"], ["dimethylglycine", "5XFAD mice", "ADMINISTERED"], ["Maternal obesity", "offspring", "TARGET"], ["gut microbiota composition", "obesity", "IS LINKED TO"], ["Gut Dysbiosis", "Rats", "TARGET"], ["Bone fragility", "susceptibility", "AFFECT"], ["fecal microbiota", "MPTP-induced PD", "IS LINKED TO"], ["MCI", "Firmicutes", "CHANGE ABUNDANCE"], ["Depression", "mental illnesses", "IS A"], ["MPTP-Induced Nigrostriatal Degeneration", "Aged Mice", "TARGET"], ["dopamine agonists", "PD", "CHANGE EFFECT"], ["mild to moderate Alzheimer's", "age- and sex-matched controls", "TARGET"], ["Lactiplantibacillus plantarum SG5", "neuroinflammation", "INFLUENCE"], ["Huntington's", "neurodegenerative diseases", "IS A"], ["acetate", "chronic cerebral hypoperfusion", "INFLUENCE"], ["gut microbiota", "oxidative stress", "IS LINKED TO"], ["Gut Microbiota", "Neuroinflammation", "IS LINKED TO"], ["SCFAs", "Alzheimer's disease", "INFLUENCE"], ["reactive astrocytosis", "age-related cognitive decline", "AFFECT"], ["Gut microbiota", "neurodegeneration", "IS LINKED TO"], ["Parkinson's and Alzheimer's", "Patients", "TARGET"], ["dopamine agonists", "host's gut microbiota", "IMPACT"], ["depression", "neurodegenerative disorders", "IS A"], ["Aberrant Intestinal Microbiome", "adults", "LOCATED IN"], ["non-motor and motor symptoms", "PD", "AFFECT"], ["cyclophosphamide", "Enterococcus hirae", "IMPACT"], ["KD", "neurodegenerative diseases", "INFLUENCE"], ["Parkinson's disease", "age-associated diseases", "IS A"], ["gut microbiome", "16S amplicon sequencing", "USED BY"], ["BEVs", "neuroinflammation", "INFLUENCE"], ["RA", "Chinese patients", "TARGET"], ["phytochemicals", "neurological and psychological problems", "INFLUENCE"], ["Meth", "Toll-like receptor 4 (TLR4)-related colonic inflammation", "CHANGE EFFECT"], ["PD", "human participants", "TARGET"], ["herbal extracts", "gut microbiota", "IMPACT"], ["metabolic dysfunction", "hormonal alterations", "AFFECT"], ["Dysbiosis", "bacterial imbalance", "AFFECT"], ["neurodegeneration", "FD", "AFFECT"], ["Gut Microbiota", "Parkinson's Disease Pathophysiology", "IS LINKED TO"], ["<i>B. lactis</i> MH-022 supplementation", "motor deficits", "INFLUENCE"], ["toxin-like peptides", "gut microbiome", "IMPACT"], ["autoimmune disorders", "depression", "AFFECT"], ["Huntington's disease", "neurological and psychological disorders", "IS A"], ["cecal microbiome", "metagenomic analysis", "USED BY"], ["Morphine-Induced Conditioned Place Preference", "Rats", "TARGET"], ["Parkinson Disease", "neurodegenerative disorders", "IS A"], ["Parkinson disease", "gut microbiota", "CHANGE ABUNDANCE"], ["Cannabinoids", "intestinal inflammation", "INFLUENCE"], ["acetate", "depression", "INFLUENCE"], ["Gut Microbiome", "Isolated Dystonia", "IS LINKED TO"], ["Dysbiosis", "depression", "AFFECT"], ["fibers", "PD", "INFLUENCE"], ["Bacteroides thetaiotaomicron", "PTSD", "INFLUENCE"], ["FC patients", "liquid chromatography-mass spectrometry", "USED BY"], ["A. muciniphila", "PD", "INFLUENCE"], ["gut microbiota", "neuropathic pain-associated anhedonia", "IS LINKED TO"], ["de novo Parkinson disease", "patients", "TARGET"], ["psychological distress", "women", "TARGET"], ["BEVs", "pathology", "INFLUENCE"], ["Gastrodia elata", "Parkinson's disease", "INFLUENCE"], ["APs", "disruptive behavioral conditions", "CHANGE EFFECT"], ["Dysbiosis", "Crohn's disease", "AFFECT"], ["antibiotic treatment", "intestinal microbiota", "IMPACT"], ["constipation", "Parkinson's disease", "AFFECT"], ["gut microbiota", "delirium", "IS LINKED TO"], ["Parkinson's Disease", "neurological, psychiatric and metabolic disorders", "IS A"], ["microbiota-derived molecules", "inflammation", "INFLUENCE"], ["carnitine", "insomnia", "INFLUENCE"], ["fecal microbiota", "enzyme-linked immunosorbent assay", "USED BY"], ["MDD patients", "Metagenomics sequencing", "USED BY"], ["Metformin", "cancer", "CHANGE EFFECT"], ["Parkinson's disease", "neurodegenerative ailment", "IS A"], ["Multiple Sclerosis", "neurodegenerative disorders", "IS A"], ["comorbid spatial working memory impairment", "subdiaphragmatic vagus nerve", "STRIKE"], ["inflammatory bowel diseases", "patients", "TARGET"], ["inflammation", "epilepsy", "AFFECT"], ["gestational diabetes mellitus", "OB mothers", "TARGET"], ["microbiota of the newborn", "pregnant women", "LOCATED IN"], ["females", "metabolomics", "USED BY"], ["intestinal dysbiosis", "Huntington's disease", "AFFECT"], ["rheumatoid arthritis", "Parkinson's disease patients", "TARGET"], ["cecal microbiome", "broiler chickens", "LOCATED IN"], ["gut microbiota", "mammals", "LOCATED IN"], ["glyphosate", "neurobehavioral disorders", "INFLUENCE"], ["cognitive decline", "Neurodegenerative diseases", "AFFECT"], ["intestinal bacterial imbalance", "type 2 diabetes", "AFFECT"], ["inflammatory bowel disease", "IBD patients", "TARGET"], ["fecal calprotectin", "gut-barrier injury", "INFLUENCE"], ["abnormal", "IBDs", "AFFECT"], ["Central inflammation", "brain", "STRIKE"], ["SNI rats", "SPT", "USED BY"], ["probiotic", "PD patients", "ADMINISTERED"], ["ulcerative colitis", "patients", "TARGET"], ["gut microbiota", "acute dysbiosis", "IS LINKED TO"], ["vitamin D3", "constipation", "INFLUENCE"], ["study populations", "whole metagenome sequencing reads", "USED BY"], ["intestinal flora", "mental disorders", "IS LINKED TO"], ["Firmicutes", "acute mice", "LOCATED IN"], ["antibiotics", "intestinal microbiota", "IMPACT"], ["dioscin", "PD", "INFLUENCE"], ["Alzheimer's disease", "individuals", "TARGET"], ["anxiety", "F1 females", "TARGET"], ["NDDs", "neurological conditions", "IS A"], ["PD", "participants", "TARGET"], ["rotenone", "Aged (12-month-old) mice", "ADMINISTERED"], ["Parkinson's disease", "Scatolibacter", "CHANGE ABUNDANCE"], ["GABA", "psychological disorders", "INFLUENCE"], ["gut microbiota", "delirium-like behaviors", "IS LINKED TO"], ["microbiota dysbiosis", "AD", "AFFECT"], ["Environmental toxins", "mucosal inflammation", "INFLUENCE"], ["behavioral", "OV/OB mothers", "TARGET"], ["probiotics", "constipation symptoms", "INFLUENCE"], ["gut microbiota", "psychiatric symptoms", "IS LINKED TO"], ["AD transgenic mice", "mass spectrometry", "USED BY"], ["PD", "dual-hit mice", "TARGET"], ["Huntington's disease", "neurological diseases", "IS A"], ["<i>L. plantarum</i> CCFM405", "neuroinflammation", "INFLUENCE"], ["Parkinson's disease", "disability", "IS A"], ["acute COVID-19", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["SD", "chronic inflammatory responses", "AFFECT"], ["Mn", "Alzheimer's disease", "INFLUENCE"], ["capsaicin", "gut microbiota", "IMPACT"], ["biofilm-associated amyloids", "Gut microbiota", "IMPACT"], ["gut microbiome", "stroke", "AFFECT"], ["dietary polysaccharides", "CNS diseases", "INFLUENCE"], ["\u03b1-synuclein", "brain", "LOCATED IN"], ["gut microbiome", "multi-omics sequencing techniques", "USED BY"], ["Post-infectious fatigue", "depression", "AFFECT"], ["mouse", "Metabolomic analysis", "USED BY"], ["IBS", "participants", "TARGET"], ["dysbiosis of", "gut microbiome", "CHANGE ABUNDANCE"], ["MS", "Coprococcus", "CHANGE ABUNDANCE"], ["brain-region-specific metabolic abnormalities", "MPTP-induced PD mice", "TARGET"], ["PD", "mice", "TARGET"], ["gut microbiota", "gastrointestinal tract disorders", "IS LINKED TO"], ["IBD", "gut microbiota", "CHANGE ABUNDANCE"], ["gut dysbiosis-induced neurodegeneration", "Parkinson's disease", "AFFECT"], ["chicken gut microbiome", "humans", "LOCATED IN"], ["bipolar disorder", "neurodevelopmental disorders", "IS A"], ["gut microbiota", "mental illnesses", "IS LINKED TO"], ["nervous system-targeted drugs", "gut microbiome", "IMPACT"], ["intestinal flora", "Metagenomics", "USED BY"], ["3,4-Methylenedioxymethamphetamine", "suicide thoughts", "CHANGE EFFECT"], ["multiple sclerosis", "patients", "TARGET"], ["Parkinson's and Alzheimer's diseases", "elderly", "TARGET"], ["OCN", "PD", "INFLUENCE"], ["violent behaviors", "schizophrenia patients", "TARGET"], ["gastrointestinal illnesses", "patients", "TARGET"], ["Bifidobacterium", "gut microbiota", "PART OF"], ["COVID-19 infection", "gut microbiota", "CHANGE ABUNDANCE"], ["Gastrointestinal dysfunction", "PD", "AFFECT"], ["gut microbiota", "dementia with Lewy bodies", "IS LINKED TO"], ["Puerarin", "inflammatory response", "INFLUENCE"], ["gut microbiota mediated oxidative stress", "neurodegeneration", "AFFECT"], ["adolescent patients aged 12 to", ",", "USED BY"], ["low-fat diets", "gut microbiome", "IMPACT"], ["Autism spectrum disorder", "ASD", "IS A"], ["Gut Microbiome", "Major Depressive Disorder", "IS LINKED TO"], ["gut microbiota dysbiosis", "obesity", "AFFECT"], ["psychiatric symptoms", "Parkinson's disease", "AFFECT"], ["gut microbiota", "mice", "LOCATED IN"], ["biofilm-associated amyloids", "neurodegeneration", "INFLUENCE"], ["Neuroinflammation", "Neurological Disorders", "AFFECT"], ["SCFAs", "CNS disorders", "INFLUENCE"], ["gut microbes", "endocrine system diseases", "INFLUENCE"], ["depression-like behaviors", "MDD patients", "TARGET"], ["short-chain fatty acids", "inflammatory bowel disease", "INFLUENCE"], ["PD", "chronic neurodegenerative disease", "IS A"], ["depression", "antibiotic-treated mice", "TARGET"], ["GLP-1 1", "Akkermansia", "IMPACT"], ["clinical symptoms", "frail patients", "TARGET"], ["major depressive disorder", "individuals", "TARGET"], ["Gastrointestinal (GI) disturbances", "PD", "AFFECT"], ["Curcumin", "gut microbiota", "IMPACT"], ["MS", "neurological disorders", "IS A"], ["AA-MF", "neurodegenerative and inflammatory diseases", "INFLUENCE"], ["microbiota genus Blautia", "PD patients", "LOCATED IN"], ["GI dysfunction", "patients", "TARGET"], ["PM2.5 Exposure", "Neurodevelopmental toxicity", "INFLUENCE"], ["COVID-19 clinical manifestations", "extreme tiredness", "AFFECT"], ["Sodium", "gut dysfunction", "INFLUENCE"], ["females", "Shotgun metagenomics", "USED BY"], ["altered gut microbiota", "individuals", "LOCATED IN"], ["substantia nigra", "Parkinsonian mice", "LOCATED IN"], ["Melatonin", "Alzheimer's disease", "INFLUENCE"], ["Synbiotic supplementation", "non-motor symptoms", "INFLUENCE"], ["patients", "16S ribosomal DNA (rDNA) gene sequencing", "USED BY"], ["Urolithin A", "Parkinson's Disease", "INFLUENCE"], ["intestinal microbiota", "quantitative metaproteomics", "USED BY"], ["early neuroinflammation", "substantia nigra", "STRIKE"], ["motor neuron disease", "neurodegenerative diseases", "IS A"], ["PD", "motor impediments", "IS A"], ["neuropsychiatric disorders", "elderly people", "TARGET"], ["neurodegenerative disorders", "individuals", "TARGET"], ["prednisolone", "rats", "ADMINISTERED"], ["Polyphenols", "neurological disorders", "INFLUENCE"], ["gut microbiome", "obesity", "IS LINKED TO"], ["fiber", "chronic inflammatory diseases", "INFLUENCE"], ["RBD", "prodromal PD", "AFFECT"], ["depression", "neurological and psychological disorders", "IS A"], ["microbiota", "Meth-induced mental disorders", "IS LINKED TO"], ["Intestinal inflammation", "Parkinson disease", "AFFECT"], ["B. lactis</i> MH-022", "inflammation", "INFLUENCE"], ["COVID-19 infection", "PTSD", "AFFECT"], ["gut microbiome", "neurodegeneration", "IS LINKED TO"], ["gut microbiota", "anxious distress", "IS LINKED TO"], ["Fermented foods", "depression", "INFLUENCE"], ["Sodium butyrate", "motor deficits", "INFLUENCE"], ["gut microbiota", "Iranian patients", "LOCATED IN"], ["Antibiotics", "gastrointestinal microbiota", "IMPACT"], ["ASD", "Autism spectrum disorder", "IS A"], ["SCFAs", "schizophrenia", "INFLUENCE"], ["manganese", "toxic effects", "INFLUENCE"], ["succinic acid", "behavioral symptoms", "INFLUENCE"], ["gut microbiota", "posttraumatic stress disorder", "IS LINKED TO"], ["gut microbiota", "CFA mice", "LOCATED IN"], ["RF", "hepatic encephalopathy", "CHANGE EFFECT"], ["mPFC", "OCD-colonized mice", "LOCATED IN"], ["gut microbiota", "immune dysbiosis", "IS LINKED TO"], ["intestinal dysbiosis", "Alzheimer's disease", "AFFECT"], ["Gut Microbiota", "Alzheimer's and Parkinson's Diseases", "IS LINKED TO"], ["initial dysregulation", "gastrointestinal tract", "STRIKE"], ["gastrointestinal symptoms", "hypersalivation", "AFFECT"], ["Alcohol use disorder", "disability", "AFFECT"], ["Osteoporosis", "bone inflammation", "AFFECT"], ["Huntington's disease", "depression", "AFFECT"], ["Changes", "Depressive Symptoms", "AFFECT"], ["Parkinson's Disease", "epithelium", "STRIKE"], ["Lactobacillus", "wild-type mice", "LOCATED IN"], ["dimethylglycine", "amyloid-\u03b2", "INTERACT"], ["IL-17", "ischemic injury", "INFLUENCE"], ["Probio-M8", "Ruminococcaceae", "IMPACT"], ["probiotic", "inflammatory changes", "INFLUENCE"], ["prebiotics", "neurological diseases", "INFLUENCE"], ["GM", "neurological conditions", "IS LINKED TO"], ["age-related dysbiosis", "brain", "STRIKE"], ["resveratrol", "MPTP/P-induced Parkinson's disease", "INFLUENCE"], ["depression", "mental disorders", "IS A"], ["probiotics", "Patients", "ADMINISTERED"], ["Systemic inflammation", "brain", "STRIKE"], ["ambient fine particulate matter", "mental disorders", "INFLUENCE"], ["short-chain fatty-acid-producing bacteria", "neuronal damage", "INFLUENCE"], ["vitamins", "PD", "INFLUENCE"], ["mothers", "16SrRNA sequencing", "USED BY"], ["Insulin resistance", "Parkinson's disease", "AFFECT"], ["newly diagnosed type 2 diabetes", "people", "TARGET"], ["MCI", "Bacteroidetes", "CHANGE ABUNDANCE"], ["PARK7/DJ-1", "gut microbiome", "IMPACT"], ["constipation", "subjects", "TARGET"], ["microbial metabolite short-chain fatty acids", "Dysbiosis", "INFLUENCE"], ["gut microbiota alteration", "inflammation", "AFFECT"], ["GM", "PD pathogenesis", "IS LINKED TO"], ["TMAO", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "anxiety", "IS LINKED TO"], ["Ferulic acid esterases", "gut microbiota", "IMPACT"], ["gut microbes", "AD", "IS LINKED TO"], ["gastrointestinal microbiome", "depression", "IS LINKED TO"], ["Polyphenols", "Parkinson's disease", "INFLUENCE"], ["GMn", "gut microbiota dysbiosis", "INFLUENCE"], ["neuronal damage", "Parkinson's disease", "AFFECT"], ["inflammatory bowel disease", "IBD", "AFFECT"], ["child internalizing and externalizing behaviors", "Parents", "TARGET"], ["Major depressive disorder", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "gut microbiota-related neurological disorders", "IS LINKED TO"], ["propionate", "epilepsy", "INFLUENCE"], ["brain-derived neurotrophic factor", "CRS-exposed mice", "LOCATED IN"], ["choline", "cognitive decline", "INFLUENCE"], ["gut microbiota", "traumatic brain injury", "IS LINKED TO"], ["HIV-associated neurocognitive disorder", "cognitive impairment", "AFFECT"], ["microbial metabolites", "Alzheimer's disease", "INFLUENCE"], ["Parkinson's disease", "ageing population", "TARGET"], ["\u03b1Syn", "Parkinson's disease", "INFLUENCE"], ["Gut", "central nervous system (CNS) and psychiatric disorders", "INFLUENCE"], ["Lactiplantibacillus plantarum", "neurodegenerative disease", "INFLUENCE"], ["HD", "dementia", "AFFECT"], ["Parkinson's syndrome", "extra-intestinal diseases", "IS A"], ["ADHD", "Megamonas", "CHANGE ABUNDANCE"], ["(R)-ketamine", "ketamine", "INTERACT"], ["Heightened circulating inflammation", "stress-related psychiatric disorders", "AFFECT"], ["gut-resident bacteria", "cerebrovascular diseases", "INFLUENCE"], ["Cu", "AD", "INFLUENCE"], ["dimethylglycine", "cognitive decline", "INFLUENCE"], ["classic antidepressants", "gut dysbiosis", "CHANGE EFFECT"], ["prodromal dysfunctions", "severe gastrointestinal (GI) motility disorders", "AFFECT"], ["Metformin", "lipid lowering", "CHANGE EFFECT"], ["gut microbiome", "FMT mice", "LOCATED IN"], ["probiotics", "mental health disorders", "INFLUENCE"], ["motor dysfunction", "mice", "TARGET"], ["AN", "patients", "TARGET"], ["(R,S)-ketamine", "MDD", "CHANGE EFFECT"], ["gut microbiota", "underweight PD", "IS LINKED TO"], ["PD", "NSE-h\u03b1Syn Tg mice", "TARGET"], ["Gastrointestinal symptoms", "PD", "AFFECT"], ["Intestinal inflammation", "IBD", "AFFECT"], ["3,4-Methylenedioxymethamphetamine", "depression", "CHANGE EFFECT"], ["Insulin resistance", "Alzheimer's disease", "AFFECT"], ["GABA", "brain", "LOCATED IN"], ["Polycystic ovary syndrome", "gynecological endocrine disease", "IS A"], ["endothelial damage", "PD", "AFFECT"], ["Short-chain fatty acids", "neuropsychiatric disorders", "INFLUENCE"], ["fecal microbiota", "16S rRNA sequencing", "USED BY"], ["ABX", "phenotypes", "CHANGE EFFECT"], ["IBD", "chronic inflammatory diseases", "IS A"], ["insulin resistance", "PD", "AFFECT"], ["impulsive and/or violent behavior", "children", "TARGET"], ["females", "metagenomic sequencing", "USED BY"], ["Gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["multiple sclerosis", "older adults", "TARGET"], ["Gut Microbiota", "Rheumatoid Arthritis", "IS LINKED TO"], ["progressive neuronal cell death", "elderly people", "TARGET"], ["disruptions of circadian rhythmicity", "AD", "AFFECT"], ["melatonin", "intestinal microbiota disturbances", "INFLUENCE"], ["Parkinson's disease", "microbiotas", "CHANGE ABUNDANCE"], ["Bacterial Metabolites", "Human Gut Microbiota", "IMPACT"], ["vancomycin", "infections", "CHANGE EFFECT"], ["PD", "disease", "IS A"], ["clozapine", "gut microbiota", "IMPACT"], ["gut microbiota", "LH resilient rats", "LOCATED IN"], ["patients", "predictive metagenome profiling", "USED BY"], ["cytokines", "Alzheimer's disease", "INFLUENCE"], ["Parkinson's disease", "rotenone-induced Parkinson's disease mice", "TARGET"], ["Biglycan", "colorectal cancer", "INFLUENCE"], ["Cardinal motor impairment", "Parkinson's disease", "AFFECT"], ["behavioral dysfunction", "mice", "TARGET"], ["<i>L. plantarum</i> CCFM405", "intestinal inflammation", "INFLUENCE"], ["\u03b1-synuclein pathology", "brain", "STRIKE"], ["ADHD", "Dialister", "CHANGE ABUNDANCE"], ["type 2 diabetes", "Alzheimer's and Parkinson's diseases", "AFFECT"], ["TMAO", "neuroinflammation", "INFLUENCE"], ["Idiopathic Rapid Eye Movement Sleep Behavior Disorder", "Multiple System Atrophy", "AFFECT"], ["Butyricimonas synergistica", "PD non-motor symptoms", "INFLUENCE"], ["medicinal herbs", "gut microbiota", "IMPACT"], ["Parkinson's disease", "brain", "STRIKE"], ["VAP", "oxidative stress", "INFLUENCE"], ["Gut Microbiota", "Insulin Resistance", "IS LINKED TO"], ["salt", "Gut Microbiota", "IMPACT"], ["PCOS", "patients", "TARGET"], ["Gut dysbiosis", "bacterial overgrowth", "AFFECT"], ["Inflammatory", "Parkinson's Diseases", "AFFECT"], ["young microbiota", "gut inflammation", "IS LINKED TO"], ["Bipolar Depression", "Patients", "TARGET"], ["HCs", "Real-time quantitative PCR", "USED BY"], ["Microbial dysbiosis", "Verrucomicrobiaceae", "CHANGE ABUNDANCE"], ["probiotic supplementation", "non-motor", "INFLUENCE"], ["short-chain fatty acids", "juvenile offspring", "LOCATED IN"], ["probiotics", "Microbiota abnormalities", "INFLUENCE"], ["obesity", "obese women", "TARGET"], ["microbial metabolites", "MS", "INFLUENCE"], ["antibiotic cocktail", "GM", "IMPACT"], ["cytokines", "neuroinflammation", "INFLUENCE"], ["psychiatric disorders", "people", "TARGET"], ["COVID-19 infection", "acute ischemic stroke (AIS) patients", "TARGET"], ["ambient fine particulate matter", "central nervous system damage", "INFLUENCE"], ["gut microbiota", "healthy individuals", "LOCATED IN"], ["gut microbiota", "ALS", "IS LINKED TO"], ["inflammation-derived oxidative damage", "PD", "AFFECT"], ["Bacterial EV", "intestine", "LOCATED IN"], ["(S)-ketamine", "depression", "CHANGE EFFECT"], ["Dysbiosis of", "gut frailty", "AFFECT"], ["c_Clostridia", "gut microbiota", "PART OF"], ["human gut microbiota", "HTN", "IS LINKED TO"], ["polyphenols", "PD", "INFLUENCE"], ["Fecal Short-Chain Fatty Acid Alterations", "MSA", "INFLUENCE"], ["BU", "inflammatory response", "INFLUENCE"], ["gut microbiome", "neurological illnesses", "IS LINKED TO"], ["gut microbiota dysbiosis", "AIS patients", "TARGET"], ["attention-deficit/hyperactivity disorder", "medication-na\u00efve adults", "TARGET"], ["prodromal dysfunctions", "dysphagia", "AFFECT"], ["Dysbiosis", "patients", "TARGET"], ["Perimenopausal panic disorder", "PPD patients", "TARGET"], ["gut microbiota", "neuropathic pain", "IS LINKED TO"], ["OS", "PD", "AFFECT"], ["Psychological stress", "depression", "AFFECT"], ["GM", "autism spectrum disorder", "IS LINKED TO"], ["patients", "1:1 randomized, double-blind, placebo-controlled clinical trial", "USED BY"], ["dysregulation of", "schizophrenia", "AFFECT"], ["brain-derived neurotrophic factor", "prefrontal cortex", "LOCATED IN"], ["Mental disorders", "gut problems", "AFFECT"], ["gut microbiota", "pre-dementia subjects", "LOCATED IN"], ["gut microbes", "gastrointestinal disorders", "INFLUENCE"], ["monoamine", "prefrontal cortex", "LOCATED IN"], ["gut microbiota alterations", "dysbiosis", "AFFECT"], ["Escherichia-Shigella", "Morganella", "INTERACT"], ["FLZ", "gastrointestinal dysfunctions", "CHANGE EFFECT"], ["Gut microbiota dysbiosis", "Parkinson's disease", "AFFECT"], ["depression-like behavior", "CUMS mice", "TARGET"], ["probiotic", "Bifidobacterium longum subsp. longum 35624", "IMPACT"], ["Parkinson's disease patients", "multicentre cross-sectional, longitudinal ambulatory clinical trial", "USED BY"], ["chondroitin sulfate", "CRC", "INFLUENCE"], ["microbiomes", "type 2 diabetes", "IS LINKED TO"], ["MS", "Faecalibacterium", "CHANGE ABUNDANCE"], ["Behavioral and psychological symptoms of dementia", "mild cognitive impairment", "AFFECT"], ["gestational diabetes mellitus", "offspring", "TARGET"], ["Fecal microbiota", "A53T mice", "LOCATED IN"], ["gastrointestinal microorganisms", "human disorders", "IS LINKED TO"], ["gut microbiota", "POD", "IS LINKED TO"], ["AD", "brain disorders", "IS A"], ["Huntington's disease", "progressive movement disorder", "AFFECT"], ["ALS", "neurological disorders", "IS A"], ["Depression-like behavior", "dysbiosis", "AFFECT"], ["Perimenopausal panic disorder", "PPD", "AFFECT"], ["Neurodegenerative Diseases", "Subjects", "TARGET"], ["age-associated diseases", "frail patients", "TARGET"], ["Intestinal dysbiosis", "Parkinson's Disease", "AFFECT"], ["probiotics", "mental health conditions", "INFLUENCE"], ["synuclein pathology", "gastrointestinal tract", "STRIKE"], ["anorexia nervosa", "individuals", "TARGET"], ["gut microbiota dysbiosis", "PD", "AFFECT"], ["fecal microbiota", "the 16S rDNA", "USED BY"], ["Ru", "neuronal apoptosis", "INFLUENCE"], ["carotenoids", "neurological disorders", "INFLUENCE"], ["C. minuta", "chronic stress-induced depressive, anxiogenic and antisocial behavior", "INFLUENCE"], ["gastrointestinal dysfunctions", "rotenone-challenged mice", "TARGET"], ["gamma-aminobutyric acid", "stress", "INFLUENCE"], ["Malfunction", "Dysfunction of the gut microbiome", "AFFECT"], ["Serotonergic dysfunction", "PD", "AFFECT"], ["Alzheimer's disease", "patients", "TARGET"], ["alterations in gut microbiota composition", "NDs", "AFFECT"], ["polyamines", "ND pathogenesis", "INFLUENCE"], ["GM", "PD patients", "LOCATED IN"], ["gut microbiota", "schizophrenia", "IS LINKED TO"], ["medium-chain triglyceride KD", "MPTP-induced damage", "INFLUENCE"], ["pro-inflammatory mediators", "PD affected brain areas", "LOCATED IN"], ["depression", "central nervous system disorders", "IS A"], ["medium-chain triglyceride KD", "antioxidant stress", "INFLUENCE"], ["gut-microbiome", "Parkinson's disease", "IS LINKED TO"], ["gut microbiota", "16S rRNA sequencing", "USED BY"], ["RBD", "butyrate-producing bacteria", "CHANGE ABUNDANCE"], ["bacitracin", "C. jejuni infection", "CHANGE EFFECT"], ["brain abscess", "severe infection-related pathologies", "IS A"], ["SN", "MPTP-induced PD mice", "LOCATED IN"], ["PD-related underweight", "PD patients", "TARGET"], ["PD", "gut microbiome", "CHANGE ABUNDANCE"], ["intestinal microbiota dysbiosis", "Multiple Sclerosis", "AFFECT"], ["rotenone", "gastrointestinal dysfunction", "CHANGE EFFECT"], ["baicalein", "PD", "INFLUENCE"], ["microbiota dysbiosis", "PD progression", "AFFECT"], ["schizophrenia", "long-term inpatients", "TARGET"], ["Gammaproteobacteria", "Thy1-\u03b1Syn and wild-type (WT) animals", "LOCATED IN"], ["depression", "gut microbiota", "CHANGE ABUNDANCE"], ["pre and probiotic formulations", "depressive illness", "INFLUENCE"], ["dementia", "Gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "subjects", "LOCATED IN"], ["iRBD", "Parkinson's Disease", "AFFECT"], ["Gut microbiota", "inflammation", "IS LINKED TO"], ["dopaminergic neuron death", "rotenone-challenged mice", "TARGET"], ["GM", "control mice", "LOCATED IN"], ["bipolar disorder", "depressed patients", "TARGET"], ["gut microbiota", "fecal microbiota transplantation", "USED BY"], ["HD", "peripheral symptoms", "AFFECT"], ["participants", "electronic cognitive test", "USED BY"], ["Gut Microbiota", "Diet-Induced Obesity Effects", "IS LINKED TO"], ["taurine supplement", "microglial activation", "INFLUENCE"], ["KBs", "Alzheimer's disease", "INFLUENCE"], ["gut microbiota", "common health disorders", "IS LINKED TO"], ["cytokines", "Parkinson's disease dementia", "INFLUENCE"], ["infants", "16S rRNA sequencing", "USED BY"], ["GABA", "stress", "INFLUENCE"], ["Parabacteroides", "Jamaican and the US populations", "LOCATED IN"], ["attention deficit and hyperactivity disorder", "neurodevelopmental disorders", "IS A"], ["acetylcholine", "Parkinson's disease", "INFLUENCE"], ["gut microbes", "neurodevelopmental, neuropsychiatric, and neurological conditions", "IS LINKED TO"], ["neurological diseases", "patients", "TARGET"], ["TRH and TRH-like peptides", "peripheral tissues", "LOCATED IN"], ["BAPs", "synucleinopathies", "INFLUENCE"], ["Inflammation", "brain", "STRIKE"], ["PD", "Akkermansia muciniphila", "CHANGE ABUNDANCE"], ["probiotics", "motor and non-motor symptoms", "INFLUENCE"], ["gut microbes", "patients", "LOCATED IN"], ["antidepressants", "gut microbiota", "IMPACT"], ["fatigue", "Patients", "TARGET"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "PD", "INFLUENCE"], ["bactEV", "intestine", "LOCATED IN"], ["polycyclic aromatic hydrocarbons", "Alzheimer's disease", "INFLUENCE"], ["Migraine", "vomiting", "AFFECT"], ["MDD", "neuropsychiatric disorders", "IS A"], ["motor or cognitive impairment", "healthy elderly subjects", "TARGET"], ["IBD", "IBD patients", "TARGET"], ["Brain injuries", "gut microbiome", "CHANGE ABUNDANCE"], ["PD", "older group", "TARGET"], ["PD", "Progressive neurodegenerative disorders", "IS A"], ["gut microbiota", "brain", "LOCATED IN"], ["Thy1-\u03b1Syn mice", "16S ribosomal RNA sequencing", "USED BY"], ["Prodromal PD", "age-related impairments", "AFFECT"], ["Dysbiosis", "AD", "AFFECT"], ["prodromal dysfunctions", "delayed gastric emptying", "AFFECT"], ["placebo", "anxiety", "CHANGE EFFECT"], ["gut microbiome", "Neurodegenerative diseases", "IS LINKED TO"], ["Gut microbiota", "Alzheimer's disease", "IS LINKED TO"], ["intracerebral hemorrhage", "mice", "TARGET"], ["Multidrug-resistant (MDR) superbugs", "pro-inflammatory", "INTERACT"], ["NDDs", "Parkinson's disease", "AFFECT"], ["PD patients", "clinical trial", "USED BY"], ["food addiction symptoms", "tobacco use disorder", "AFFECT"], ["Sodium", "motor deficits", "INFLUENCE"], ["PD", "Flavobacteriaceae_noname", "CHANGE ABUNDANCE"], ["intestinal and brain pathologies", "PD patients", "TARGET"], ["prebiotics", "gut microbiota", "IMPACT"], ["Dysbacteria", "AD", "AFFECT"], ["altered microbiota", "neurological diseases", "IS LINKED TO"], ["MDMA", "U.S. adults", "ADMINISTERED"], ["gut dysbiosis-induced neurodegeneration", "amyotrophic lateral sclerosis", "AFFECT"], ["GDM", "OB mothers", "TARGET"], ["neurodevelopmental impairment", "Familial Dysautonomia", "AFFECT"], ["toxic heavy metals", "gut microbiota", "IMPACT"], ["fecal microbiomes", "Chinese patients", "LOCATED IN"], ["Gut Microbiome", "Cognitive Decline", "IS LINKED TO"], ["PD", "gut", "STRIKE"], ["gut microbiota", "Alzheimer's", "IS LINKED TO"], ["THC", "Adult male DIO and lean mice", "ADMINISTERED"], ["Microbiome or Infections", "Complex Human Diseases", "AFFECT"], ["prodromal dysfunctions", "chronic constipation", "AFFECT"], ["Depression", "humans", "TARGET"], ["conventional dairy products", "women", "ADMINISTERED"], ["individuals", "psychometric questionnaires", "USED BY"], ["GM", "DBS", "USED BY"], ["ligature-induced periodontitis", "dopaminergic neuron loss", "AFFECT"], ["engineered <i>Escherichia coli</i> Nissle 1917", "Parkinson's disease", "INFLUENCE"], ["Gut microbiota signature", "treatment-na\u00efve attention-deficit/hyperactivity disorder", "IS LINKED TO"], ["chronic neuroinflammation", "neuronal death", "AFFECT"], ["coronavirus infection", "neurodegenerative diseases", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "dopaminergic (DA) neuron death", "INFLUENCE"], ["motor and non-motor symptoms", "Parkinson's Disease", "AFFECT"], ["Gut dysbiosis", "neurodegenerative diseases", "AFFECT"], ["gut microbiota", "participants", "LOCATED IN"], ["Infection", "Parkinson's disease", "AFFECT"], ["Parkinson's Disease", "PD patients", "TARGET"], ["fecal microbiota", "healthy control mice", "LOCATED IN"], ["healthy volunteers", "16S rRNA sequencing", "USED BY"], ["faecal microbiota", "anorexia nervosa", "IS LINKED TO"], ["gut microbiota", "metastasis", "IS LINKED TO"], ["of", "substantia nigra", "STRIKE"], ["gut", "dysbiosis", "IS LINKED TO"], ["GM", "patients", "LOCATED IN"], ["mycobiota", "enzyme-linked immunosorbent assay", "USED BY"], ["PUFA", "gut microbiome", "IMPACT"], ["microbiota dysbiosis", "Parkinson's disease", "AFFECT"], ["gut microbiota", "psychiatric disorders", "IS LINKED TO"], ["gut microbes", "disease", "INFLUENCE"], ["gut microbiota", "blood", "LOCATED IN"], ["levodopa", "L-DOPA", "INTERACT"], ["Dysbiosis", "systemic inflammation", "AFFECT"], ["Alcohol use disorder", "high-risk psychiatric disorder", "IS A"], ["gut microbiota", "drug-resistant epilepsy", "IS LINKED TO"], ["neuronal loss", "Synucleinopathies", "AFFECT"], ["VD supplementation", "chronically stressed rodents", "ADMINISTERED"], ["BAP amyloids", "\u03b1-synucleinopathies", "INFLUENCE"], ["gut microbiome", "neurological disorders", "IS LINKED TO"], ["(R)-ketamine", "susceptible mice", "ADMINISTERED"], ["Mn<sup>2+</sup>", "fecal metabolomes", "IMPACT"], ["Systemic Inflammation", "Male Subjects", "TARGET"], ["agmatine", "hippocampus", "LOCATED IN"], ["gut microbiota", "gut dysbiosis", "IS LINKED TO"], ["broad-spectrum or species-specific antibiotics", "pro-inflammatory", "INTERACT"], ["systemic inflammation", "Chrna7 knock-out (KO) mice", "TARGET"], ["Nichi Glucan", "ASD", "INFLUENCE"], ["component", "human gut microbiota", "IMPACT"], ["PD", "Alistipes", "CHANGE ABUNDANCE"], ["cortisol", "stress", "INFLUENCE"], ["THC", "adiposity", "CHANGE EFFECT"], ["COVID-19 infection", "post-traumatic stress disorder", "AFFECT"], ["gut bacteria", "neuropsychiatric disorders", "INFLUENCE"], ["neurodegenerative disease", "middle-aged and elderly people", "TARGET"], ["epilepsy", "neurological diseases", "IS A"], ["gut microbiota", "GID", "IS LINKED TO"], ["Synucleinopathies", "MSA", "AFFECT"], ["Gut dysbiosis", "rats", "TARGET"], ["\u03b1-synuclein pathology", "middle brain", "STRIKE"], ["colon microbiota", "Patients", "LOCATED IN"], ["dysfunctional gut microbiota", "mice", "LOCATED IN"], ["curcumin", "anxiety", "INFLUENCE"], ["Intestinal Microbiome", "Neurodegeneration", "IS LINKED TO"], ["neurodevelopmental impairment", "Parkinson's", "AFFECT"], ["Ischemic stroke", "gut microbiota", "CHANGE ABUNDANCE"], ["fecal microbiota", "subjects", "LOCATED IN"], ["MDD", "MDD patients", "TARGET"], ["saturated fats", "Parkinson's disease", "INFLUENCE"], ["prion proteins", "PD", "INFLUENCE"], ["Constipation", "PD", "AFFECT"], ["Tau", "hippocampus", "LOCATED IN"], ["Intestinal inflammation", "Parkinson's disease", "AFFECT"], ["IBD", "Alzheimer disease", "AFFECT"], ["prebiotics", "stress", "INFLUENCE"], ["gut-resident bacteria", "cognitive dysfunction", "INFLUENCE"], ["central nervous system diseases", "patients", "TARGET"], ["PD", "nonmotor symptom", "IS A"], ["Diet", "Neurodegenerative Diseases", "INFLUENCE"], ["ASCA", "IBD", "INFLUENCE"], ["gut microbiome", "age-related neurodegenerative disorders", "IS LINKED TO"], ["Fecal microbiota", "control or CUMS mice", "LOCATED IN"], ["pain", "antibiotics-treated pseudo-germ-free mice", "TARGET"], ["gut dysbiosis", "metabolic dysregulation", "AFFECT"], ["age-related health problems", "world population", "TARGET"], ["PD", "PD patients", "TARGET"], ["microbiota dysbiosis", "Alzheimer's disease", "AFFECT"], ["chronic stress", "individuals", "TARGET"], ["PCDs", "PD", "AFFECT"], ["depression-like behaviors", "recipients", "TARGET"], ["probiotics", "neurological disorders", "INFLUENCE"], ["dysregulated gut microbiota", "depression", "IS LINKED TO"], ["Huntington's disease", "neurodegenerative diseases", "IS A"], ["HD", "neurogenerative disorder", "IS A"], ["BU", "PD", "INFLUENCE"], ["TMAO", "motor fluctuations", "INFLUENCE"], ["gut microbiome", "Parkinson's disease", "IS LINKED TO"], ["SCFAs", "obesity", "INFLUENCE"], ["inflammation", "coronavirus infection", "AFFECT"], ["reactive oxygen species", "neurotoxicity", "INFLUENCE"], ["antibiotic-induced dysbiosis", "rats", "TARGET"], ["curcumin", "IBD", "INFLUENCE"], ["gut microbiota alteration", "neurodegenerative and psychiatric disbalances", "AFFECT"], ["probiotics", "patients", "ADMINISTERED"], ["Cecal microbiota", "untargeted metabolomics", "USED BY"], ["Gammaproteobacteria", "mice", "LOCATED IN"], ["gut eubiosis", "dysbiosis", "AFFECT"], ["fecal microbiota", "brain", "LOCATED IN"], ["flavonoids", "mood disorders", "INFLUENCE"], ["Dysbiosis of the gut microbiota", "osteoporosis", "AFFECT"], ["Wumei Wan", "intestinal inflammation", "INFLUENCE"], ["carnitine", "neuroinflammation", "INFLUENCE"], ["probiotic/prebiotic supplementation", "PD", "INFLUENCE"], ["GM", "neurodevelopmental and neurological disorders", "IS LINKED TO"], ["Gut Microbiota", "Neurological Disorders", "IS LINKED TO"], ["dysbiosis", "nasal passages", "STRIKE"], ["\u03b1-synuclein aggregates", "brain", "LOCATED IN"], ["Benserazide", "Parkinson's disease", "CHANGE EFFECT"], ["gut microbiota dysbiosis", "gastrointestinal function impairment", "AFFECT"], ["curcuminoid", "IBS symptoms", "INFLUENCE"], ["urolithins", "urolithin A", "INTERACT"], ["rotenone", "motor deficits", "CHANGE EFFECT"], ["flavonoids", "neurological disorders", "INFLUENCE"], ["gut microbiome (GM) dysbiosis", "PD", "AFFECT"], ["Antibiotic growth promoters", "clinical and subclinical diseases", "CHANGE EFFECT"], ["healthy controls", "shotgun metagenomics", "USED BY"], ["NDs", "pathological illnesses", "IS A"], ["mood disorders", "adults", "TARGET"], ["IBD", "IBD", "AFFECT"], ["Rats", "Open-field tests", "USED BY"], ["(R)-ketamine", "gut microbiota", "IMPACT"], ["plazomicin", "severe infection-related pathologies", "CHANGE EFFECT"], ["fisetin", "gut microbiota", "IMPACT"], ["midbrain", "PD-like mice", "LOCATED IN"], ["PM2.5", "brain", "LOCATED IN"], ["antibiotic treatment", "gut microbiota", "IMPACT"], ["microbiome", "mental disorders", "IS LINKED TO"], ["PM2.5", "CNS damage", "INFLUENCE"], ["vegetables", "mood disorders", "INFLUENCE"], ["gut microbiome", "diabetes", "IS LINKED TO"], ["probiotics", "Parkinson's disease", "INFLUENCE"], ["EC-12 supplementation", "mice", "ADMINISTERED"], ["intestinal microbiota", "next generation sequencing", "USED BY"], ["Phytochemicals", "ASD", "INFLUENCE"], ["inflammation", "overweight adolescents", "TARGET"], ["chronic unpredictable mild stress", "mouse models", "TARGET"], ["sugar", "mental health concerns", "INFLUENCE"], ["PD", "Parkinson's disease rats", "TARGET"], ["psychobiotics", "psychiatric diseases", "INFLUENCE"], ["PD patients", "DNA methylation analysis", "USED BY"], ["intestinal microbiota dysbiosis", "Amyotrophic Lateral Sclerosis", "AFFECT"], ["gut microbiome", "Alzheimer's disease", "IS LINKED TO"], ["\u03b1-Synuclein", "PD", "INFLUENCE"], ["\u03b1-synuclein", "depressive-like behavior", "INFLUENCE"], ["Autism", "males", "TARGET"], ["neurodegeneration", "PD mice", "TARGET"], ["panic attacks", "PPD", "AFFECT"], ["major depressive episode", "participants", "TARGET"], ["gut microbiome", "Huntington's disease", "IS LINKED TO"], ["protein", "gut", "LOCATED IN"], ["macro- and micronutrients", "bone fragility", "INFLUENCE"], ["gastrointestinal problems", "PD patients", "TARGET"], ["impulsive behavior", "participants", "TARGET"], ["oxidative stress", "neuronal damage", "AFFECT"], ["Phytochemicals", "neurological and psychological disorders", "INFLUENCE"], ["Gamma-aminobutyric acid", "neurological diseases", "INFLUENCE"], ["FLZ", "gut microbiota", "PRODUCED BY"], ["loose fecal consistency", "antibiotic-treated rats", "TARGET"], ["Gut Microbiota", "inflammatory diseases", "IS LINKED TO"], ["Mental illness", "mental disorders", "AFFECT"], ["SCZ microbiota", "mice", "LOCATED IN"], ["antibiotic cocktail", "phenotypes", "CHANGE EFFECT"], ["Pesticides", "PD", "INFLUENCE"], ["Mollicutes", "POD mice", "LOCATED IN"], ["SIBO", "Alzheimer's dementia", "AFFECT"], ["Parkinson's disease", "motor symptoms", "IS A"], ["dysbiosis", "NDs", "AFFECT"], ["oral and gut microbiota", "AD patient partners", "LOCATED IN"], ["gut microbiome", "neuroinflammation", "IS LINKED TO"], ["Functional constipation", "children", "TARGET"], ["alpha-synuclein", "PD", "INFLUENCE"], ["Lactobacillus intestinalis", "anhedonia-like phenotypes", "INFLUENCE"], ["Fecal microbiota", "neurodegeneration", "IS LINKED TO"], ["multi-probiotic supplementation", "Akkermansia muciniphila", "IMPACT"], ["Huntington's disease", "chorea", "AFFECT"], ["isobutyric acid", "PD", "INFLUENCE"], ["gut microbiota", "honeybees", "LOCATED IN"], ["AD", "Neurodegenerative diseases", "IS A"], ["Dystonia", "complex neurological movement disorder", "IS A"], ["gut microbiota", "ischemic stroke", "IS LINKED TO"], ["CEREBIOME", "depression symptoms", "IS LINKED TO"], ["neuroinflammation", "PD", "AFFECT"], ["spatial working memory impairment", "healthy naive mice", "TARGET"], ["peripheral branched-chain amino acids", "neurodegenerative diseases", "INFLUENCE"], ["Gut Microbiota", "Oxidative Damage", "IS LINKED TO"], ["postbiotics", "mental disorders", "INFLUENCE"], ["HC", "Metagenomics sequencing", "USED BY"], ["3,4-Methylenedioxymethamphetamine", "US adults", "ADMINISTERED"], ["GLP-1", "cognitive disorders", "INFLUENCE"], ["CSDS", "anhedonia-like phenotype", "AFFECT"], ["gut microbiome", "Clinical symptoms", "IS LINKED TO"], ["MPP<sup>+</sup>", "apoptosis", "INFLUENCE"], ["PD", "patients", "TARGET"], ["AD transgenic mice", "behavioral test", "USED BY"], ["COVID-19", "critically ill patients", "TARGET"], ["cytokines", "\u03b1-synuclein pathology", "INFLUENCE"], ["Calprotectin", "motor fluctuations", "INFLUENCE"], ["PD", "non-motor symptom", "IS A"], ["neuroactive compounds", "neurological disorders", "INFLUENCE"], ["prebiotics", "PTSD", "INFLUENCE"], ["\u03b1S", "Parkinson's disease", "INFLUENCE"], ["GM", "mice", "LOCATED IN"], ["gut microbiota", "geriatric syndrome", "IS LINKED TO"], ["muscle atrophy", "Amyotrophic lateral sclerosis", "AFFECT"], ["stereotypies", "animals", "TARGET"], ["healthy gut microbiota", "bipolar disorder", "IS LINKED TO"], ["ginger supplementation", "Actinobacteria", "IMPACT"], ["Parkinson's disease", ", and progressive", "IS A"], ["Gut dysbacteriosis", "intestinal and extraintestinal diseases", "IS A"], ["Parkinson's disease", "bacteria", "CHANGE ABUNDANCE"], ["Alzheimer's disease", "neurodegenerative diseases", "IS A"], ["prebiotics", "dysbiosis", "INFLUENCE"], ["gut microbes", "anxiety", "IS LINKED TO"], ["isobutyric acid", "ET", "INFLUENCE"], ["gut microbiota", "metabolic dysfunction", "IS LINKED TO"], ["IBS", "neurodegenerative and neuropsychiatric diseases", "IS A"], ["butyrate", "depression", "INFLUENCE"], ["Fecal bacteria", "non-POD and POD mice", "LOCATED IN"], ["Probiotics", "panic anxiety", "INFLUENCE"], ["dietary polysaccharides", "anxiety disorders", "INFLUENCE"], ["Rh4", "neuronal damage", "CHANGE EFFECT"], ["LPS", "brain", "LOCATED IN"], ["PD-related constipation", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiome", "inflammation", "IS LINKED TO"], ["BD", "Mood disorders", "IS A"], ["Neuropsychiatric disturbances", "mild cognitive impairment", "AFFECT"], ["TPPU", "social interaction deficits", "CHANGE EFFECT"], ["Fermented Foods", "depression", "INFLUENCE"], ["gut microbial dysbiosis", "patients", "TARGET"], ["gut microbiota", "hepatocellular carcinoma", "IS LINKED TO"], ["neurodegeneration", "Parkinson's", "AFFECT"], ["gut microbiome", "healthy and immuno-compromised individuals", "LOCATED IN"], ["normal controls", "gas chromatography-mass spectrometry", "USED BY"], ["Dysbiosis of the gut microbiota", "extra-intestinal diseases", "AFFECT"], ["Antrodia camphorata", "neurological symptoms", "INFLUENCE"], ["women", "randomized, double-blind, placebo-controlled clinical trial", "USED BY"], ["autism spectrum disorder", "neurological disorders", "IS A"], ["Cancer", "Diseases", "IS A"], ["Prebiotics", "Alzheimer's Disease", "INFLUENCE"], ["fecal microbiota", "stress-resistant mice", "LOCATED IN"], ["Phytochemicals", "PD", "INFLUENCE"], ["gut dysbiosis", "central nervous system (CNS)-related disorders", "AFFECT"], ["Damaged", "chronic diseases", "AFFECT"], ["aberrant microbiota-derived metabolites", "PD", "INFLUENCE"], ["inflammatory cytokines", "colonic lumen", "LOCATED IN"], ["gut microbiome", "stable isotope probing", "USED BY"], ["gut microbiome", "SCZ patients", "LOCATED IN"], ["PD", "microbiota dysbiosis", "AFFECT"], ["Motor Symptomatology", "Parkinson's Disease", "AFFECT"], ["insomnia", "EE|MH group", "TARGET"], ["Gut Microbe-Modifying Diet", "Neurodegenerative Diseases", "INFLUENCE"], ["gut microbiota", "PD-related behaviors", "IS LINKED TO"], ["saturated fat", "inflammatory diseases", "INFLUENCE"], ["sEH", "PFC", "LOCATED IN"], ["Alzheimer's disease", "neuropsychiatric and neurological disorders", "IS A"], ["depression", "IBD patients", "TARGET"], ["\u03949-Tetrahydrocannabinol", "Gut Microbiota", "IMPACT"], ["dysphagia", "autonomic issues", "IS A"], ["ROS", "imbalance of immune functions", "INFLUENCE"], ["gut microbiota", "PD mice", "LOCATED IN"], ["cellular toxicity", "neurodegenerative proteinopathies", "AFFECT"], ["gut microbiota", "16S rDNA sequencing", "USED BY"], ["terpenoids", "gut flora", "IMPACT"], ["depression", "Individuals", "TARGET"], ["AKK", "chronic stress-induced gut microbial abnormalities", "INFLUENCE"], ["depression", "treatment-resistant patients", "TARGET"], ["Chronic Stress", "Young Adults", "TARGET"], ["polyunsaturated fatty acids", "AN", "INFLUENCE"], ["human gut microbiota", "neuropsychiatric disorders", "IS LINKED TO"], ["PM2.5 Exposure", "Neurodegenerative and mental disorders", "INFLUENCE"], ["Mediterranean diet", "Parkinson's disease", "INFLUENCE"], ["microbiota disturbances", "depression", "AFFECT"], ["infection", "gut microbiota dysbiosis", "AFFECT"], ["Gut Microbiome", "Pathology", "IS LINKED TO"], ["PD patients", "shotgun metagenomics sequencing", "USED BY"], ["Alzheimer's disease", "neuropsychiatric diseases", "IS A"], ["Alzheimer's disease", "functional and cognitive impairments", "AFFECT"], ["UDCA", "infarction", "INFLUENCE"], ["constipation", "neurodegenerative disorders", "AFFECT"], ["gut microbiota-mediated inflammation", "gut", "STRIKE"], ["Region-specific alterations in gene expression", "controls", "TARGET"], ["gut microbiota alterations", "neuropsychiatric diseases", "AFFECT"], ["bacterial overgrowth", "small intestine", "STRIKE"], ["PD mice", "immunofluorescence", "USED BY"], ["paternal gut microbiome", "mice", "LOCATED IN"], ["food additives", "Parkinson's disease", "INFLUENCE"], ["Bipolar disorder", "mental health disorder", "IS A"], ["psychobiotics", "gastro-intestinal disorders", "INFLUENCE"], ["maltodextrin", "headache", "INFLUENCE"], ["Gut microbiota", "Alzheimer's and Parkinson's diseases", "IS LINKED TO"], ["dysfunction of", "C57 BL/J mice", "TARGET"], ["Rosmarinic acid", "oxidative stress", "INFLUENCE"], ["gastrointestinal symptoms", "PD patients", "TARGET"], ["\u03b1-synuclein", "mice brain", "LOCATED IN"], ["gastrointestinal microbiota", "comorbid mental health conditions", "IS LINKED TO"], ["psychological symptoms", "individuals", "TARGET"], ["gut microbiota", "anorexia nervosa", "IS LINKED TO"], ["GLP-1", "gut microbiota", "IMPACT"], ["inflammatory bowel disease", "IBD and non-IBD patients", "TARGET"], ["bacteria", "gut microbiome", "PART OF"], ["microbes", "PPD", "IS LINKED TO"], ["MPP<sup>+</sup> -stimulated oxidative stress", "inflammatory response", "AFFECT"], ["motor deficits", "Heterozygous mice", "TARGET"], ["Oral aged garlic", "ulcerative colitis", "INFLUENCE"], ["Intestinal inflammation", "inflammatory bowel diseases", "AFFECT"], ["metabolic dysfunction", "central insulin resistance", "AFFECT"], ["Parkinson's disease", "Thermosediminibacter", "CHANGE ABUNDANCE"], ["Autism Spectrum Disorder", "and", "AFFECT"], ["imbalance in gut microbiota composition", "neurological disorders", "AFFECT"], ["cytokines", "LBD", "INFLUENCE"], ["gut microbiota", "neurodegenerative illnesses", "IS LINKED TO"], ["TMAO", "Parkinson's", "INFLUENCE"], ["neurodegenerative disorders", "gut microbiome", "CHANGE ABUNDANCE"], ["bacteria phyla", "obesity", "INFLUENCE"], ["dysbiosis", "AD", "AFFECT"], ["ginger", "gut microbiota", "IMPACT"], ["Probiotics", "microbiota-gut-brain axis dysfunction", "INFLUENCE"], ["butyrate", "motor deficits", "INFLUENCE"], ["Gut microbiota", "adiposity", "IS LINKED TO"], ["PD", "multisystem disease", "IS A"], ["phylum Actinobacteria", "gallbladder cancer", "INFLUENCE"], ["emotional", "offspring", "TARGET"], ["neuronal damage", "PD", "AFFECT"], ["appendix", "PD patients", "LOCATED IN"], ["NDDs", "amyotrophic lateral sclerosis", "AFFECT"], ["Dysbiosis", "neurological disorders", "AFFECT"], ["Prodromal PD", "sleep disruption", "AFFECT"], ["gut microbiota alterations", "Parkinson's Disease", "AFFECT"], ["Banxia xiexin decoction", "intestinal inflammation", "INFLUENCE"], ["altered gut microbiota", "depression", "IS LINKED TO"], ["Rh4", "depression", "CHANGE EFFECT"], ["gut microbiota", "resting-state functional magnetic resonance imaging", "USED BY"], ["LcS", "gut microbiota", "IMPACT"], ["42-PD patients", "16S rRNA amplicon-sequencing", "USED BY"], ["gut microbiota", "Chrna7 KO mice", "LOCATED IN"], ["probiotic supplementation", "constipation", "INFLUENCE"], ["<i>Lactobacillus plantarum</i> PS128", "motor deficits", "INFLUENCE"], ["colorectal cancer", "patients", "TARGET"], ["Major depressive disorder", "patients", "TARGET"], ["steviol bisglucoside", "Rubus chingii var. suavissimus (S.K.Lee) L.T.Lu", "IMPACT"], ["Inflammatory mechanisms", "imbalance of immune functions", "AFFECT"], ["intestinal microflora", "multiple sclerosis", "IS LINKED TO"], ["schizophrenia", "dysbiosis", "AFFECT"], ["Depression", "medical disorders", "AFFECT"], ["gut microbiota", "ELISA", "USED BY"], ["intestinal microbiome", "neurological disorders", "IS LINKED TO"], ["short chain fatty acid-producing bacteria", "psychiatric conditions", "INFLUENCE"], ["Parkinson's disease", "gastrointestinal diseases", "AFFECT"], ["systemic immune dysregulation", "Parkinson's disease", "AFFECT"], ["gut microbiota", "insomnia", "IS LINKED TO"], ["Gut microbiota", "endocrine system diseases", "IS LINKED TO"], ["gut microbiota", "PD-related constipation", "IS LINKED TO"], ["anxiety-like behavior", "Male mice", "TARGET"], ["MDD", "Patients", "TARGET"], ["NaB", "gut microbial dysbiosis", "INFLUENCE"], ["motor neuron disease", "NDDs", "IS A"], ["gut microbiota", "ED", "IS LINKED TO"], ["cecal microbiome", "chickens", "LOCATED IN"], ["ketamine", "gut microbiome", "IMPACT"], ["rotenone", "motor dysfunction", "CHANGE EFFECT"], ["PCDs", "disability", "AFFECT"], ["Colombian participants", "16S rRNA gene sequencing", "USED BY"], ["MPTP-induced motor dysfunction", "Mice", "TARGET"], ["antibiotics", "dysbiosis", "CHANGE EFFECT"], ["probiotics", "autism spectrum disorders", "INFLUENCE"], ["microbiota-mediated UDCA", "inflammatory responses", "INFLUENCE"], ["gut microbiota", "ELS", "IS LINKED TO"], ["dysbiosis", "genital regions", "STRIKE"], ["MEs", "inflammatory", "INFLUENCE"], ["\u03b1-Synuclein pathology", "appendix", "STRIKE"], ["prebiotic supplement", "gut microbiota", "IMPACT"], ["Human microbiota", "drug-naive patients", "LOCATED IN"], ["fecal microbiota dysbiosis", "Firmicutes", "CHANGE ABUNDANCE"], ["dysbiosis", "systemic inflammation", "AFFECT"], ["dysbiosis", "neurological or neuropsychiatric diseases", "AFFECT"], ["Dysbiosis", "Parkinson's disease", "AFFECT"], ["fecal microbiota", "PD mice", "LOCATED IN"], ["gut", "PD patients", "LOCATED IN"], ["depression-like phenotypes", "Chrna7 knock-out mice", "TARGET"], ["chemotherapy drugs", "CRC patients", "ADMINISTERED"], ["AD", "autoimmune diseases", "IS A"], ["gut microbiota", "dysregulation of appetite", "IS LINKED TO"], ["Morphine", "Gut Dysbiosis", "CHANGE EFFECT"], ["microbiome", "stress-related disorders", "IS LINKED TO"], ["Parkinson's disease", "Bifidobacterium bifidum", "CHANGE ABUNDANCE"], ["cognitive impairment", "patients", "TARGET"], ["medications", "disorders", "CHANGE EFFECT"], ["rotenone administration", "gastrointestinal function impairment", "CHANGE EFFECT"], ["dopaminergic neuronal death", "mice", "TARGET"], ["Central inflammation", "depression", "AFFECT"], ["Clinical PD", "mitochondrial impairment", "AFFECT"], ["insufficient neurotrophic support", "PD", "AFFECT"], ["Alzheimer's disease", "neurodegenerative and neurodevelopmental diseases", "IS A"], ["<i>B. lactis</i> MH-022 supplementation", "inflammation", "INFLUENCE"], ["single strain probiotics", "gut microbiota", "IMPACT"], ["motor deficits", "patients", "TARGET"], ["mice", "melatonin supplement", "USED BY"], ["Immune-related alterations", "Parkinson's disease", "AFFECT"], ["decrease in mucus secretion", "gut frailty", "AFFECT"], ["gut microbiota", "obesity", "IS LINKED TO"], ["inflammatory bowel", "patients", "TARGET"], ["gut microbiota", "sleep deprivation", "IS LINKED TO"], ["Probiotics", "PD patients", "ADMINISTERED"], ["Resveratrol", "PD", "INFLUENCE"], ["Parkinson's disease", "neuropsychiatric and neurological disorders", "IS A"], ["microbiota -derived metabolites", "PD", "INFLUENCE"], ["Isovaleric", "ET", "INFLUENCE"], ["Parkinson's disease", "motor, physical and behavioral symptoms", "IS A"], ["prebiotics", "depression-like and anxiety-like behavior", "INFLUENCE"], ["iron", "MCI", "INFLUENCE"], ["dopaminergic neuron loss", "Parkinson's disease", "AFFECT"], ["Epilepsy", "patients", "TARGET"], ["autism", "neuropsychiatric and neurodegenerative disorders", "IS A"], ["gut microbiota", "neurodegeneration", "IS LINKED TO"], ["structural and functional gut microbiota", "PD", "IS LINKED TO"], ["gut microbiome", "healthy controls", "LOCATED IN"], ["and non-motor symptoms", "Parkinson's Disease", "AFFECT"], ["proteins", "diabetes", "INFLUENCE"], ["drug-induced dysbiosis", "brain diseases", "AFFECT"], ["gut microbiota", "METH users", "LOCATED IN"], ["brain", "PD mice", "LOCATED IN"], ["inflammation", "middle brain", "STRIKE"], ["COVID-19", "AIS patients", "TARGET"], ["gut microbiota", "mental and neurological diseases", "IS LINKED TO"], ["OCD microbiota", "abnormal anxiety-like and compulsive-like behaviors", "IS LINKED TO"], ["MS", "neurodegenerative disorders", "IS A"], ["dopaminergic deficit", "PD subjects", "TARGET"], ["Parkinson's disease", "neuropsychiatric diseases", "IS A"], ["probiotics", "gastrointestinal and neurological conditions", "INFLUENCE"], ["Semaglutide", "Cognitive Impairment", "CHANGE EFFECT"], ["imbalance in gut microbiota composition", "anxiety", "AFFECT"], ["EGCG", "gut microbiota", "IMPACT"], ["microglia overactivation", "mice", "TARGET"], ["Parkinson's disease", "neurodegenerative disorders", "IS A"], ["Severe iron deficiency", "performance intolerance", "AFFECT"], ["B-vitamins", "psychiatric disorders", "INFLUENCE"], ["Parkinson's Disease", "progressive neurodegenerative disease", "IS A"], ["gut microbiota", "GI and non-GI diseases", "IS LINKED TO"], ["MPTP", "neuroinflammation", "INFLUENCE"], ["inflammation", "brain", "STRIKE"], ["elements", "health disorders", "INFLUENCE"], ["Mn", "toxic effects", "INFLUENCE"], ["inescapable electric stress", "rats", "TARGET"], ["microbiota-derived molecules", "pain", "INFLUENCE"], ["major depressive disorder", "gut microbiome", "CHANGE ABUNDANCE"], ["healthy gut microbiota", "Alzheimer's disease", "IS LINKED TO"], ["probiotics", "neuropsychiatric disorders", "INFLUENCE"], ["<i>Lacticaseibacillus paracasei</i> strain Shirota", "Parkinson's disease", "INFLUENCE"], ["MET-2", "Patients", "ADMINISTERED"], ["OCD", "mice", "TARGET"], ["human microbiome", "pathology", "IS LINKED TO"], ["depressive symptoms", "subjects", "TARGET"], ["Saturated fatty acids", "chronic low-grade inflammation", "INFLUENCE"], ["gut microbiota", "systemic inflammation", "IS LINKED TO"], ["gut microbes", "brain", "LOCATED IN"], ["diferuloylmethane", "IBS symptoms", "INFLUENCE"], ["Alzheimer's or Parkinson's diseases", "neurodegenerative protein conformational diseases", "IS A"], ["\u03b1-syn", "Synucleinopathies", "INFLUENCE"], ["Bone fragility", "increased mortality", "AFFECT"], ["microbiota dysregulation", "multiple sclerosis", "AFFECT"], ["physician-diagnosed mood disorders", "Adults", "TARGET"], ["metals", "LBD", "INFLUENCE"], ["PD", "brain disorders", "IS A"], ["VD deficiency", "depression", "AFFECT"], ["Parkinson's disease", "participants", "TARGET"], ["xenobiotics", "gut microbiome", "IMPACT"], ["ROS", "Inflammatory mechanisms", "INFLUENCE"], ["gastrointestinal microbiota", "adults", "LOCATED IN"], ["gut microbiota dysbiosis", "chronic immune activation", "AFFECT"], ["incidental dementia", "Spouses", "TARGET"], ["Age related neurodegenerative disorders", "people", "TARGET"], ["stroke", "neurological disorders", "IS A"], ["microbiota", "IMQ-treated mice", "LOCATED IN"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine", "neuroinflammation", "INFLUENCE"], ["depression", "neurodegenerative diseases", "IS A"], ["probiotic", "oxidative stress", "INFLUENCE"], ["ambient fine particulate matter", "neurodegenerative diseases", "INFLUENCE"], ["intracellular inclusions", "Parkinson's disease", "AFFECT"], ["Dysbiosis", "neuroinflammation", "AFFECT"], ["polymyxins", "infections", "CHANGE EFFECT"], ["gut microbiota", "distal organs", "LOCATED IN"], ["<sup>14</sup>C-Tyr", "gut microbiota", "IMPACT"], ["gut microbiome", "stress", "IS LINKED TO"], ["PUFA", "adolescent patients aged 12 to", "ADMINISTERED"], ["depressive symptoms", "sample population", "TARGET"], ["gut bacteria metabolites", "neurodegeneration", "INFLUENCE"], ["PD", "mouse model", "TARGET"], ["intestinal microbiota", "neural developmental disorders", "IS LINKED TO"], ["Dietary polysaccharides", "exercise-induced fatigue", "INFLUENCE"], ["gut", "PD", "AFFECT"], ["GLP-1 1", "Enterobacteriaceae", "IMPACT"], ["inulin supplementation", "migraine", "INFLUENCE"], ["gut microbiota", "chronic stress", "IS LINKED TO"], ["hyperhomocysteinemia", "patients", "TARGET"], ["Gastrointestinal disorders", "Parkinson's disease", "AFFECT"], ["Parkinson's disease", "mice", "TARGET"], ["RBD", "gut dysbiosis", "AFFECT"], ["Commensal protist Tritrichomonas musculus", "gut microbiota", "PART OF"], ["Gamma-aminobutyric acid", "stress", "INFLUENCE"], ["\u03b1-synuclein misfolding", "vagus nerve", "STRIKE"], ["inflammation", "neurodegenerative diseases", "AFFECT"], ["dairy products", "PD", "INFLUENCE"], ["altered salivary cortisol awakening response", "Young adults", "TARGET"], ["Parkinson's disease", "gastrointestinal tract", "STRIKE"], ["Psychobiotics", "gut microbiota", "IMPACT"], ["schizophrenia patients", "16S rRNA gene sequencing", "USED BY"], ["IBD", "chronic neurodegeneration", "AFFECT"], ["gastrointestinal (GI) dysfunction", "PD", "AFFECT"], ["prebiotics", "AD", "INFLUENCE"], ["Isovaleric", "PD", "INFLUENCE"], ["gut microbiota", "mental illness", "IS LINKED TO"], ["stroke", "age-related neurodegenerative disorders", "IS A"], ["intestinal microbiota", "BD", "IS LINKED TO"], ["mitochondrial dysfunction", "neurodegeneration", "AFFECT"], ["CEL", "C. jejuni infection", "INFLUENCE"], ["Sodium butyrate", "neurological disorders", "INFLUENCE"], ["proximal colon", "PD-like mice", "LOCATED IN"], ["AD", "Central nervous system (CNS) disorders", "IS A"], ["MDD", "gut microbiota", "CHANGE ABUNDANCE"], ["Bacterial Metabolites", "Common Brain Diseases", "INFLUENCE"], ["cytokines", "dementia with Lewy body", "INFLUENCE"], ["AD", "functional and cognitive impairments", "IS A"], ["HCC", "liver cancers", "IS A"], ["Gut microbiota", "disrupted gut microbiota composition and function", "IS LINKED TO"], ["gut dysbiosis", "neurodegenerative diseases", "AFFECT"], ["histopathological changes", "gastrointestinal (GI) tract", "STRIKE"], ["healthy subjects", "16S rDNA sequencing", "USED BY"], ["PD patients", "Diet History Questionnaire II", "USED BY"], ["systemic inflammation", "PD", "AFFECT"], ["Gut Microbiota", "Major Depressive Disorder", "IS LINKED TO"], ["gut microbiota", "Dysbiosis", "IS LINKED TO"], ["Intestinal Inflammation", "Humans", "TARGET"], ["depression", "neuropsychiatric and neurological disorders", "IS A"], ["GM", "CUMS-donor", "LOCATED IN"], ["gut mycobiota dysbiosis", "patients", "TARGET"], ["tablet", "healthy young adults", "ADMINISTERED"], ["copper", "mild cognitive impairment", "INFLUENCE"], ["Bone fragility", "disability", "AFFECT"], ["gastrointestinal microbiome", "neurological disorders", "IS LINKED TO"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "male C57BL/6J mice", "ADMINISTERED"], ["Bifidobacterium infantis M-63", "irritable bowel syndrome", "INFLUENCE"], ["PCOS", "gynecological endocrine disease", "IS A"], ["Sleep disorders", "obesity", "AFFECT"], ["fiber supplementation", "depressive", "INFLUENCE"], ["alcohol overconsumption", "Proteobacteria", "CHANGE ABUNDANCE"], ["antibiotics", "seizure", "CHANGE EFFECT"], ["celiac disease", "patients", "TARGET"], ["\u03b1-synuclein misfolding", "gut", "STRIKE"], ["anorexia nervosa", "small intestine", "STRIKE"], ["synbiotics", "compulsivity", "INFLUENCE"], ["vitamins", "neurodegenerative diseases", "INFLUENCE"], ["Gut Microbiota", "Neurodegenerative Disorders", "IS LINKED TO"], ["gut microbiota", "C57 BL/J mice", "LOCATED IN"], ["acetylcholine", "PD", "INFLUENCE"], ["monoamine", "hippocampus", "LOCATED IN"], ["Parkinson's disease", "motor impediments", "IS A"], ["bipolar disorder", "low-grade inflammation", "AFFECT"], ["CP2305", "placebo", "INTERACT"], ["microbial metabolites", "PD", "INFLUENCE"], ["Parkinson's disease", "healthy young", "TARGET"], ["genus Parabacteroides", "mental disorders", "INFLUENCE"], ["L-dopa", "Parkinson's", "CHANGE EFFECT"], ["prebiotics", "post-traumatic stress disorder", "INFLUENCE"], ["colorectal cancer", "UC", "AFFECT"], ["probiotics", "subjects", "ADMINISTERED"], ["intestinal microbiota", "patients", "LOCATED IN"], ["depression-like behavior", "rats", "TARGET"], ["gut microbiome", "depressive symptoms", "IS LINKED TO"], ["Post-infectious fatigue", "decreased physical efficiency", "AFFECT"], ["dairy products", "mental disorders", "INFLUENCE"], ["compulsivity", "psychiatric disorders", "AFFECT"], ["obesity", "cannabis users", "TARGET"], ["human gut microbiota", "psychiatric diseases", "IS LINKED TO"], ["PMU", "depressive-like behavior", "INFLUENCE"], ["SA participants", "Gut microbial composition analysis", "USED BY"], ["autism spectrum disorder", "neurodevelopmental disorders", "IS A"], ["wild-type mice", "mass spectrometry", "USED BY"], ["probiotics", "GI problems", "INFLUENCE"], ["Klebsiella", "PD", "INFLUENCE"], ["Parkinson's disease", "neurodegenerative and neurodevelopmental diseases", "IS A"], ["gut microbiota", "humans", "LOCATED IN"], ["SARS-CoV-2", "Coronavirus disease 2019", "AFFECT"], ["microbiota", "skin", "LOCATED IN"], ["Gut microbiota alteration", "PD", "AFFECT"], ["post-biotics", "gut frailty", "INFLUENCE"], ["ketogenic", "oxidative stress", "INFLUENCE"], ["ADHD", "adults", "TARGET"], ["food addiction", "addictive substance use disorders", "IS A"], ["metabolites", "inflammation", "INFLUENCE"], ["metabolic disorders", "psychiatric disorders", "AFFECT"], ["dietary polysaccharides", "psychiatric, neurodevelopmental disorders", "INFLUENCE"], ["THC", "gut microbiota", "IMPACT"], ["gut microbiota", "neurodegenerative disorder", "IS LINKED TO"], ["IBS", "flood-affected individuals", "TARGET"], ["gastrointestinal microbiome", "Parkinson's disease", "IS LINKED TO"], ["Melatonin", "Gut microbiota", "IMPACT"], ["probiotics", "seizure", "INFLUENCE"], ["fecal microbiota", "systemic inflammation", "IS LINKED TO"], ["epilepsy", "patients", "TARGET"], ["intestinal microbiota", "Parkinson's disease development", "IS LINKED TO"], ["psychobiotic combination", "depression symptoms", "INFLUENCE"], ["<i>B. lactis</i> MH-022 supplementation", "gut microbiota", "IMPACT"], ["obesity", "bariatric patients", "TARGET"], ["MDD", "stress-related disorders", "IS A"], ["Microbiota", "Endometriosis", "IS LINKED TO"], ["altered gut microbiota", "amplicon sequencing", "USED BY"], ["Alzheimer's disease", "cognitive and motor deficits", "IS A"], ["\u03b1-synuclein", "neurological disorders", "INFLUENCE"], ["oral agents", "GM", "IMPACT"], ["Prodromal PD", "orthostatic hypotension", "AFFECT"], ["paraprobiotics", "mental health disorders", "INFLUENCE"], ["anhedonia", "depression", "AFFECT"], ["Synucleinopathies", "Parkinson's disease", "AFFECT"], ["Fermented foods", "anxiety", "INFLUENCE"], ["progressive neuron loss", "PD", "AFFECT"], ["gut dysbiosis", "behavioral disorders", "AFFECT"], ["PDD", "manganese", "INTERACT"], ["cytokines", "PD", "INFLUENCE"], ["autism spectrum disorders", "females", "TARGET"], ["fecal microbiota dysbiosis", "Bacteroidetes", "CHANGE ABUNDANCE"], ["hyperalertness", "animals", "TARGET"], ["motor deficits", "mice", "TARGET"], ["RBD", "PD patients", "TARGET"], ["\u03b1Syn", "PD", "INFLUENCE"], ["gut microbiota", "ageing mice", "LOCATED IN"], ["AEAP", "beneficial bacteria", "IMPACT"], ["Alzheimer's dementia", "inflammation", "AFFECT"], ["PD", "older people", "TARGET"], ["isolated dystonia", "patients", "TARGET"], ["\u03b1-syn transgenic mice", "Illumina sequencing", "USED BY"], ["synaptic proteins", "PFC", "LOCATED IN"], ["Gut microbiomes", "16S rRNA gene sequencing", "USED BY"], ["GAD", "patients", "TARGET"], ["gut microbiota", "postpartum depression", "IS LINKED TO"], ["Infections", "parkinsonism", "AFFECT"], ["adult patients", "blood-, urine-, and fecal-based measures", "USED BY"], ["\u03b1-synucleinopathy", "PD", "AFFECT"], ["Parkinson's", "AD", "AFFECT"], ["neurodegeneration", "PD", "AFFECT"], ["gut-microbiota", "PD", "IS LINKED TO"], ["gut microbiota", "Whole genome metagenome (WGM) sequencing", "USED BY"], ["multitarget directed ligands", "NDDs", "CHANGE EFFECT"], ["depressive-like behavior", "mice", "TARGET"], ["metabolites", "neuropsychiatric disorders", "INFLUENCE"], ["primary neurodegenerative dementias", "elderly", "TARGET"], ["depressive episodes", "patients", "TARGET"], ["SCFAs", "inflammation", "INFLUENCE"], ["microbial metabolite short-chain fatty acids", "PD", "INFLUENCE"], ["psoriasis", "patients", "TARGET"], ["Healthy college students", "double-blind, placebo-control, and randomization-control study", "USED BY"], ["WEG", "intestinal damage", "INFLUENCE"], ["gastrointestinal microbiome", "Alzheimer's disease", "IS LINKED TO"], ["Rapid eye movement sleep behavior disorder", "Parkinson's disease", "AFFECT"], ["internalizing problems", "children clinically \"at risk\"", "TARGET"], ["Tau", "C57BL/6 mice", "LOCATED IN"], ["\u03b1S pathology", "brain", "STRIKE"], ["CSDS", "interleukin-6", "INTERACT"], ["schizophrenia", "people", "TARGET"], ["hospital-treated gastrointestinal and respiratory infections", "Parkinson's disease", "AFFECT"], ["gut microbiota", "depressive illness", "IS LINKED TO"], ["Microbiot<sup>\u00ae</sup>", "microglial activation", "INFLUENCE"], ["colon", "Stress-sensitive animals", "LOCATED IN"], ["Parkinson's disease", "NSE-h\u03b1Syn Tg mice", "TARGET"], ["gut microbiota", "pathogen-free mice", "LOCATED IN"], ["HTN subjects", "metagenomic sequencing", "USED BY"], ["gut microbiota", "gastrointestinal tract", "LOCATED IN"], ["GM", "seizures", "IS LINKED TO"], ["chronic liver disease", "patients", "TARGET"], ["Gastrointestinal Issues", "Depression", "AFFECT"], ["aging", "intestinal bacteria", "CHANGE ABUNDANCE"], ["gut microbiome", "neuropsychiatric disorders", "IS LINKED TO"], ["gut microbiome", "aging and neurodegenerative diseases", "IS LINKED TO"], ["healthy older", "compositional data analysis", "USED BY"], ["alterations in gut microbiota composition", "depression", "AFFECT"], ["AKK", "depression", "INFLUENCE"], ["gut microbiome", "MDD", "IS LINKED TO"], ["healthy subjects", "16S rRNA gene-sequencing analysis", "USED BY"], ["PD", "subjects", "TARGET"], ["Gut microbiota changes", "PD", "AFFECT"], ["constipation", "HD subjects", "TARGET"], ["Serum Propionic Acid", "Cognitive Decline", "INFLUENCE"], ["gut microbiota", "OCD", "IS LINKED TO"], ["insulin resistance", "Diabetic mice", "TARGET"], ["diabetes", "endocrine system diseases", "IS A"], ["obesity", "non-users", "TARGET"], ["Depression", "mental disorder", "IS A"], ["THP", "severe withdrawal syndrome", "CHANGE EFFECT"], ["Bifidobacterium breve Bif11", "inflammatory changes", "INFLUENCE"], ["Gut Microbiome", "Nursing Students", "LOCATED IN"], ["depressive-like behaviors", "F1 females", "TARGET"], ["gut microbiota", "adult nursing students", "LOCATED IN"], ["nutritional supplements", "gut microbiome", "IMPACT"], ["Gut microbiome dysbiosis", "REM sleep behavior disorder", "AFFECT"], ["prodromal dysfunctions", "autonomic issues", "AFFECT"], ["OCD microbiota", "core behavioral deficits", "IS LINKED TO"], ["Rk3", "Rk3", "INTERACT"], ["Gut microbiota", "dementia with Lewy body", "IS LINKED TO"], ["Parkinson's disease", "neuropsychiatric and neurodegenerative disorders", "IS A"], ["Dysbiosis of gut microbiota", "Parkinson's disease", "AFFECT"], ["M1", "gut microbiota", "PRODUCED BY"], ["MPTP-induced motor dysfunction", "young mice", "TARGET"], ["HCs", "stool sample analysis", "USED BY"], ["substantia nigra", "NSE-h\u03b1Syn Tg mice", "LOCATED IN"], ["next-generation probiotic", "chronic stress-induced depressive-like behavior", "INFLUENCE"], ["baicalein", "pathological illnesses", "INFLUENCE"], ["Meth", "mental disorders", "CHANGE EFFECT"], ["B-vitamins", "psychopathology", "INFLUENCE"], ["gut dysbiosis", "AD", "AFFECT"], ["gut-resident bacteria", "neurodegeneration", "INFLUENCE"], ["meropenem", "severe infection-related pathologies", "CHANGE EFFECT"], ["probiotic", "impairment of motor coordination", "INFLUENCE"], ["\u03b1-synuclein", "Alzheimer's disease", "INFLUENCE"], ["gut microbiota", "Metagenomics sequencing", "USED BY"], ["bipolar disorder", "patients", "TARGET"], ["glaucoma", "neurodegenerative disorders", "IS A"], ["gut microbiota", "Parkinson's disease mouse model", "LOCATED IN"], ["toxic metals", "T2DM", "INFLUENCE"], ["motor symptoms", "patients", "TARGET"], ["Resveratrol", "A53T transgenic mice", "ADMINISTERED"], ["toxin-like peptides", "gut microbiome", "PRODUCED BY"], ["depression", "Parkinson's disease", "AFFECT"], ["Ketamine", "dissociation", "CHANGE EFFECT"], ["mood disorders", "IBD patients", "TARGET"], ["vitamin D3", "motor symptoms", "INFLUENCE"], ["PD", "Roseburia", "CHANGE ABUNDANCE"], ["intestinal microbiota", "mood disorders", "IS LINKED TO"], ["Gut microbiota", "mental disorders", "IS LINKED TO"], ["gut microbiota", "high-throughput sequencing", "USED BY"], ["dysbiosis", "neurological disorders", "AFFECT"], ["RHSD", "neuropathy", "INFLUENCE"], ["Benserazide", "PD", "CHANGE EFFECT"], ["(R)-ketamine", "Clostridiales", "IMPACT"], ["gut microbiota", "mental health disorders", "IS LINKED TO"], ["psychobiotics", "depression", "INFLUENCE"], ["Insulin resistance", "PD", "AFFECT"], ["Rubusoside", "neuroinflammation", "INFLUENCE"], ["small intestinal bacterial overgrowth", "PD", "AFFECT"], ["motor deficits", "Parkinson's disease", "AFFECT"], ["PD", "PD group", "TARGET"], ["gut microbiota", "human synucleinopathies", "IS LINKED TO"], ["adult patients", "physiological assessments", "USED BY"], ["behavioural problems", "Prevotella", "CHANGE ABUNDANCE"], ["gut disorders", "neurodegenerative and neuropsychiatric diseases", "AFFECT"], ["gastrointestinal microbiome", "inflammation", "IS LINKED TO"], ["casein", "PD", "INFLUENCE"], ["psychedelics", "enteric microbiome populations", "IMPACT"], ["vegetables", "mental disorders", "INFLUENCE"], ["Phytochemicals", "gut microbiota", "IMPACT"], ["Gut Microbiota", "Novel Biomarker", "USED BY"], ["nuclear factor erythroid 2 related factor", "gut microbiota", "IMPACT"], ["Dysbiosis", "beneficial microbial metabolites", "INTERACT"], ["Reduced glucose metabolism", "neuronal death", "AFFECT"], ["fiber", "depression", "INFLUENCE"], ["RBD", "non-motor symptom", "IS A"], ["controls", "metagenomic sequencing", "USED BY"], ["Malfunction", "cytokine storm", "AFFECT"], ["abnormal behaviour", "pro-inflammatory and lactic acid-producing bacteria", "CHANGE ABUNDANCE"], ["Helicobacter", "rigidity", "INFLUENCE"], ["gut dysbiosis-induced neurodegeneration", "multiple sclerosis", "AFFECT"], ["gut microbiota", "psychological symptoms", "IS LINKED TO"], ["neuroinflammatory changes", "Parkinson's disease", "AFFECT"], ["saturated fat", "depression", "INFLUENCE"], ["depressive symptoms", "Japanese workers", "TARGET"], ["edaravone", "mice", "ADMINISTERED"], ["butyrate-producing bacterium B. producta", "motor dysfunction", "INFLUENCE"], ["PD patients", "GC-MS", "USED BY"], ["antibiotics", "neurodegenerative diseases", "CHANGE EFFECT"], ["PD", "neurological degenerative condition", "IS A"], ["intestinal microbiota", "mice", "LOCATED IN"], ["gut microbiota", "human body", "LOCATED IN"], ["alpha-lactalbumin", "gut microbiota", "IMPACT"], ["Lewy body dementia", "LBD", "AFFECT"], ["gut dysbiosis", "PD", "TARGET"], ["PD", "subdiaphragmatic vagus nerve", "STRIKE"], ["mental disorders", "METH users", "TARGET"], ["betaine", "motor fluctuations", "INFLUENCE"], ["PD", "Neurodegenerative diseases", "IS A"], ["probiotic interventions", "depressive symptoms", "INFLUENCE"], ["Parkinson's", "IBD", "AFFECT"], ["Amyotrophic Lateral Sclerosis", "neurodegenerative disease", "IS A"], ["flavonoids", "PD", "INFLUENCE"], ["bipolar disorder", "morbidity", "AFFECT"], ["Bifidobacterium", "CSDS", "INFLUENCE"], ["PD", "neurological disorder", "IS A"], ["diazepam", "Male Wistar rats", "ADMINISTERED"], ["Peripheral cytokines", "neuroinflammation", "INFLUENCE"], ["probiotics", "Lactobacillus", "IMPACT"], ["Intestinal Inflammation", "Animals", "TARGET"], ["neuroendocrine", "psychiatry-related disorders", "INFLUENCE"], ["PD", "neurodegenerative condition", "IS A"], ["defects in the gut function", "motor symptoms", "AFFECT"], ["gastrointestinal dysfunctions", "treated advanced PD patients", "TARGET"], ["PD", "Bilophila", "CHANGE ABUNDANCE"], ["VLCKD", "obesity", "INFLUENCE"], ["ALS", "fatal neurodegenerative disease", "IS A"], ["Impaired circadian rhythms", "psychiatric metabolic comorbidities", "AFFECT"], ["non-Alzheimer's neurodegeneration and dementias", "neurological diseases", "IS A"], ["fecal microbiota", "stress-sensitive mice", "LOCATED IN"], ["gut microbiota", "ferroptosis", "IS LINKED TO"], ["epilepsy", "gastrointestinal tract", "STRIKE"], ["Antrodia camphorata", "neurological disorders", "INFLUENCE"], ["gut microbiome", "allergic disease", "IS LINKED TO"], ["gut microbiota", "EAE/MS", "IS LINKED TO"], ["THP", "oxidative stress", "CHANGE EFFECT"], ["colorectal cancer", "hold-out cohorts", "TARGET"], ["Sodium butyrate", "gut microbiota dysbiosis", "INFLUENCE"], ["household controls", "16S amplicon sequencing", "USED BY"], ["CSDS", "mice", "TARGET"], ["Functional Constipation", "Patients", "TARGET"], ["Parkinson's disease", "gut microbiome", "CHANGE ABUNDANCE"], ["striatum", "water-treated mice", "LOCATED IN"], ["affective behavioral syndromes", "offspring", "TARGET"], ["Amyotrophic Lateral Sclerosis", "neurological diseases", "IS A"], ["depression-like phenotypes", "Chrna7 KO mice", "TARGET"], ["intestinal", "bacterial imbalance", "IS LINKED TO"], ["PD", "chronic neurological disorder", "IS A"], ["pathological proteins", "psychiatric disorders", "INFLUENCE"], ["VD", "anxiety", "INFLUENCE"], ["Gut microbiota disturbance", "Parkinson's disease", "AFFECT"], ["dietary fibers", "Lactobacillus family", "IMPACT"], ["PDD", "Zn", "INTERACT"], ["Ferulic acid esterases", "FA", "INTERACT"], ["fecal microbiota", "OCD", "IS LINKED TO"], ["intestinal barrier disruption", "microbiota-gut-brain axis disorder", "AFFECT"], ["gut", "neurodegenerative disease", "AFFECT"], ["polyphenols", "neurological and psychological conditions", "INFLUENCE"], ["GEP", "GFAP", "INTERACT"], ["endometriosis", "healthy individuals", "TARGET"], ["fruits", "mood disorders", "INFLUENCE"], ["PD-related behaviors", "gut microbiota", "CHANGE ABUNDANCE"], ["GM", "CUMS-recipient", "LOCATED IN"], ["acute COVID-19 infection", "AIS patients", "TARGET"], ["gut microbiome", "neurodegenerative disorders", "IS LINKED TO"], ["diseases", "the CNS", "AFFECT"], ["SCFAs", "inflammatory bowel disease", "INFLUENCE"], ["dysbiosis", "Alzheimer's disease", "AFFECT"], ["oral microbiome", "depression symptoms", "IS LINKED TO"], ["Fe", "MCI", "INFLUENCE"], ["bipolar disorder", "neuropsychiatric and neurological disorders", "IS A"], ["<i>L. plantarum</i> CCFM405", "rotenone-induced motor deficits", "INFLUENCE"], ["Depression", "adults", "TARGET"], ["\u03b1-syn transgenic mice", "metagenomics", "USED BY"], ["gamma-aminobutyric acid", "anxiety", "INFLUENCE"], ["Dysfunction of the gut microbiome", "cytokine storm", "AFFECT"], ["PD", "Oscillospira", "CHANGE ABUNDANCE"], ["dysbiosis", "anxiety", "AFFECT"], ["PD", "rotenone-challenged mice", "TARGET"], ["gut microbiome", "Malfunction", "IS LINKED TO"], ["Parkinson's disease", "Akkermansia muciniphila", "CHANGE ABUNDANCE"], ["bipolar depression", "patients", "TARGET"], ["Gut microbiota", "dementia", "IS LINKED TO"], ["GM", "PD mice", "LOCATED IN"], ["abnormal gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["fecal microbiota", "pain", "IS LINKED TO"], ["gut microbial population imbalance", "HD", "AFFECT"], ["VD", "neurological dysfunction", "INFLUENCE"], ["ED", "gut microbiota", "CHANGE ABUNDANCE"], ["gut microbiota", "control animals", "LOCATED IN"], ["dementia", "Older persons", "TARGET"], ["Autism", "females", "TARGET"], ["standardized ginger (Zingiber officinale) root powder", "gastrointestinal bacteria", "IMPACT"], ["manganese", "Parkinson's-like neurological disorders", "INFLUENCE"], ["gut-microbiota", "worry", "IS LINKED TO"], ["gut dysbiosis", "motor neuron disease", "AFFECT"], ["Gut microbiome alterations", "neurodegenerative diseases", "AFFECT"], ["Dietary antibiotics", "cecal microbiome", "IMPACT"], ["metabolic dysfunction", "mood disorders", "AFFECT"], ["Gut Microbiota", "Adults", "LOCATED IN"], ["prenatal chronic stress", "emotional injury", "AFFECT"], ["probiotic supplementation", "motor and non-motor symptoms", "INFLUENCE"], ["Parkinson's disease", "older group", "TARGET"], ["L-DOPA", "Parkinson's disease", "CHANGE EFFECT"], ["microbiota", "community-dwelling older adults", "LOCATED IN"], ["MA", "PD mice", "ADMINISTERED"], ["substance use disorders", "population", "TARGET"], ["Akkermansiaceae", "PD patients", "LOCATED IN"], ["Gut Microbiota", "Mood Disorders", "IS LINKED TO"], ["PTSD", "patients", "TARGET"], ["PD mice", "behavioral tests", "USED BY"], ["depression", "neurological, psychiatric and metabolic disorders", "IS A"], ["fecal microbiota", "intestinal inflammation", "IS LINKED TO"], ["ALS", "neurodegenerative disease", "IS A"], ["Gut microbes", "stress", "IS LINKED TO"], ["gut microbiota", "MPTP-induced mouse model", "LOCATED IN"], ["ASD", "children", "TARGET"], ["Sub-chronic inflammation", "neurodegenerative diseases", "AFFECT"], ["probiotics", "neurodegenerative disorders", "INFLUENCE"], ["vitamin D3", "PD", "INFLUENCE"], ["AD", "Bacteroides", "CHANGE ABUNDANCE"], ["Parkinson's Disease", "substantia nigra region", "STRIKE"], ["neuromodulatory compounds", "inflammation", "INFLUENCE"], ["RBD", "pro-inflammatory Collinsella", "CHANGE ABUNDANCE"], ["PD", "A53T mice", "TARGET"], ["feruloylated sugar ester conjugates", "FA", "INTERACT"], ["Coronavirus Disease 2019", "critically ill patients", "TARGET"], ["the gut microbiome", "cytokine storm", "AFFECT"], ["GABA", "anxiety", "INFLUENCE"], ["PD", "Parkinson's disease", "IS A"], ["gut microbiota", "aberrant immune responses", "IS LINKED TO"], ["gut microbiome", "people", "LOCATED IN"], ["metabolite butyrate", "MPTP/MPP<sup>+</sup> -induced Parkinson's disease", "INFLUENCE"], ["MDMA", "suicide thoughts", "CHANGE EFFECT"], ["Sodium butyrate", "degradation", "INFLUENCE"], ["healthy control", "multi-omics analysis", "USED BY"], ["CD", "hold-out cohorts", "TARGET"], ["ginsenoside Rh4", "mouse model", "ADMINISTERED"], ["Mediterranean diet", "PD", "INFLUENCE"], ["ALS", "neurological diseases", "IS A"], ["levodopa", "side effects", "CHANGE EFFECT"], ["HD", "neurological and psychological disorders", "IS A"], ["Methamphetamine", "anxiety", "CHANGE EFFECT"], ["respiratory muscle paralysis", "patients", "TARGET"], ["dementia", "neuropsychiatric disorders", "IS A"], ["probiotic treatment", "depressed individuals", "ADMINISTERED"], ["motor and sensory deficits", "Parkinson's disease", "AFFECT"], ["B subunit", "PD", "INFLUENCE"], ["Schizophrenia", "chronic mental disorder", "IS A"], ["bacterial endotoxin", "Parkinson's disease", "INFLUENCE"], ["type 2 diabetes", "people", "TARGET"], ["NaB", "motor deficits", "INFLUENCE"], ["healthy gut microbiota", "epilepsy", "IS LINKED TO"], ["major mood disorders", "serious mental illnesses", "IS A"], ["NSAIDs", "gut microbiota", "IMPACT"], ["mental disorders", "humans", "TARGET"], ["bacitracin methylene disalicylate", "cecal microbiome", "IMPACT"], ["gut microbiome", "Humans", "LOCATED IN"], ["gut dysbiosis", "gastrointestinal tract", "STRIKE"], ["Curcumin", "MPTP-induced mice", "ADMINISTERED"], ["tea", "PD", "INFLUENCE"], ["statins", "gut microbiota", "IMPACT"], ["phytochemical", "colitis", "INFLUENCE"], ["gut microbiota metabolites", "CNS-related diseases", "INFLUENCE"], ["gut microbiota", "neuroinflammation", "IS LINKED TO"], ["early-stage PD mice", "gas chromatography", "USED BY"], ["PD", "Tenericutes", "CHANGE ABUNDANCE"], ["Gut Microbiota", "Alzheimer's Disease", "IS LINKED TO"], ["Inflammation", "neurologic", "AFFECT"], ["culprit proteins", "disability", "INFLUENCE"], ["gut microflora", "AD", "IS LINKED TO"], ["IBD", "ischemic stroke", "AFFECT"], ["saturated fats", "PD", "INFLUENCE"], ["unintentional weight loss", "PD patients", "TARGET"], ["lipid peroxides", "Ferroptosis", "INFLUENCE"], ["gut microbiota", "gender-specific Parkinson's disease", "IS LINKED TO"], ["Damaged", "systemic inflammation", "AFFECT"], ["MPTP-induced weight loss", "mice", "TARGET"], ["gut dysbiosis", "Alzheimer's disease", "AFFECT"], ["(R)-ketamine", "depression-like behaviors", "CHANGE EFFECT"], ["Obesity", "metabolic disorder", "IS A"], ["gut microbiota", "body-first Parkinson Disease", "IS LINKED TO"], ["depression", "Coprococcus spp.", "CHANGE ABUNDANCE"], ["rotenone-induced mice", "16S RNA sequencing", "USED BY"], ["tablet", "anxiety", "INFLUENCE"], ["PD", "debilitating motor symptoms", "IS A"], ["probiotic", "male and female rats", "ADMINISTERED"], ["Toxic Metals", "Gut Microbiota", "IMPACT"], ["Antipsychotics", "psychiatric disorders", "CHANGE EFFECT"], ["gut microbiota", "PrP-A53T mice", "LOCATED IN"], ["dietary polysaccharides", "autism spectrum disorder", "INFLUENCE"], ["Probio-M8", "anxiety", "INFLUENCE"], ["bipolar disorder", "Iranian patients", "TARGET"], ["gut microbiota", "SD", "IS LINKED TO"], ["gut microbiota", "gastroenteric inflammation", "IS LINKED TO"], ["alcohol overconsumption", "patients", "TARGET"], ["gut microbiota", "major depressive disorders", "IS LINKED TO"], ["fecal microbiota", "na\u00efve ones", "LOCATED IN"], ["p-\u03b1-Syn", "colon", "LOCATED IN"], ["gut microbiota dysbiosis", "Parkinson disease", "AFFECT"], ["Parkinson's Disease", "rigidity", "AFFECT"], ["Parkinson's disease", "NDDs", "IS A"], ["psychiatric disorders", "individuals", "TARGET"], ["ginger", "gastrointestinal bacteria", "IMPACT"], ["prenatal chronic stress", "rats", "TARGET"], ["Parkinson's disease", "PD patients", "TARGET"], ["gut microbiota", "MS", "IS LINKED TO"], ["EC-12 supplementation", "Enterococcus", "IMPACT"], ["resveratrol-shaped microbiota", "PD mice", "LOCATED IN"], ["IBDs", "IBDs", "AFFECT"], ["PD", "neurological disorders", "IS A"], ["Prebiotics", "pro-inflammatory species", "IMPACT"], ["synaptic proteins", "CRS-exposed mice", "LOCATED IN"], ["inflammatory changes", "enteric nervous system", "STRIKE"], ["patients", "16S ribosomal RNA sequencing", "USED BY"], ["psychobiotics", "neurodegenerative diseases", "INFLUENCE"], ["Valeric acid", "Alzheimer's", "INFLUENCE"], ["L-dopa", "brain", "LOCATED IN"], ["Neurodegenerative protein conformational diseases", "disability", "AFFECT"], ["Irritable Bowel Syndrome", "Adults", "TARGET"], ["probiotics", "PD symptoms", "INFLUENCE"], ["gut microbiota", "inflammation", "IS LINKED TO"], ["indoles", "human neurological and neuropsychiatric disorders", "INFLUENCE"], ["Parkinson's disease", "first-degree relatives", "TARGET"], ["GOS", "stress-induced anxiety-like behavior", "INFLUENCE"], ["OCN", "dopaminergic neuronal loss", "INFLUENCE"], ["Idiopathic Rapid Eye Movement Sleep Behavior Disorder", "Parkinson's Disease", "AFFECT"], ["GM", "ASD", "IS LINKED TO"], ["Inflammation", "gut dysbiosis", "AFFECT"], ["polysaccharides", "fatigue", "INFLUENCE"], ["substantia nigra", "MPTP-induced Parkinson's disease mice", "LOCATED IN"], ["mild dementia", "participants", "TARGET"], ["PPD", "PPD patients", "TARGET"], ["LPS endotoxins", "Gram-negative bacteria", "IMPACT"], ["Dietary fiber", "gut microbiota", "IMPACT"], ["Infections", "Parkinson's disease", "AFFECT"], ["PM2.5", "bipolar disorder", "INFLUENCE"], ["AGPs", "clinical and subclinical diseases", "CHANGE EFFECT"], ["schizophrenia", "neurodevelopmental disorders", "IS A"], ["GM", "epilepsy", "IS LINKED TO"], ["Reduced glucose metabolism", "neurodegeneration", "AFFECT"], ["Clostridium difficile infection", "human subjects", "TARGET"], ["taurine-conjugated bile acids", "motor symptoms", "INFLUENCE"], ["probiotic supplementation", "patients", "ADMINISTERED"], ["KBs", "neuroinflammation", "INFLUENCE"], ["puerarin", "inflammatory response", "INFLUENCE"], ["<i>Camelina sativa</i> oil", "gut microbiota", "IMPACT"], ["antibiotics", "low-grade systemic inflammation", "CHANGE EFFECT"], ["Gut microbiota", "neurological diseases", "IS LINKED TO"], ["dopaminergic degeneration", "people", "TARGET"], ["gut microbiota", "complex diseases", "IS LINKED TO"], ["GM", "Alzheimer's diseases", "IS LINKED TO"], ["biologically active polyphenols", "PD", "INFLUENCE"], ["gut microbiota", "neurogenerative disorders", "IS LINKED TO"], ["prebiotics", "anxiety", "INFLUENCE"], ["Akkermansia", "polycystic ovary syndrome", "INFLUENCE"], ["Schizophrenia", "disability", "AFFECT"], ["Parkinson Disease", "MPTP Mouse Model", "TARGET"], ["females", "resting-state functional magnetic resonance imaging", "USED BY"], ["gut microbiota dysregulation", "AD", "AFFECT"], ["intestinal microbiota", "schizophrenia", "IS LINKED TO"], ["SIBO", "patients", "TARGET"], ["clozapine", "metabolic abnormalities", "CHANGE EFFECT"], ["alpha-synuclein", "cognitive impairment", "INFLUENCE"], ["MDD", "patients", "TARGET"], ["Depression", "individuals", "TARGET"], ["human gut microbiota", "hypertension", "IS LINKED TO"], ["MS", "cognitive and motor deficits", "IS A"], ["gut microbiota", "neurological and psychiatric conditions", "IS LINKED TO"], ["idiopathic Parkinson's disease", "patients", "TARGET"], ["virus infection", "Dysfunction of the gut microbiome", "AFFECT"], ["Dysbiosis", "PD", "AFFECT"], ["circadian disruptions", "mental disorders", "AFFECT"], ["acute COVID-19", "Ruminococcaceae", "CHANGE ABUNDANCE"], ["MA use disorder", "Individuals", "TARGET"], ["PD", "female patients", "TARGET"], ["Dysbiosis", "autism", "AFFECT"], ["NDDs", "Neurodegenerative diseases", "IS A"], ["gut microbiome", "mental disorders", "IS LINKED TO"], ["trauma", "eating disorders", "AFFECT"], ["constipation", "cardiovascular diseases", "AFFECT"], ["gut microbiota", "neuropsychiatric disorders", "IS LINKED TO"], ["melatonin", "gut", "LOCATED IN"], ["toxic metals", "type 2 diabetes", "INFLUENCE"], ["probiotic supplement", "pregnant women", "ADMINISTERED"], ["Urease of the Gut Bacterium <i>Proteus mirabilis", "Altered Gut-Brain Talk", "INFLUENCE"], ["Bifidobacterium", "control and susceptible mice", "LOCATED IN"], ["CUMS", "Male C57BL/6J mice", "TARGET"], ["Parkinson's disease", "Parkinson's disease mice models", "TARGET"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "resveratrol-shaped microbiota", "IMPACT"], ["gut microbiota", "prion disorders", "IS LINKED TO"], ["PD", "Roseburia intestinalis", "CHANGE ABUNDANCE"], ["intestinal bacterial imbalance", "dysbiosis", "AFFECT"], ["COVID-19 infection", "Acute ischemic stroke (AIS) patients", "TARGET"], ["indoles", "Alzheimer's disease", "INFLUENCE"], ["Calprotectin", "depression", "INFLUENCE"], ["microbial metabolites", "gut microbiota", "IMPACT"], ["HVA", "synaptic autophagic death", "INFLUENCE"], ["Neuroinflammation", "infection", "AFFECT"], ["gut microbiota", "impaired immune functions", "IS LINKED TO"], ["KD", "Parkinson's disease", "INFLUENCE"], ["Depression", "people", "TARGET"], ["Neuroinflammation", "Parkinson's disease", "AFFECT"], ["Mn", "gut microbiota dysbiosis", "AFFECT"], ["gut microbiota", "chronic alcohol overconsumption", "IS LINKED TO"], ["melatonin", "neural damage", "INFLUENCE"], ["semaglutide", "microgliosis", "CHANGE EFFECT"], ["gut microbial dysbiosis", "PD mice", "TARGET"], ["butyrate", "gut dysfunction", "INFLUENCE"], ["proteins", "neurodegenerative diseases", "INFLUENCE"], ["prebiotics", "stress-induced BBB dysfunction", "INFLUENCE"], ["dysfunction of gastrointestinal tract (GIT) motility", "PD", "AFFECT"], ["melatonin", "gut microbiota", "IMPACT"], ["gut microbiota alteration", "neurological deficits", "AFFECT"], ["Parkinson's disease-related constipation", "gastrointestinal dysfunction", "AFFECT"], ["GM", "chronic stress", "IS LINKED TO"], ["feces metabolic disorders", "PD", "AFFECT"], ["males", "metagenomic sequencing", "USED BY"], ["Alzheimer's", "neurological diseases", "IS A"], ["PD", "gastrointestinal infections", "AFFECT"], ["lanicemine", "susceptible mice", "ADMINISTERED"], ["Trp", "GBA disorders", "INFLUENCE"], ["dysbiosis of the skin microbiome", "skin diseases", "AFFECT"], ["VLCKD", "intestinal microbiota", "IMPACT"], ["motor impairment", "PD patients", "TARGET"], ["gut dysbiosis", "PD pathology", "AFFECT"], ["salt", "depression", "INFLUENCE"], ["lactate", "ND pathogenesis", "INFLUENCE"], ["brain-gut-axis (BGA) dysregulation", "people", "TARGET"], ["Schizophrenia", "abnormal mental function and behavior", "AFFECT"], ["Dioscin", "neuroinflammation", "INFLUENCE"], ["Lactobacillaceae", "PD patients", "LOCATED IN"], ["p-\u03b1-Syn", "mice", "LOCATED IN"], ["Gastrointestinal nonmotor symptoms", "PD", "AFFECT"], ["valeric acid", "Alzheimer's", "INFLUENCE"], ["intestinal flora", "early intestinal pathology", "AFFECT"], ["dyskinesia", "PD patients", "TARGET"], ["synaptic proteins", "prefrontal cortex", "LOCATED IN"], ["ASD", "gut microbiota", "CHANGE ABUNDANCE"], ["cognitive deficits", "rodent offspring", "TARGET"], ["PD", "inflammatory bowel disease", "AFFECT"], ["Flavonoids", "Parkinson's disease", "INFLUENCE"], ["gut microbes", "disorders of cognitive functioning and social interaction", "INFLUENCE"], ["butyrate", "Parkinson's disease", "INFLUENCE"], ["casein", "PD-related symptoms", "INFLUENCE"], ["gut microbiota", "overweight adolescents", "LOCATED IN"], ["chronic unpredictable mild stress", "Male C57BL/6J mice", "TARGET"], ["omega-3 fatty acids", "stress", "INFLUENCE"], ["postbiotics", "neurodegenerative and viral diseases", "INFLUENCE"], ["Lactobacillus", "metabolic disorders", "INFLUENCE"], ["Parkinson's disease", "non-motor symptom", "IS A"], ["autism", "psychiatric disorders", "IS A"], ["Fecal propionic acid", "constipation", "INFLUENCE"], ["cytokines", "vascular dementia", "INFLUENCE"], ["Inflammatory bowel diseases", "gastrointestinal tract", "STRIKE"], ["Vitamin D3 deficiency", "COVID-19", "AFFECT"], ["Stress during pregnancy", "woman", "TARGET"], ["Gut Microbiota", "obesity", "IS LINKED TO"], ["AG", "colon damage", "INFLUENCE"], ["Gut Microbiota", "Brain", "LOCATED IN"], ["Bifidobacterium", "resilient mice", "LOCATED IN"], ["Parkinson's disease", "substantia nigra", "STRIKE"], ["Mn", "behavioral dysfunction", "AFFECT"], ["GM", "LCIG", "USED BY"], ["motor and gastrointestinal dysfunction", "Parkinson's disease", "AFFECT"], ["GABA", "gut", "LOCATED IN"], ["unhealthy diets", "disability", "INFLUENCE"], ["NCGS/WS", "individuals", "TARGET"], ["CSDS", "IL-6", "INTERACT"], ["Alzheimer's disease", "brain-related diseases", "IS A"], ["\u03b1-synuclein", "appendix", "LOCATED IN"], ["Bacteroides", "deconjugation", "INTERACT"], ["Mollicutes", "non-POD mice", "LOCATED IN"], ["mental health disorders", "adults", "TARGET"], ["PD", "brain", "STRIKE"], ["chronic inflammatory pain", "subdiaphragmatic vagus nerve", "STRIKE"], ["Cognitive impairment", "major depression", "AFFECT"], ["gut microbiome (GM) dysbiosis", "AD", "AFFECT"], ["commensal microbiota", "chronic pain", "IS LINKED TO"], ["PD", "CDD", "AFFECT"], ["autism spectrum disorder", "neurological diseases", "IS A"], ["microbiota-derived molecules", "host-derived cytokines", "INTERACT"], ["dysbiosis", "ASD", "AFFECT"], ["Metals", "primary neurodegenerative dementias", "INFLUENCE"], ["gut microbiota", "motor impairment", "IS LINKED TO"], ["meningitis", "severe infection-related pathologies", "IS A"], ["LcS", "constipation-related symptoms", "INFLUENCE"], ["mental disorders", "neurodevelopmental disorders", "IS A"], ["Probio-M8", "Lachnospira", "IMPACT"], ["COVID-19 infection", "acute ischemic stroke patients", "TARGET"], ["\u03b1-synuclein fibrils", "substantia nigra", "LOCATED IN"], ["cognitive impairment", "healthy control subjects", "TARGET"], ["constipation", "individuals", "TARGET"], ["oxidative stress", "Parkinson's disease", "AFFECT"], ["internalizing or externalizing behaviors", "preschool children", "TARGET"], ["trehalose", "PD", "INFLUENCE"], ["HAND", "PLWH", "TARGET"], ["depressive-like behavior", "male", "TARGET"], ["Firmicutes", "subchronic mice", "LOCATED IN"], ["APs", "weight gain", "CHANGE EFFECT"], ["coffee", "intestinal inflammation", "INFLUENCE"], ["baicalein", "NDs", "INFLUENCE"], ["gut microbiomes", "Parkinson's Disease", "IS LINKED TO"], ["gut microbiota alterations", "depression", "AFFECT"], ["Polyphenols", "PD pathogenesis", "INFLUENCE"], ["SCFAs supplementation", "anxiety- and depression-like behaviors", "INFLUENCE"], ["\u03b1-Syn", "brain", "LOCATED IN"], ["Dietary fiber", "depressive symptoms", "INFLUENCE"], ["gut microbiota", "OS", "IS LINKED TO"], ["human gut microbiota", "depression", "IS LINKED TO"], ["Gut microbiota", "gut", "LOCATED IN"], ["PPD patients", "16S rRNA sequencing", "USED BY"], ["NDDs", "elderly people", "TARGET"], ["Mn", "neurogenesis impairment", "AFFECT"], ["bipolar disorder", "disability", "AFFECT"], ["non-motor symptoms", "patients", "TARGET"], ["bowel disorder", "patients", "TARGET"], ["MDMA", "PTSD", "CHANGE EFFECT"], ["dysbiosis", "Alzheimer's and Parkinson's diseases", "AFFECT"], ["PD", "resting tremor", "AFFECT"], ["PD", "global population", "TARGET"], ["depression", "US adults", "TARGET"], ["colon", "mice", "LOCATED IN"], ["immune dysregulation", "PD", "AFFECT"], ["K. pastoris KM71H", "antibiotic-induced intestinal dysbiosis", "INFLUENCE"], ["butyrate", "neuroinflammation", "INFLUENCE"], ["succinic acid", "neuroinflammation", "INFLUENCE"], ["muscle wasting", "PD", "AFFECT"], ["microbial metabolites", "gut inflammation", "INFLUENCE"], ["patients", "metagenomic sequencing", "USED BY"], ["healthy controls", "metagenomic sequencing", "USED BY"], ["PM2.5", "Parkinson's disease", "INFLUENCE"], ["patients", "omics analysis", "USED BY"], ["processed fava beans", "PD", "INFLUENCE"], ["gut microbiome", "sham + MDMA + CRS group", "LOCATED IN"], ["gut microbiota", "healthy controls", "LOCATED IN"], ["anxiety", "neuropsychiatric disorders", "IS A"], ["Gamma-aminobutyric acid", "psychological disorders", "INFLUENCE"], ["PD", "Faecalibacterium", "CHANGE ABUNDANCE"], ["oxidative stress", "aging", "AFFECT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "PD-like neurotoxicity", "INFLUENCE"], ["Sodium butyrate", "PD", "INFLUENCE"], ["gut microbiota", "type II diabetes", "IS LINKED TO"], ["gut microbiome", "PD symptoms", "IS LINKED TO"], ["probiotics", "depressive and neurodevelopmental disorders", "INFLUENCE"], ["Phytochemicals", "HD", "INFLUENCE"], ["Dextran Sulfate Sodium", "Gut Microbiome", "IMPACT"], ["Mn<sup>2+</sup>", "gut microbiome", "IMPACT"], ["Huntington's disease gene expansion carriers", "16S V3 to V4 rRNA sequencing", "USED BY"], ["stress vulnerability", "mice", "TARGET"], ["KD", "inflammation", "INFLUENCE"], ["dysregulated transcript response", "mice", "TARGET"], ["Inflammatory mechanisms", "neurotoxicity", "AFFECT"], ["PD", "substantia nigra region", "STRIKE"], ["metabolic abnormalities", "psychotic diseases", "AFFECT"], ["functional foods", "depression", "INFLUENCE"], ["adolescents", "16S rRNA gene amplicon sequencing", "USED BY"], ["gut microbes", "Parkinson's disease", "IS LINKED TO"], ["gut microbiota", "normal mice", "LOCATED IN"], ["lipopolysaccharide (LPS) endotoxins", "PD", "INFLUENCE"], ["prebiotics", "abdominal discomfort", "INFLUENCE"], ["Probiotics", "PD", "INFLUENCE"], ["gut microbiota-derived metabolites", "PD", "INFLUENCE"], ["gut microbiome", "lifestyle diseases", "IS LINKED TO"], ["fecal microbiota", "schizophrenia-like (SCZ-like) symptoms", "IS LINKED TO"], ["Phe-free amino acid medical foods", "neurodegenerative and inflammatory diseases", "INFLUENCE"], ["AD", "MCI subjects", "TARGET"], ["TLR2 deficiency", "MPTP-induced Parkinson' disease mice", "TARGET"], ["PD", "people", "TARGET"], ["culprit proteins", "neurodegenerative PCDs", "INFLUENCE"], ["Butyrivibrio gut microbiota", "Parkinson's disease", "IS LINKED TO"], ["cytokines", "FTD", "INFLUENCE"], ["PD", "motor symptoms", "AFFECT"], ["MPTP", "motor symptoms", "INFLUENCE"], ["probiotic intake", "MS", "INFLUENCE"], ["disorder of gut microbiota", "PD", "AFFECT"], ["Anorexia nervosa", "severe psychiatric disease", "IS A"], ["anxiety-like behaviors", "mice", "TARGET"], ["gut", "dysbiosis", "AFFECT"], ["Elevated postprandial blood glucose levels", "type II diabetes", "AFFECT"], ["biotin", "depressed individuals", "ADMINISTERED"], ["alterations in gut microbiota composition", "neurological disorders", "AFFECT"], ["Parkinson's disease", "controls", "TARGET"], ["dysbiosis", "intestine", "STRIKE"], ["Rett syndrome", "neurological diseases", "IS A"], ["polyphenols", "neurological disorders", "INFLUENCE"], ["PM2.5", "Alzheimer's disease", "INFLUENCE"], ["butyrate", "inflammation", "INFLUENCE"], ["gut microbiota", "motor or non-motor symptoms", "IS LINKED TO"], ["Gut dysbiosis", "patients", "TARGET"], ["disability", "individuals", "TARGET"], ["oxidative stress", "THP withdrawal", "AFFECT"], ["Cecal microbiota", "16S rRNA gene sequencing", "USED BY"], ["cognitive function deficits", "patients", "TARGET"], ["patients", "16S rRNA gene amplicon sequencing", "USED BY"], ["deficits", "and", "AFFECT"], ["serum metabolic disorder", "mice", "TARGET"], ["Akkermansia", "PCOS", "INFLUENCE"], ["casein", "gastrointestinal dysfunction", "INFLUENCE"], ["Insulin resistance", "type II diabetes", "AFFECT"], ["healthy diet", "gut microbiome", "IMPACT"], ["Probiotic supplementation", "PD", "INFLUENCE"], ["indoles", "Parkinson's disease", "INFLUENCE"], ["low-to-moderate depression", "patients", "TARGET"], ["genus Coprococcus", "gallbladder cancer", "INFLUENCE"], ["systemic immune dysregulation", "Amyotrophic lateral sclerosis", "AFFECT"], ["insufficient neurotrophic support", "Parkinson's Disease", "AFFECT"], ["sulforaphane", "frontal brain damage", "INFLUENCE"], ["disabling motor alterations", "Parkinson's disease", "AFFECT"], ["PD patients", "fMRI", "USED BY"], ["IEMs", "patients", "TARGET"], ["Gut Dysbiosis", "Neurological Diseases", "AFFECT"], ["FLZ", "intestinal inflammation", "CHANGE EFFECT"], ["Systemic Inflammation", "Fecal Microbiota", "CHANGE ABUNDANCE"], ["learning and memory deficits", "Aging dogs", "TARGET"], ["comorbid memory impairment", "mice", "TARGET"], ["BAs", "brain", "LOCATED IN"], ["adult patients", "neuropsychological cognitive tests", "USED BY"], ["Parkinson's disease", "neurological conditions", "IS A"], ["flavonoids", "gut microbiota", "IMPACT"], ["Gut Microbiota", "Neurodegenerative diseases", "IS LINKED TO"], ["gut microbiota", "rotenone-treated mice", "LOCATED IN"], ["bacterial products", "dysbiosis", "INFLUENCE"], ["Psychedelics", "autoimmune conditions", "CHANGE EFFECT"], ["Lactobacillus plantarum</i> CCFM405", "Gut Microbiota", "PART OF"], ["Parkinson's Disease", "Neurological/Autoimmune Diseases", "IS A"], ["Amyotrophic lateral sclerosis", "fatal neurodegenerative disease", "IS A"], ["THP", "depressive-like behaviors", "CHANGE EFFECT"], ["psychiatric disorders", "patients", "TARGET"], ["Alzheimer's diseases", "host brain disorders", "IS A"], ["S. mutans", "neurodegeneration", "INFLUENCE"], ["gastrointestinal symptoms", "MS", "AFFECT"], ["gut microbiota", "neuropsychiatric disease states", "IS LINKED TO"], ["Parkinson's disease", "host brain disorders", "IS A"], ["Posttraumatic stress disorder", "mental health disorder", "IS A"], ["stroke", "neurodegenerative disorders", "IS A"], ["Very-Low-Calorie Ketogenic Diet", "Gut Microbiota", "IMPACT"], ["Phytochemicals", "AD", "INFLUENCE"], ["PD", "non-motor symptoms", "IS A"], ["motor and non-motor symptoms", "Parkinson's disease", "AFFECT"], ["rotenone", "endotoxemia", "CHANGE EFFECT"], ["alterations in gut microbiota composition", "Parkinson's disease", "AFFECT"], ["human fecal microbiomes", "binning", "USED BY"], ["neuroinflammation", "behavioral symptoms", "AFFECT"], ["gut microbiome", "age-related neurodegenerative disorders", "AFFECT"], ["FGF21", "Parkinson's disease", "INFLUENCE"], ["Antibiotic use", "depression", "CHANGE EFFECT"], ["C57BL/6 mice", "wire-hanging tests", "USED BY"], ["Dysbiosis of", "Neurological Disorders", "AFFECT"], ["Viruses", "neuroinflammation", "INFLUENCE"], ["SD", "Rats", "TARGET"], ["vancomycin", "severe infection-related pathologies", "CHANGE EFFECT"], ["Central inflammation", "Parkinson's disease", "AFFECT"], ["polyphenols", "Parkinson's disease", "INFLUENCE"], ["Mediterranean diet", "age-related diseases", "INFLUENCE"], ["Oxymatrine", "white matter injury", "INFLUENCE"], ["synbiotics", "adults", "ADMINISTERED"], ["Chronic gut inflammation", "leaky gut", "AFFECT"], ["Schizophrenia", "population", "TARGET"], ["Gastrointestinal (GI) dysfunction", "motor symptoms", "AFFECT"], ["lanicemine", "gut microbiota", "IMPACT"], ["cognitive, psychosocial and intellectual disabilities", "population", "TARGET"], ["gut microbiota", "cardiometabolic disease", "IS LINKED TO"], ["food addiction symptoms", "individuals", "TARGET"], ["gut microbiome", "Parkinson's disease", "AFFECT"], ["Parkinson's disease", "brain regions", "STRIKE"], ["dysbiosis of the skin microbiome", "Parkinson's", "AFFECT"], ["gut microbiota", "motor symptoms", "IS LINKED TO"], ["psychobiotics", "IBD", "INFLUENCE"], ["immune dysregulation", "neurodegenerative disorders", "AFFECT"], ["semaglutide", "anxiety", "CHANGE EFFECT"], ["MS", "Bifidobacterium", "CHANGE ABUNDANCE"], ["essential bacteria", "obesity", "INFLUENCE"], ["Fermented Foods", "Gut Microbiota", "IMPACT"], ["curcumin", "IBS symptoms", "INFLUENCE"], ["RBD", "Parkinson's disease", "AFFECT"], ["placebo", "adolescent patients aged 12 to", "ADMINISTERED"], ["PD", "primary chronic neurodegenerative disorder", "IS A"], ["microcrystalline cellulose (MCC) placebo", "gastrointestinal bacteria", "IMPACT"], ["Male C57BL/6J mice", "16S rRNA sequencing", "USED BY"], ["RF", "prostatitis", "CHANGE EFFECT"], ["Parkinson's Disease", "Humans", "TARGET"], ["fiber supplements", "depressive", "INFLUENCE"], ["intestinal microbiota", "humans", "LOCATED IN"], ["gastrointestinal (GI) dysfunction", "complex neurodegenerative disease", "IS A"], ["gut microbiota", "intestinal and brain pathologies", "IS LINKED TO"], ["gut microbiota", "autoimmune disorders", "IS LINKED TO"], ["gut microbiota", "Parkinson's", "IS LINKED TO"], ["PD", "Christensenella", "CHANGE ABUNDANCE"], ["Classic serotonergic psychedelics", "mental health afflictions", "CHANGE EFFECT"], ["NDDs", "Americans", "TARGET"], ["loss of movement coordination", "PD", "AFFECT"], ["Parkinson's disease dementia", "Zn", "INTERACT"], ["Systemic inflammation", "Inflammatory bowel diseases", "AFFECT"], ["cognitive decline", "Aging dogs", "TARGET"], ["Dietary polyphenols", "gut dysbiosis associated neurodegeneration", "INFLUENCE"], ["anxiety", "pregnant and lactating women", "TARGET"], ["grains", "neurodegenerative diseases", "INFLUENCE"], ["Western-style diets", "gut microbiota", "IMPACT"], ["alterations in gut microbiota composition", "Alzheimer's disease", "AFFECT"], ["gut microbiome", "metabolic diseases", "IS LINKED TO"], ["ASD", "offspring", "TARGET"], ["Gut Microbiota", "Depression", "IS LINKED TO"], ["dietary polysaccharides", "Parkinson's disease", "INFLUENCE"], ["fecal microbiota", "healthy human controls", "LOCATED IN"], ["GABA", "epilepsy", "INFLUENCE"], ["gut microbiota", "dystonia", "IS LINKED TO"], ["Microbiome", "Age-Related Cognitive Decline", "IS LINKED TO"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "Mice", "ADMINISTERED"], ["steroid hormones", "Parkinson's disease", "INFLUENCE"], ["Probiotics supplementation", "anxiety", "INFLUENCE"], ["probiotic strains", "healthy gut microbiota", "IMPACT"], ["SCD", "gut microbiomes", "CHANGE ABUNDANCE"], ["antidepressant", "depression-like behaviors", "CHANGE EFFECT"], ["\u03b1-synuclein pathology", "patients", "TARGET"], ["essential bacteria", "small intestine bacterial overgrowth", "INFLUENCE"], ["gut microbiome dysbiosis", "gut microbiome dysbiosis", "AFFECT"], ["disruptions in cellular processes", "Parkinson's disease", "AFFECT"], ["pathological", "patients", "TARGET"], ["fecal microbial alterations", "neuropsychiatric diseases", "AFFECT"], ["males", "fMRI", "USED BY"], ["gut microbiota", "Quantitative PCR", "USED BY"], ["Wilson-Konovalov disease", "neurological diseases", "IS A"], ["gut microbiome", "Alzheimer's disease", "AFFECT"], ["gut microbiome", "Huntington's disease", "AFFECT"], ["gastrointestinal microbiota", "depression", "IS LINKED TO"], ["gut biotics", "inflammation", "INFLUENCE"], ["necrotic enteritis", "broilers", "TARGET"], ["Parkinson's disease", "brain disorders", "IS A"], ["lactic acid", "IMQ-treated mice", "LOCATED IN"], ["fecal microbiota dysbiosis", "rotenone-treated mice", "TARGET"], ["microbiota dysregulation", "motor neuron disease", "AFFECT"], ["Saturated fatty acids", "dysfunction of the blood-brain barrier", "INFLUENCE"], ["melatonin", "PD", "INFLUENCE"], ["Prodromal PD", "constipation", "AFFECT"], ["abnormal microglia activation and polarization phenotypes", "ASD", "AFFECT"], ["Meth", "depression", "CHANGE EFFECT"], ["Parkinson's disease", "individual", "TARGET"], ["alpha-synuclein-mediated motor deficits", "PD patients", "TARGET"], ["alterations of intestinal epithelial barrier", "Parkinson's disease", "AFFECT"], ["dietary antibiotics", "cecal microbiome", "IMPACT"], ["indoles", "ischemic stroke", "INFLUENCE"], ["gut microbiota", "synucleinopathies", "IS LINKED TO"], ["C57BL/6 mice", "catalepsy", "USED BY"], ["MPTP", "PD", "INFLUENCE"], ["intestinal", "Dysbiosis", "IS LINKED TO"], ["Bacterial extracellular vesicles", "Parkinson's", "INFLUENCE"], ["gamma-aminobutyric acid", "humans", "LOCATED IN"], ["water extract of ginseng", "Parkinson's disease", "INFLUENCE"], ["Verrucomicrobiota", "acute MPTP mice", "LOCATED IN"], ["Gut microbiomes", "mass spectrometry approach", "USED BY"], ["Gut Microbiota", "Irritable Bowel Syndrome", "IS LINKED TO"], ["Probio-M8", "gastrointestinal symptoms", "INFLUENCE"], ["dietary polysaccharides", "Alzheimer's disease", "INFLUENCE"], ["psychobiotics", "Alzheimer's disease", "INFLUENCE"], ["CUMS microbiota", "Mice", "LOCATED IN"], ["Antipsychotics", "disruptive behavioral conditions", "CHANGE EFFECT"], ["subjects", "16S rRNA amplicon-sequencing", "USED BY"], ["intestinal microbial alteration", "PD", "AFFECT"], ["metabolite", "Parkinson's disease", "INFLUENCE"], ["intestinal microorganisms", "endocrine system diseases", "INFLUENCE"], ["gut microbiota", "inflammatory noncommunicable diseases", "IS LINKED TO"], ["B-vitamins", "Alzheimer's and Parkinson's diseases", "INFLUENCE"], ["Gut microbiota", "FTD", "IS LINKED TO"], ["Intestinal inflammation", "small and large intestine", "STRIKE"], ["PD", "PD model mice", "TARGET"], ["dysbiosis", "autism", "AFFECT"], ["Gut Microbiome", "Parkinson's Disease Symptom Progression", "IS LINKED TO"], ["SCFAs supplementation", "Meth-induced microbial dysbiosis", "INFLUENCE"], ["Gut microbiota alteration", "muscle wasting", "AFFECT"], ["mucin", "PD", "INFLUENCE"], ["Gut bacteria-driven homovanillic acid", "depression", "INFLUENCE"], ["psychobiotics", "bipolar disorder", "INFLUENCE"], ["intestinal microbiota", "autism", "IS LINKED TO"], ["Oral [60]fullerene", "neuroinflammation", "INFLUENCE"], ["gut microbiome", "hypertension", "IS LINKED TO"], ["long sleepers", "16S rRNA gene sequencing", "USED BY"], ["PM2.5", "schizophrenia", "INFLUENCE"], ["ASD", "individuals", "TARGET"], ["intestinal microbiota", "obesity", "IS LINKED TO"], ["gut microbiota", "gas chromatography-mass spectrometry", "USED BY"], ["ambient fine particulate matter", "depression", "INFLUENCE"], ["Intestinal dysbiosis", "neurodegenerative pathologies", "AFFECT"], ["Major depressive disorder", "psychiatric disorders", "IS A"], ["Amyloid-Containing Biofilms", "Complex Human Diseases", "IS LINKED TO"], ["Behavioral and psychological symptoms of dementia", "MCI", "AFFECT"], ["anhedonia-like phenotype", "saline-treated mice", "TARGET"], ["IL-1\u03b2", "substantia nigra", "LOCATED IN"], ["Parkinson's disease", "PrP-A53T mice", "TARGET"], ["gut microbiota", "MDD", "IS LINKED TO"], ["ADHD", "Veillonellaceae", "CHANGE ABUNDANCE"], ["Probiotics", "worry", "INFLUENCE"], ["Dysbiosis", "OCD", "AFFECT"], ["Gut dysbiosis", "systemic inflammation", "AFFECT"], ["midbrain", "mice", "LOCATED IN"], ["PD patients", "16S rRNA gene amplicon sequencing", "USED BY"], ["polycyclic aromatic hydrocarbons", "type II diabetes", "INFLUENCE"], ["steroid saponin", "neurodegenerative conditions", "INFLUENCE"], ["gut microbiota", "V4 16S rRNA sequencing", "USED BY"], ["AKK", "\u03b2-alanyl-3-methyl-l-histidine", "INTERACT"], ["cognitive changes", "people", "TARGET"], ["gastrointestinal (GI) disorders", "PD", "AFFECT"], ["mood disorders", "inflammatory bowel diseases", "AFFECT"], ["TNF\u03b1", "small and large intestine", "LOCATED IN"], ["Probio-M8", "Bifidobacterium animalis", "IMPACT"], ["PM2.5", "autism spectrum disorders", "INFLUENCE"], ["schizophrenia", "Oscillibacter", "CHANGE ABUNDANCE"], ["Parkinson's Disease", "de novo Patients", "TARGET"], ["neurodegenerative protein conformational diseases", "PD", "AFFECT"], ["metabolic disorders", "diabetes", "AFFECT"], ["gut microbes", "CNS disorders", "INFLUENCE"], ["propionic", "ET", "INFLUENCE"], ["gut microbiota dysregulation", "Parkinson's disease", "AFFECT"], ["gut microbiota", "male weanling pigs", "LOCATED IN"], ["Bone fragility", "comorbidities", "AFFECT"], ["WMI", "distal corticospinal tract (CST) region", "STRIKE"], ["HC", "16S rRNA sequencing", "USED BY"], ["\u03b1-synuclein", "neurodegenerative disorder", "INFLUENCE"], ["Gamma-aminobutyric acid", "anxiety", "INFLUENCE"], ["cognitive impairment", "wild-type mice", "TARGET"], ["PD", "gastrointestinal neoplasms", "AFFECT"], ["anxiety", "Individuals", "TARGET"], ["THP", "gut dysbiosis", "CHANGE EFFECT"], ["gut dysbiosis", "cognitive deficits", "AFFECT"], ["Polyphenol prebiotics", "gut microbiome", "IMPACT"], ["prefrontal cortex", "juvenile offspring", "LOCATED IN"], ["gut microbiome", "aged rats", "LOCATED IN"], ["PM2.5", "neurodevelopmental disorders", "INFLUENCE"], ["gut microbiota", "animals", "LOCATED IN"], ["microbiome", "bipolar disorder", "IS LINKED TO"], ["neurodegenerative diseases", "older adults", "TARGET"], ["metabolites", "brain", "LOCATED IN"], ["neurodevelopmental impairment", "AD", "AFFECT"], ["Curcumin", "anxiety", "INFLUENCE"], ["PD", "chronic progressive neurodegenerative disease", "IS A"], ["oral maslinic acid", "Parkinson's disease", "INFLUENCE"], ["Chronic pain", "diminished working memory", "AFFECT"], ["gut microbiome", "16S rRNA analysis", "USED BY"], ["Olanzapine", "insulin resistance", "CHANGE EFFECT"], ["TNF\u03b1", "Intestinal inflammation", "INFLUENCE"], ["TMAO", "brain diseases", "INFLUENCE"], ["rotenone", "PD", "CHANGE EFFECT"], ["semaglutide", "depressive- and anxiety-like behaviors", "CHANGE EFFECT"], ["neurotoxin", "motor deficits", "INFLUENCE"], ["probiotics", "dysbiosis", "INFLUENCE"], ["gut microbiome", "single-cell chemical imaging", "USED BY"], ["Bifidobacterium", "inflammation", "INFLUENCE"], ["serotonin", "gut microbiota", "IMPACT"], ["stress", "humans", "TARGET"], ["MDD", "Bacteroidaceae", "CHANGE ABUNDANCE"], ["diet-induced microbiome changes", "brain disorders", "AFFECT"], ["Synucleinopathies", "PD", "AFFECT"], ["Periodontitis", "neurodegenerative diseases", "AFFECT"], ["MDD", "Fusicatenibacter", "CHANGE ABUNDANCE"], ["basal dysbiosis", "midgut microbiota", "CHANGE ABUNDANCE"], ["Gut dysbiosis", "neurological disorders", "AFFECT"], ["major fragility fractures", "Patients", "TARGET"], ["polysaccharide", "Parkinson's disease", "INFLUENCE"], ["Creutzfeldt-Jakob disease", "patients", "TARGET"], ["serotonin", "anxiety-related behavior", "INFLUENCE"], ["gut microbiota", "early life stress", "IS LINKED TO"], ["KD", "dopaminergic neuron loss", "INFLUENCE"], ["antibiotics", "gut dysbiosis", "CHANGE EFFECT"], ["cytokines", "PDD", "INFLUENCE"], ["isoleucine", "PD", "INFLUENCE"], ["high energy diet", "human gut microbiome", "IMPACT"], ["Neuroinflammation", "major depressive disorder", "AFFECT"], ["saturated fatty acids", "Parkinson's disease", "INFLUENCE"], ["gut microbiota", "neurological and psychiatric disorders", "IS LINKED TO"], ["BEVs", "neurodegeneration", "INFLUENCE"], ["compounds", "dysfunctions", "INFLUENCE"], ["neurodevelopmental impairment", "neurodegeneration", "AFFECT"], ["acamprosate", "alcohol addiction", "CHANGE EFFECT"], ["Gut Microbiome", "nursing students", "LOCATED IN"], ["probiotic supplementation", "motor symptoms", "INFLUENCE"], ["gut microbiota", "Parkinson's Disease", "IS LINKED TO"], ["gut microbiota", "adult mice", "LOCATED IN"], ["circadian misalignment", "severe psychiatric symptoms", "AFFECT"], ["intestinal bacterium Christensenella minuta DSM 32891", "mental health problems", "INFLUENCE"], ["PD", "oxidative stress", "AFFECT"], ["amino acids", "increased membrane permeability", "INFLUENCE"], ["Parkinson's", "neuropsychiatric/neurological diseases", "IS A"], ["calprotectin", "PD", "INFLUENCE"], ["RHSD", "gut microbiota dysbiosis", "INFLUENCE"], ["psychotic disorders", "Patients", "TARGET"], ["Akkermansia", "IBD", "INFLUENCE"], ["tryptophan", "cardiovascular disease", "INFLUENCE"], ["vegetables", "neurodegenerative diseases", "INFLUENCE"], ["Gut Microbiota", "Parkinson's disease", "IS LINKED TO"], ["gut microbiota dysbiosis", "depression", "AFFECT"], ["psychological disorders", "neurological diseases", "IS A"], ["Gastrointestinal symptoms", "early-stage Parkinson's disease", "AFFECT"], ["obesity", "individuals", "TARGET"], ["AGPs", "cecal microbiome", "IMPACT"], ["gut", "neurodegeneration", "IS LINKED TO"], ["fluoroquinolones", "neurotoxic adverse events", "CHANGE EFFECT"], ["CXCL1", "rotenone-induced neuronal damage", "INFLUENCE"], ["AD", "neurological diseases", "IS A"], ["oxidative stress", "amyotrophic lateral sclerosis", "AFFECT"], ["gut microbiome", "COVID-19 patients", "LOCATED IN"], ["childhood obesity", "eating disorders", "AFFECT"], ["modern therapeutic drugs", "cognitive impairment", "CHANGE EFFECT"], ["prenatal chronic stress", "gut microbiota", "CHANGE ABUNDANCE"], ["short-chain fatty acids", "Parkinson's disease", "INFLUENCE"], ["MDMA", "post-traumatic stress disorder", "CHANGE EFFECT"], ["gut microbiota", "offspring", "LOCATED IN"], ["gut microbiome", "inflammaging", "IS LINKED TO"], ["Metabolic Dysfunction", "Mood Disorders", "AFFECT"], ["ketamine", "BD", "CHANGE EFFECT"], ["NJ241", "dysbiosis", "INFLUENCE"], ["amyotrophic lateral sclerosis", "NDDs", "IS A"], ["cognitive impairments", "individuals", "TARGET"], ["melatonin", "human diseases", "INFLUENCE"], ["EC-12", "anxiety-like behavior", "INFLUENCE"], ["gut biotics", "gut microbiota", "IMPACT"], ["mechanical allodynia", "healthy naive mice", "TARGET"], ["gut microbiota", "rodents", "LOCATED IN"], ["Parkinson's", "celiac disease", "AFFECT"], ["brain disorders", "GM dysbiosis", "AFFECT"], ["intestinal microbiome", "workers", "LOCATED IN"], ["multiple sclerosis", "neurological diseases", "IS A"], ["PD", "A53T transgenic mice", "TARGET"], ["non-motor symptoms", "Parkinson's disease patients", "TARGET"], ["dietary fibers", "gut microbiota", "IMPACT"], ["gut microbiota", "cohort", "LOCATED IN"], ["Ketogenic Diet", "Neurodegenerative Diseases", "INFLUENCE"], ["Gut microbiome alterations", "Alzheimer's", "AFFECT"], ["gut microbiota", "bats", "LOCATED IN"], ["Cognitive impairment", "major mood disorders", "AFFECT"], ["Severe iron deficiency", "shortness of breath", "AFFECT"], ["Intestinal dysbiosis", "Parkinson's disease", "AFFECT"], ["EDCs", "gut microbiota", "IMPACT"], ["BU", "MPTP-induced motor dysfunction", "INFLUENCE"], ["gut microbiome", "depression", "IS LINKED TO"], ["ligature-induced periodontitis", "motor dysfunction", "AFFECT"], ["germ-free mice", "Nuclear magnetic resonance spectrometry analysis", "USED BY"], ["<i>L. plantarum</i> CCFM405", "constipation", "INFLUENCE"], ["dopaminergic neuronal damage", "MPTP-induced Parkinson's disease mice", "TARGET"], ["VLCKD", "multiple sclerosis", "INFLUENCE"], ["Eisenbergiella", "LH susceptible rats", "LOCATED IN"], ["complex microbiota", "GF Swiss-Webster mice", "LOCATED IN"], ["pre- and pro-biotics", "gut microbiome", "IMPACT"], ["Parabacteroides", "mental disorders", "INFLUENCE"], ["alcohol dependence", "patients", "TARGET"], ["PD mice", "ELISA", "USED BY"], ["FAE-producing gut microbiota", "neurodegenerative disorders", "IS LINKED TO"], ["PD", "Parkinson's Disease", "AFFECT"], ["EcN-GLP-1", "gut microbiota", "IMPACT"], ["Gamma-aminobutyric acid", "depression", "INFLUENCE"], ["ADHD", "Gracilibacteraceae", "CHANGE ABUNDANCE"], ["statins", "MDD", "CHANGE EFFECT"], ["gastrointestinal dysfunction", "mice", "TARGET"], ["WD", "neurological diseases", "IS A"], ["mucin-degrading Akkermansia", "PD", "INFLUENCE"], ["SCZ microbiota", "dysregulated transcript response", "IS LINKED TO"], ["Parkinson's disease", "Lewy body diseases", "IS A"], ["sulforaphane", "brain injury", "INFLUENCE"], ["Major depressive disorder", "peripheral blood", "STRIKE"], ["gut microbiome alterations", "de novo PD subjects", "TARGET"], ["probiotics", "gut microbiome", "IMPACT"], ["gut microbiota", "stool sample analysis", "USED BY"], ["respiratory muscle paralysis", "families", "TARGET"], ["Parkinson's disease dementia", "iron", "INTERACT"], ["intestine", "IMQ-treated mice", "LOCATED IN"], ["acetylcholine", "AD", "INFLUENCE"], ["Coffee", "type 2 diabetes", "INFLUENCE"], ["dysbiosis", "neurodegenerative disease", "AFFECT"], ["melatonin", "neurological diseases", "INFLUENCE"], ["ASD", "Individuals", "TARGET"], ["Gut Microbiome", "Hispanics", "LOCATED IN"], ["gut microbiota", "epilepsy patients", "LOCATED IN"], ["microbial metabolites", "AD", "INFLUENCE"], ["serum metabolites", "Cecal microbiota", "PRODUCED BY"], ["male subjects", "16S rRNA sequencing", "USED BY"], ["Akkermansia</i>", "IBD", "INFLUENCE"], ["early-stage PD mice", "16S ribosomal RNA gene sequencing", "USED BY"], ["Gastrointestinal (GI) disturbances", "patients", "TARGET"], ["mitochondrial dysfunction", "Parkinson's Disease", "AFFECT"], ["Fecal Microbiota", "Systemic Inflammation", "IS LINKED TO"], ["folate", "depression symptoms", "INFLUENCE"], ["KBs", "neurodegenerative diseases", "INFLUENCE"], ["metals", "cognitive impairment", "INFLUENCE"], ["GM", "emotional disorders", "IS LINKED TO"], ["MPTP", "Mice", "ADMINISTERED"], ["gut microbes", "thyroid disease", "INFLUENCE"], ["gut microbiota", "germ-free mice", "LOCATED IN"], ["gut microbiome", "host psychiatric disorders", "IS LINKED TO"], ["MUD", "Megasphaera", "CHANGE ABUNDANCE"], ["Gut dysbiosis", "Alzheimer's disease", "AFFECT"], ["Gastrointestinal symptoms", "gut dysbiosis", "AFFECT"], ["major depressive disorder", "Faecalibacterium", "CHANGE ABUNDANCE"], ["gut microbiota", "ED patients", "LOCATED IN"], ["oral berberine", "gut bacteria", "IMPACT"], ["Amyotrophic lateral sclerosis", "cognitive and motor deficits", "IS A"], ["motor deficits", "PD", "AFFECT"], ["Post-Infectious Fatigue", "Patients", "TARGET"], ["herbal extracts", "mood disorders", "INFLUENCE"], ["psychotropic agents", "mental illness", "CHANGE EFFECT"], ["intestinal microflora", "depression", "IS LINKED TO"], ["ferroptosis", "PD", "AFFECT"], ["NaB", "neurological disorders", "INFLUENCE"], ["depression-like behaviors", "Mice", "TARGET"], ["Central inflammation", "neuropsychiatric disorders", "AFFECT"], ["Fe", "mild cognitive impairment", "INFLUENCE"], ["gut", "Dysbiosis", "IS LINKED TO"], ["food addiction", "tobacco use disorder", "AFFECT"], ["Fatigue", "Parkinson's", "AFFECT"], ["Infant colic", "attachment difficulties", "AFFECT"], ["control individuals", "deep shotgun sequencing of fecal DNA", "USED BY"], ["constipation", "hypersalivation", "AFFECT"], ["Osteocalcin", "dopaminergic neuronal loss", "INFLUENCE"], ["\u03b1-Syn", "mice brain", "LOCATED IN"], ["prebiotics", "mental health disorders", "INFLUENCE"], ["gut microbiome", "inflammatory processes", "IS LINKED TO"], ["<i>Lactobacillus gasseri</i> CP2305", "stress-associated symptoms", "INFLUENCE"], ["neuronal loss", "multiple system atrophy", "AFFECT"], ["gut microbiota", "internalizing or externalizing behaviors", "IS LINKED TO"], ["Parkinson's disease", "PD group", "TARGET"], ["abnormal mental function and behavior", "population", "TARGET"], ["gut microbiota", "metabolopathy", "IS LINKED TO"], ["Impaired circadian rhythms", "severe psychiatric symptoms", "AFFECT"], ["GM", "multiple sclerosis", "IS LINKED TO"], ["Huntington's disease", "dementia", "AFFECT"], ["xylooligosaccharides", "tumor microbiota", "IMPACT"], ["PD", "neurodegenerative disorders", "IS A"], ["microbiomes", "reflux oesophagitis", "IS LINKED TO"], ["gut microbiome", "mental health problems", "IS LINKED TO"], ["early-stage Parkinson's disease", "early-stage PD mice", "TARGET"], ["Flavonoids", "gut microbiota alterations", "INFLUENCE"], ["neuroinflammatory changes", "Amyotrophic lateral sclerosis", "AFFECT"], ["healthy controls", "16S rRNA gene amplicon sequencing", "USED BY"], ["butyrate", "gut microbiota alterations", "INFLUENCE"], ["Neuroinflammation", "MDD", "AFFECT"], ["ADHD", "participants", "TARGET"], ["intestinal flora", "mental health conditions", "IS LINKED TO"], ["gut microbiota", "people", "LOCATED IN"], ["fecal microbiota", "deficits in sociability", "IS LINKED TO"], ["gut microbiome", "aged versus adult rats", "LOCATED IN"], ["psychiatric subjects", "16S rRNA sequencing", "USED BY"], ["(R)-ketamine", "depression", "CHANGE EFFECT"], ["intestinal flora", "neurological disorder", "IS LINKED TO"], ["PQ", "gut microbiome", "IMPACT"], ["AG", "colitis", "INFLUENCE"], ["fecal microbiomes", "RA", "IS LINKED TO"], ["gut dysbiosis", "epilepsy", "AFFECT"], ["inflammatory bowel disease", "people", "TARGET"], ["Rapid eye movement sleep behavior disorder", "PD", "AFFECT"], ["probiotic supplementation", "PD", "INFLUENCE"], ["intestinal microbiota dysbiosis", "neurodegenerative diseases", "AFFECT"], ["metals", "frontotemporal dementia", "INFLUENCE"], ["Pharmaceuticals", "Parkinson's disease", "CHANGE EFFECT"], ["GABA", "neurological diseases", "INFLUENCE"], ["antibiotic growth promoters", "cecal microbiome", "IMPACT"], ["Dysfunction of the gut microbiome", "oxidative stress", "AFFECT"], ["Enterococcus faecium", "Parkinson's disease (PD) mice", "LOCATED IN"], ["Butyrate", "Parkinson's disease", "INFLUENCE"], ["Neuroinflammation", "treatment-resistant depression", "AFFECT"], ["seizures", "Epilepsy", "AFFECT"], ["Infant microbiota", "problem crying", "IS LINKED TO"], ["PD", "short-chain fatty acid (SCFA)-producing bacteria", "CHANGE ABUNDANCE"], ["Parkinson's disease", "Neurodegenerative diseases", "IS A"], ["mood disorders", "hyperglycemia", "AFFECT"], ["bacteria", "PD", "INFLUENCE"], ["polymyxins", "pro-inflammatory", "INTERACT"], ["OCN", "Bacteroidetes", "IMPACT"], ["Gut microbiota", "PDD", "IS LINKED TO"], ["Neuroinflammation", "PD", "AFFECT"], ["Parkinson's disease", "neurological disorder", "IS A"], ["fiber", "anxiety", "INFLUENCE"], ["diet", "neurodegenerative diseases", "INFLUENCE"], ["gut microbiota", "nervous system diseases", "IS LINKED TO"], ["Parkinson's disease", "neurodegenerative condition", "IS A"], ["Dysbiosis", "gut microbiota", "CHANGE ABUNDANCE"], ["disruptions of diurnal oscillation", "gut microbiota", "CHANGE ABUNDANCE"], ["Akkermansia", "type 2 diabetes", "INFLUENCE"], ["intestinal bacterium Christensenella minuta DSM 32891", "mental health", "INFLUENCE"], ["Parkinson's disease dementia", "zinc", "INTERACT"], ["\u03b1-synuclein", "prion illnesses", "INFLUENCE"], ["Gut microbiota disturbance", "PD", "AFFECT"], ["trimethylamine N-oxide", "central nervous system diseases", "INFLUENCE"], ["gut microbiota", "behavioral abnormalities", "IS LINKED TO"], ["HTN subjects", "16S rRNA gene sequencing", "USED BY"], ["(R,S)-ketamine", "cognitive deficits", "CHANGE EFFECT"], ["gut microbiota", "PD-related underweight", "IS LINKED TO"], ["Se", "neurological diseases", "INFLUENCE"], ["AD", "Patients", "TARGET"], ["Phe-free amino acid medical foods", "PKU patients", "ADMINISTERED"], [", soluble, insoluble, and cereal fiber", "depressive symptoms", "INFLUENCE"], ["neurological disorders", "digestive disorders", "AFFECT"], ["Parkinson's disease dementia", "Mn", "INTERACT"], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "motor deficits", "INFLUENCE"], ["Probiotics", "gastrointestinal malignancy", "INFLUENCE"], ["Synbiotic supplementation", "patients", "ADMINISTERED"], ["healthy spouses", "shotgun metagenomics sequencing", "USED BY"], ["Parkinson's disease", "chronic neurological disorder", "IS A"], ["Inflammation", "aging", "AFFECT"], ["gut barrier defects", "Parkinson's disease", "AFFECT"], ["aggression", "animals", "TARGET"], ["Alzheimer's disease", "central nervous system disorders", "IS A"], ["Alzheimer's disease", "neurological disorders", "IS A"], ["Coffee", "Parkinson's disease", "INFLUENCE"], ["dietary polysaccharides", "epilepsy", "INFLUENCE"], ["probiotics", "children", "ADMINISTERED"], ["Motor impairment", "PD patients", "TARGET"], ["Bifidobacterium breve Bif11", "neurobehavioural deficits", "INFLUENCE"], ["Escherichia-Shigella", "motor symptoms", "INFLUENCE"], ["organophosphorus pesticides", "human gut microbiome", "IMPACT"], ["Dysbiosis of gut microbiota", "PD", "AFFECT"], ["butyrate", "PD", "INFLUENCE"], ["gut microbiota", "microbiota-free honeybees", "LOCATED IN"], ["gut microbiome", "neurodegenerative and mental health conditions", "IS LINKED TO"], ["antibiotic rifaximin", "prostatitis", "CHANGE EFFECT"], ["gut microbiota", "psychiatric diseases", "IS LINKED TO"], ["toxins", "inflammation", "INFLUENCE"], ["gut microbiome", "high-performance liquid chromatography-mass spectrometry", "USED BY"], ["Probiotics", "neurocognitive symptomatology", "INFLUENCE"], ["LPS", "brain inflammation", "INFLUENCE"], ["probiotics", "gastrointestinal dysbiosis", "INFLUENCE"], ["anxiety", "neuropsychiatric and neurological disorders", "IS A"], ["TMAO", "motor dysfunction", "INFLUENCE"], ["dysfunction of the RAAS", "neurodegenerative diseases", "AFFECT"], ["Nichi Glucan", "Prevotella", "IMPACT"], ["PFC", "CRS-exposed mice", "LOCATED IN"], ["inulin", "various diseases", "INFLUENCE"], ["probiotic supplementation", "chronic constipation", "INFLUENCE"], ["healthy gut microbiota", "cerebral diseases", "IS LINKED TO"], ["Autism Spectrum Disorder", "neurological diseases", "IS A"], ["autoimmune processes", "psychiatric diseases", "AFFECT"], ["gut microbiota dysbiosis", "MPTP-induced PD mice", "TARGET"], ["non-motor symptoms", "Parkinson's disease", "AFFECT"], ["gut microbiota", "shotgun sequencing", "USED BY"], ["fecal microbiota", "hyperactivity", "IS LINKED TO"], ["gut microbiota", "major depression", "IS LINKED TO"], ["Parkinson's disease", "neurological disorders", "IS A"], ["neuronal growth factors", "neurodegenerative diseases", "INFLUENCE"], ["autoimmune diseases", "AiD patient population", "TARGET"], ["microbiota dysregulation", "Alzheimer's", "AFFECT"], ["Anorexia nervosa", "eating disorder", "IS A"], ["microbiota dysbiosis", "neurodegenerative diseases", "AFFECT"], ["microglial activation", "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice", "TARGET"], ["MDD patients", "multi-omics analysis", "USED BY"], ["inflammation", "patients", "TARGET"], ["neuroinflammation", "PD patients", "TARGET"], ["MDD", "gut microbes", "CHANGE ABUNDANCE"], ["migraine", "normal mouse", "TARGET"], ["Gut microbiota", "gastrointestinal (GI) and systemic metabolic and inflammatory disorders", "IS LINKED TO"], ["Dysbiosis of the gut microbiota", "autoimmune diseases", "AFFECT"], ["AD", "cognitive and motor deficits", "IS A"], ["placebo", "depressive", "CHANGE EFFECT"], ["Alzheimer's disease", "neurodegenerative protein conformational diseases", "IS A"], ["ulcerative colitis", "Crohn's disease", "AFFECT"], ["Depression", "participants", "TARGET"], ["fecal calprotectin", "gut dysbiosis", "INFLUENCE"], ["gut microbiome", "gut dysbiosis", "IS LINKED TO"], ["Christensenella minuta", "social defeat stress", "INFLUENCE"], ["Rapid Eye Movement Sleep Behavior Disorder", "Parkinson's Disease", "AFFECT"], ["major depression", "adults aged between 18 and 45 years old", "TARGET"], ["depressive episodes", "Enterobacteriaceae", "CHANGE ABUNDANCE"], ["Trimethylamine N-oxide", "Neuroinflammation", "INFLUENCE"], ["Neuroinflammation", "Mice", "TARGET"], ["mild cognitive impairment", "participants", "TARGET"], ["Parkinson's Disease", "neurodegenerative disorder", "IS A"], ["gut microbiota", "mental diseases", "IS LINKED TO"], ["PD", "IBD", "AFFECT"], ["brain diseases", "patients", "TARGET"], ["dietary fiber", "gut microbiota", "IMPACT"], ["gut microbiota", "dementia", "IS LINKED TO"], ["inulin", "Participants", "ADMINISTERED"], ["dopaminergic neuron loss", "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice", "TARGET"], ["anxiety", "participants", "TARGET"], ["microbiota disturbances", "PD", "AFFECT"], ["flavonoids", "neurological and psychological conditions", "INFLUENCE"], ["psychiatric symptoms", "Alzheimer's disease", "AFFECT"], ["inflammatory phenotype", "old GF mice", "TARGET"], ["Orally Administered Ginkgolide C", "Neuroinflammation", "CHANGE EFFECT"], ["gut microbiota", "migraine", "IS LINKED TO"], ["bipolar disorder", "psychiatric disorders", "IS A"], ["saturated fats", "neurodegenerative diseases", "INFLUENCE"], ["probiotics", "AD", "INFLUENCE"], ["Parkinson's disease", "neurodegenerative protein conformational diseases", "IS A"], ["lipids", "brain", "LOCATED IN"], ["Phytochemicals", "anxiety", "INFLUENCE"], ["microbes", "disease", "INFLUENCE"], ["controls", "16S rRNA gene sequencing", "USED BY"], ["microbiota dysregulation", "gut dysbiosis", "AFFECT"], ["altered gut microbiota", "GI disorders", "IS LINKED TO"], ["microbes", "central nervous system (CNS) and psychiatric disorders", "IS LINKED TO"], ["PD", "Gut Microbiota", "CHANGE ABUNDANCE"], ["imbalance of immune functions", "Inflammatory mechanisms", "AFFECT"], ["dysbiosis", "multiple sclerosis", "AFFECT"], ["fecal microbiota", "MUD", "IS LINKED TO"], ["Methamphetamine", "mental disorders", "CHANGE EFFECT"], ["SNI rats", "16S ribosomal RNA sequencing", "USED BY"], ["Gut microbiota alterations", "PD", "AFFECT"], ["Parkinson's disease", "female patients", "TARGET"], ["neurological disorders", "gut microbiota", "CHANGE ABUNDANCE"], ["imbalance in gut microbiota composition", "multiple sclerosis", "AFFECT"], ["toxic metals", "obesity", "INFLUENCE"], ["misfolded \u03b1-synuclein aggregates", "PD", "INFLUENCE"], ["prebiotics", "chronic stress", "INFLUENCE"], ["Curcumin", "1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease", "INFLUENCE"], ["metabolites", "blood", "LOCATED IN"], ["Faecalibacterium prausnitzii", "depression", "INFLUENCE"], ["Gut microbiota", "obese states", "IS LINKED TO"], ["PD", "Enterococcus", "CHANGE ABUNDANCE"], ["intestinal microflora", "autism spectrum development", "IS LINKED TO"], ["motor deficits", "MPTP-induced mice", "TARGET"], ["PD", "neurological and psychological disorders", "IS A"], ["gut microbiome", "early symptomatic Alzheimer's disease", "IS LINKED TO"], ["mitochondrial dysfunction", "PD", "AFFECT"], ["Gut dysbiosis", "Parkinson's disease", "AFFECT"], ["healthy gut microbiota", "multiple sclerosis", "IS LINKED TO"], ["prebiotics", "NCDs", "INFLUENCE"], ["propionic acid", "cognitive decline", "INFLUENCE"], ["Neuroinflammation", "TRD", "AFFECT"], ["IL-1\u03b2", "intestinal microbial disorders", "INFLUENCE"], ["\u03b1-syn", "gut", "LOCATED IN"], ["violent behavior", "patients", "TARGET"], ["repetitive/stereotyped behaviors", "ASD", "AFFECT"], ["Psoriasis", "skin disease", "IS A"], ["bipolar disorder", "sleep disturbances", "AFFECT"], ["NaB", "inflammation", "INFLUENCE"], ["biologically active polyphenols", "pathological illnesses", "INFLUENCE"], ["HD", "chorea", "AFFECT"], ["neurodevelopmental impairment", "FD", "AFFECT"], ["PD", "men", "TARGET"], ["healthy gut microbiota", "hepatic encephalopathy", "IS LINKED TO"], ["Microbiota-Modified Bile Acids", "Neurodegenerative Diseases", "INFLUENCE"], ["Synbiotics", "NDs", "INFLUENCE"], ["Gut microbiota", "AD", "IS LINKED TO"], ["PPD", "women", "TARGET"], ["gut microbiome", "neurological symptoms", "IS LINKED TO"], ["probiotic", "Parkinson's disease", "INFLUENCE"], ["Gut Microbiota", "Geriatric Syndromes", "IS LINKED TO"], ["THC", "high fat diet-induced increases in body weight", "CHANGE EFFECT"], ["gut microbiota dysbiosis", "patients", "TARGET"], ["gut microbiota", "inmates", "LOCATED IN"], ["gut microbiome", "mass spectrometry-based metabolomics", "USED BY"], ["PD", "de novo PD patients", "TARGET"], ["FLZ", "motor symptoms", "CHANGE EFFECT"], ["gut microbiome", "PD patients", "LOCATED IN"], ["gastrointestinal microbiota", "co-morbidities", "IS LINKED TO"], ["probiotics", "post-traumatic stress disorder", "INFLUENCE"], ["acute COVID-19", "AIS patients", "TARGET"], ["depression-like behavior", "antibiotic-treated rats", "TARGET"], ["psychobiotics", "schizophrenia", "INFLUENCE"], ["gut dysfunction", "PD", "AFFECT"], ["Alzheimer's and Parkinson's disease", "neuropathologies", "IS A"], ["Agmatine", "Lactobacillus", "IMPACT"], ["prebiotics", "PD patients", "ADMINISTERED"], ["region-specific dysregulation", "germ-free mice", "TARGET"], ["PD", "neurodegenerative disease", "IS A"], ["Parkinsonism", "people", "TARGET"], ["urolithins", "UA", "INTERACT"], ["copper", "MCI", "INFLUENCE"], ["bipolar disorder", "Mood disorders", "IS A"], ["behavioral deficits", "mice", "TARGET"], ["New Probiotics", "Neurodegenerative Diseases", "INFLUENCE"], ["intestinal disorders", "central and peripheral nervous system diseases", "AFFECT"], ["RNAs", "NDDs", "INFLUENCE"], ["hippocampus", "recipients", "LOCATED IN"], ["gut microbiota", "young adult Cancer survivors", "LOCATED IN"], ["gut microbiome", "brain diseases", "IS LINKED TO"], ["fecal microbiomes", "healthy Chinese controls", "LOCATED IN"], ["PD", "novel transgenic (Tg) mice", "TARGET"], ["Neurodegenerative disorders", "people", "TARGET"], ["Saturated fatty acids", "dysbiosis", "INFLUENCE"], ["psychiatric disorders", "inflammation", "AFFECT"], ["normal controls", "16S rRNA gene sequencing", "USED BY"], ["PD non-motor symptoms", "Butyricimonas synergistica", "CHANGE ABUNDANCE"], ["microbiome-derived metabolites", "stress", "INFLUENCE"], ["Alzheimer's disease", "Central nervous system (CNS) disorders", "IS A"], ["Gammaproteobacteria", "POD mice", "LOCATED IN"], ["gut dysbiosis", "AIS patients", "TARGET"], ["human GM", "mild cognitive impairment", "IS LINKED TO"], ["healthy diet", "PD patients", "ADMINISTERED"], ["Parkinson's disease", "middle-aged and elderly people", "TARGET"], ["gut microbiome", "multifactorial disorders", "IS LINKED TO"], ["Altered", "Fecal Microbiota", "CHANGE ABUNDANCE"], ["MPTP", "oxidative damage", "INFLUENCE"], ["controls", "LC-MS/MS", "USED BY"], ["Gut microbiota dysbiosis", "motor dysfunction", "AFFECT"], ["gastrointestinal symptoms", "motor symptoms", "AFFECT"], ["epigallocatechin-3-gallate", "pathological illnesses", "INFLUENCE"], ["\u03b1-synuclein", "midbrain", "LOCATED IN"], ["anxiety-like and depression-like behavior", "recipient mice", "TARGET"], ["social interaction deficits", "pregnant mothers", "TARGET"], ["alpha synuclein", "dopaminergic neuron loss", "INFLUENCE"], ["disabling motor alterations", "PD", "AFFECT"], ["metabolic disarrangements", "metabolic syndrome", "AFFECT"], ["trimethylamine N-oxide", "TMAO", "INTERACT"], ["autism spectrum disorders", "Individuals", "TARGET"], ["probiotics", "pregnant women", "ADMINISTERED"], ["ADHD", "Patients", "TARGET"], ["Fe", "Alzheimer's disease", "INFLUENCE"], ["children", "16S rRNA gene sequencing", "USED BY"], ["synuclein", "people", "TARGET"], ["Gut microbiota", "PPD patients", "LOCATED IN"], ["Acanthopanax senticosus", "metabolic disorders", "INFLUENCE"], ["microbiota -derived metabolites", "Parkinson's disease", "INFLUENCE"], ["PTSD", "people", "TARGET"], ["Phytochemicals", "depression", "INFLUENCE"], ["Cognitive Decline", "Older Persons", "TARGET"], ["MPTP", "gastrointestinal dysfunction", "INFLUENCE"], ["pesticides", "gut barrier", "IMPACT"], ["GMn", "Saccharina japonica", "IMPACT"], ["IF-elevated sarcosine", "5XFAD mice", "ADMINISTERED"], ["psychobiotics", "mental health difficulties", "INFLUENCE"], ["pregnant women", "16S rRNA gene sequencing", "USED BY"], ["GM", "Parkinson's", "IS LINKED TO"], ["NaB", "gut microbiota dysbiosis", "INFLUENCE"], ["gut microbiota", "REM sleep behavior disorder", "IS LINKED TO"], ["gut microbiota", "12-month-old WT, KO and HET female mice", "LOCATED IN"], ["GEP", "PD", "INFLUENCE"], ["OP", "gut microbiota", "IMPACT"], ["PDC", "gastrointestinal dysfunction", "AFFECT"], ["gut dysbiosis", "PD", "AFFECT"], ["frontal brain damage", "patients", "TARGET"], ["fiber", "health disorders", "INFLUENCE"], ["Gut Microbiome", "Synucleinopathies", "IS LINKED TO"], ["B-vitamins", "major depression", "INFLUENCE"], ["gut microbiota", "HC and PD groups", "LOCATED IN"], ["FGF21", "PD", "INFLUENCE"], ["Autism Spectrum Disorder", "gut microbiota", "CHANGE ABUNDANCE"], ["MPTP-induced neurotoxicity", "mice", "TARGET"], ["L. plantarum SG5", "dopaminergic neuron loss", "INFLUENCE"], ["Akk", "neuroinflammation", "INFLUENCE"], ["inflammatory bowel disease", "neurodegenerative conditions", "AFFECT"], ["chronic kidney disease", "individuals", "TARGET"], ["hexanoic (caproic) acid", "epilepsy", "INFLUENCE"], ["Gut Microbiota", "Anxiety", "IS LINKED TO"], ["PD", "Thermosediminibacter", "CHANGE ABUNDANCE"], ["Psoriasis", "chronic, inflammatory skin disease", "IS A"], ["Gut Microbiota", "Behavioural Issues", "IS LINKED TO"], ["PD", "neurodegenerative ailment", "IS A"], ["Chronic gut inflammation", "neuro inflammation", "AFFECT"], ["metabolic dysfunction", "alteration on brain cholesterol", "AFFECT"], ["probiotics", "IBD", "INFLUENCE"], ["PFC", "ABX-treated mice", "LOCATED IN"], ["neurogenesis impairment", "mice", "TARGET"], ["microRNAs", "Parkinson's Disease", "INFLUENCE"], ["gut microbiome", "metagenomics", "USED BY"], ["maltose", "Mice", "ADMINISTERED"], ["participants", "brain magnetic resonance imaging (MRI) scans", "USED BY"], ["Pediococcus pentosaceus", "MPTP-induced oxidative stress", "INFLUENCE"], ["dextran sulfate sodium salt", "anxiety", "INFLUENCE"], ["gut microbiota", "neural disorders", "IS LINKED TO"], ["healthy spouses", "shotgun metagenomic sequencing", "USED BY"], ["gut inflammation", "neuroinflammation", "AFFECT"], ["gut microbiota", "MCI", "IS LINKED TO"], ["Human microbiota", "behavioral symptoms", "IS LINKED TO"], ["HCs", "network-based functional connectivity (FC), grey matter volume (GMV) analyses", "USED BY"], ["healthy controls", "Sequencing", "USED BY"], ["probiotics", "irritable bowel syndrome", "INFLUENCE"], ["concomitant PD-associated gut dysbiosis", "Parkinson's disease", "AFFECT"], ["KD", "PD", "INFLUENCE"], ["MedDiet", "PD", "INFLUENCE"], ["amyotrophic lateral sclerosis", "brain disorders", "IS A"], ["Depression", "neuropsychiatric disease", "IS A"], ["probiotics", "psycho-physiological deficits", "INFLUENCE"], ["Sodium butyrate", "gut microbiota", "IMPACT"], ["mental disorders", "individuals", "TARGET"], ["Dysbiosis", "bacterial metabolites", "INTERACT"], ["human GM", "PC", "IS LINKED TO"], ["Parkinson's disease", "Roseburia intestinalis", "CHANGE ABUNDANCE"], ["\u03b2-alanyl-3-methyl-L-histidine", "depression", "INFLUENCE"], ["probiotics", "psoriasis", "INFLUENCE"], ["prebiotics", "gut", "IMPACT"], ["melatonin", "bacterial imbalance", "INFLUENCE"], ["chronic unpredictable mild stress", "control mice", "TARGET"], ["disruptions in cellular processes", "motor symptoms", "AFFECT"], ["Gut Microbiome", "Parkinson's Disease Patients", "LOCATED IN"], ["GM", "neurodegenerative diseases", "IS LINKED TO"], ["vitamins", "neurodegeneration", "INFLUENCE"], ["Gastrointestinal (GI) dysfunction", "nonmotor symptom", "AFFECT"], ["PD group", "shotgun metagenomic sequencing", "USED BY"], ["Parkinson's disease", "Faecalibacterium", "CHANGE ABUNDANCE"], ["Iron toxicity", "Parkinson's disease", "AFFECT"], ["VAP", "apoptosis", "INFLUENCE"], ["CSDS", "resilient mice", "TARGET"], ["TMAO", "cognitive decline", "INFLUENCE"], ["loss of motor coordination", "mice", "TARGET"], ["healthy controls", "16S rRNA sequencing", "USED BY"], ["pesticides", "dysbiosis", "INFLUENCE"], ["anxiety disorders", "patients", "TARGET"], ["high resistant protein diet", "gut microbiota", "IMPACT"], ["Diabetes", "hypertension", "AFFECT"], ["hippocampi", "CCI mice", "LOCATED IN"], ["gut microbiome", "FC", "IS LINKED TO"], ["Puerarin", "glial cell-derived neurotrophic factor", "INTERACT"], ["defective autophagy", "neurodegenerative diseases", "AFFECT"], ["immune molecules", "MDD", "INFLUENCE"], ["RA", "patients", "TARGET"], ["medium-chain triglyceride ketogenic", "MPTP-induced Parkinson's disease mice", "ADMINISTERED"], ["Oral, Nasal, and Gut Microbiota", "Parkinson's Disease", "IS LINKED TO"], ["A. muciniphila", "neurological diseases", "INFLUENCE"], ["schizophrenia", "patients", "TARGET"], ["Parkinson's Disease", "Patients", "TARGET"], ["Malfunction", "oxidative stress", "AFFECT"], ["psychobiotics", "Lactobacillus family", "IMPACT"], ["calprotectin", "intestinal inflammation", "INFLUENCE"], ["attention deficit hyperactivity disorder", "neurological diseases", "IS A"], ["L-DOPA", "gut microbiota", "IMPACT"], ["PD", "age-associated neurodegenerative diseases", "IS A"], ["gut microbiota", "gastrointestinal disturbances", "IS LINKED TO"], ["human gut microbiome", "FMT mice", "LOCATED IN"], ["Ketogenic diet", "Parkinson's disease", "INFLUENCE"], ["gastrointestinal (GI) dysfunction", "Parkinson's disease", "AFFECT"], ["cardiometabolic disease", "mental health problems", "IS A"], ["Bifidobacterium", "PD patients", "LOCATED IN"], ["hippocampus", "juvenile offspring", "LOCATED IN"], ["Manganese", "Parkinson's disease", "INFLUENCE"], ["microbial intestinal dysbiosis", "central nervous system (CNS)-related disorders", "AFFECT"], ["intestinal dysbiosis", "Parkinson's disease", "AFFECT"], ["MPTP", "TH", "CHANGE EXPRESSION"], ["Migraine", "phonophobia", "AFFECT"], ["Region-specific alterations in gene expression", "GF-mice", "TARGET"], ["perixome-proliferator-activated-receptor-cofactor-1b", "prefrontal cortex", "LOCATED IN"], ["COVID-19 infection", "stroke", "AFFECT"], ["\u03b1-synuclein", "gut", "LOCATED IN"], ["schizophrenia-like behaviors", "mice", "TARGET"], ["NaB", "gut microbiota", "IMPACT"], ["PD", "elderly population", "TARGET"], ["gut microbiome", "AD", "IS LINKED TO"], ["PD", "younger RBD-FDR subjects", "TARGET"], ["autism spectrum disorders", "males", "TARGET"], ["diseases", "neurological diseases", "IS A"], ["polymyxins", "severe infection-related pathologies", "CHANGE EFFECT"], ["behavior deficits", "Parkinson's disease mouse model", "TARGET"], ["dysbiosis", "sleeping disorders", "AFFECT"], ["<i>L. plantarum</i> CCFM405", "Bifidobacterium", "INTERACT"], ["ginsenoside Rk3", "depression", "INFLUENCE"], ["gut microbiota", "infant colic", "IS LINKED TO"], ["high saturated fatty acid diet", "intestinal microbiota", "IMPACT"], ["mental disorders", "brain disorders", "AFFECT"], ["age-associated diseases", "patients", "TARGET"], ["Indole", "inflammation", "INFLUENCE"], ["neuroinflammation", "healthy naive mice", "TARGET"], ["tobacco use disorder", "addictive substance use disorders", "IS A"], ["Rapid eye movement (REM) sleep behavior disorder", "PD", "AFFECT"], ["TPPU", "pregnant mothers", "ADMINISTERED"], ["consortia-Aviguard", "C. jejuni infection", "INFLUENCE"], ["choline", "neuroinflammation", "INFLUENCE"], ["CP2305", "anxiety", "CHANGE EFFECT"], ["aging", "gut microbiome", "CHANGE ABUNDANCE"], ["water extract of ginseng", "PD", "INFLUENCE"], ["Paraquat", "Gut Microbiome", "IMPACT"], ["prednisolone", "gut microbiota", "IMPACT"], ["dopamine agonists", "Parkinson's disease", "CHANGE EFFECT"], ["neuroinflammation", "vagus nerve", "STRIKE"], ["Psychological stress", "mental health problems", "AFFECT"], ["N-acetyl-L-leucine", "Desulfobacterota", "IMPACT"], ["\u03b2-amyloid", "Parkinson's disease", "INFLUENCE"], ["FA", "oxidative stress", "INFLUENCE"], ["resveratrol", "gut microbiota", "IMPACT"], ["gut microbiota", "methamphetamine-induced brain dysfunction", "IS LINKED TO"], ["Cognitive impairment", "patients", "TARGET"], ["mood disorders", "Actinobacteria", "CHANGE ABUNDANCE"], ["Gut microbiota alteration", "underweight PD", "AFFECT"], ["ginger supplementation", "indigestion symptoms", "INFLUENCE"], ["NDDs", "motor neuron disease", "AFFECT"], ["\u03b1Syn", "enteric nervous system", "LOCATED IN"], ["protein", "mood disorders", "INFLUENCE"], ["dystonia", "patients", "TARGET"], ["metabolite", "PD", "INFLUENCE"], ["Synucleinopathies", "brain", "STRIKE"], ["Key Gut Microbiota", "Neurological Diseases", "IS LINKED TO"], ["major depressive disorder", "neuropsychiatric disorders", "IS A"], ["neurodegeneration", "Autism Spectrum Disorder", "AFFECT"], ["dysbiosis", "infections", "AFFECT"], ["inflammatory changes", "vagus nerve branches", "STRIKE"], ["multiple sclerosis", "neurodegenerative diseases", "IS A"], ["\u03b1Syn proteins", "Non-Tg mice", "LOCATED IN"], ["depression", "U.S. adults", "TARGET"], ["Binge eating disorder", "illness", "AFFECT"], ["Manganese", "Alzheimer's disease", "INFLUENCE"], ["Mn", "gut microbiome", "IMPACT"], ["dysbiosis", "intestinal disorders", "AFFECT"], ["polyphenols", "neurodegenerative disorders", "INFLUENCE"], ["milk proteins", "psychological distress", "INFLUENCE"], ["intestinal microbiota", "gut", "LOCATED IN"], ["Environmental toxins", "PD", "INFLUENCE"], ["Gut microbiota", "patients", "LOCATED IN"], ["breast cancer", "gut microbiota", "CHANGE ABUNDANCE"], ["Probiotics", "gut microbiome", "IMPACT"], ["fecal microbiota", "healthy individuals", "LOCATED IN"], ["human gut microbiome", "human diseases", "IS LINKED TO"], ["PD", "gut microbiota", "CHANGE ABUNDANCE"], ["Crohn's disease", "hold-out cohorts", "TARGET"], ["E9 supplementation", "MPTP-induced motor dysfunctions", "INFLUENCE"], ["chronic infections", "iron deficiency", "AFFECT"], ["LPS", "neurotoxicity", "INFLUENCE"], ["schizophrenia", "neurodegenerative diseases", "IS A"], ["ASD-like behaviors", "pregnant mothers", "TARGET"], ["Probiotic", "Gut Microbiota", "IMPACT"], ["bile acid receptors", "neurodegenerative diseases", "INFLUENCE"], ["depressive episodes", "Actinobacteria", "CHANGE ABUNDANCE"], ["controls", "targeted bisulfite sequencing", "USED BY"], ["IBD", "people", "TARGET"], ["indole", "patients", "LOCATED IN"], ["biocompatible poly (lactic-co-glycolic acid) (PLGA) nanoparticles", "severe infection-related pathologies", "INFLUENCE"], ["PD", "MC", "AFFECT"], ["gut microbiota", "neuropsychiatric/neurological diseases", "IS LINKED TO"], ["PD", "GI dysfunction", "AFFECT"], ["gut microbiome", "psychological conditions", "IS LINKED TO"], ["periodontitis", "PD", "AFFECT"], ["gut microbiota", "circadian misalignment", "IS LINKED TO"], ["cytokines", "VD", "INFLUENCE"], ["Parkinson's", "brain diseases", "IS A"], ["aged rats", "serum proteomic and lipidomic profiles", "USED BY"], ["Meth", "anxiety- and depression-like behaviors", "CHANGE EFFECT"], ["Coffee", "neurological and metabolic diseases", "INFLUENCE"], ["antibiotic-induced microbiome depletion", "dopaminergic neurotoxicity", "AFFECT"], ["KBs", "oxidative stress", "INFLUENCE"], ["underweight", "PD patients", "TARGET"], ["Dysfunction of the gut microbiome", "inflammatory processes", "AFFECT"], ["Major Depression", "People", "TARGET"], ["striatal region", "mice", "LOCATED IN"], ["autism spectrum disorder", "neuropsychiatric and neurological disorders", "IS A"], ["Parkinson's disease", "global population", "TARGET"], ["l-glutamic acid", "gut microbiota", "PRODUCED BY"], ["probiotic combination", "low-to-moderate depression", "INFLUENCE"], ["dopaminergic neurotoxicity", "mouse brain", "STRIKE"], ["propionate", "neuroendocrine alterations", "INFLUENCE"], ["tablets", "anxiety", "INFLUENCE"], ["Western-Diet-Induced Microbiota", "Aged Female Mice", "LOCATED IN"], ["progressive neuron loss", "Parkinson's disease", "AFFECT"], ["dysbiosis", "mucosal surfaces", "STRIKE"], ["glial overactivation", "5XFAD mice", "TARGET"], ["AD", "patients", "TARGET"], ["short-chain fatty acids", "mental disorders", "INFLUENCE"], ["MDD", "psychiatric disorders", "IS A"], ["patients", "16S rRNA gene sequencing", "USED BY"], ["gut microbiota", "cardiovascular disease", "IS LINKED TO"], ["bone fragility", "patients", "TARGET"], ["fecal short chain fatty acids", "adiposity", "INFLUENCE"], ["tight junction proteins", "distal colon", "LOCATED IN"], ["microbiota-gut-brain axis disorder", "neurodegenerative pathologies", "AFFECT"], ["rotenone", "dopaminergic neuron loss", "CHANGE EFFECT"], ["gut microbiota dysbiosis", "IBD", "AFFECT"], ["gut microbiota", "obsessive-compulsive disorder", "IS LINKED TO"], ["\u03b1-synucleinopathy", "Parkinson's disease", "AFFECT"], ["irritable bowel syndrome", "healthy young adults", "TARGET"], ["ionizing radiation", "gut microbiota", "IMPACT"], ["neuronal loss", "dementia with Lewy bodies", "AFFECT"], ["gut microbiome", "impulsive and violent behavior", "IS LINKED TO"], ["ambient fine particulate matter", "bipolar disorder", "INFLUENCE"], ["Gut microbiota", "16S rRNA sequencing", "USED BY"], ["BD", "treatment-resistant patients", "TARGET"], ["prebiotic", "rats", "ADMINISTERED"], ["MPTP", "dopaminergic injury", "INFLUENCE"], ["Butyrivibrio gut microbiota", "PD", "IS LINKED TO"], ["Parkinson's disease", "dopaminergic neuron loss", "AFFECT"], ["Gut Microbiome Dysbiosis", "Depression", "AFFECT"], ["gut microbiome", "females", "LOCATED IN"], ["fiber", "depressive symptoms", "INFLUENCE"], ["gut microbiota", "younger and older people", "LOCATED IN"], ["SCFAs", "depression", "INFLUENCE"], ["autism", "neuropsychiatric disorders", "IS A"], ["skeletal fragility", "patients", "TARGET"], ["dysbiosis", "cognitive impairment", "AFFECT"], ["pesticides", "gut microbiota", "IMPACT"], ["Psychological stress", "psychiatric and cardiometabolic comorbidities", "AFFECT"], ["Mn", "gastrointestinal dysfunction", "INFLUENCE"], ["neurological disorders", "individuals", "TARGET"], ["broad-spectrum or species-specific antibiotics", "infections", "CHANGE EFFECT"], ["RNAs", "NPDs", "INFLUENCE"], ["gut dysbiosis", "Tourette syndrome", "AFFECT"], ["gut microbes", "small intestine", "LOCATED IN"], ["Peripheral cytokines", "brain", "LOCATED IN"], ["Bacterial Amyloids", "Synucleinopathies", "IS LINKED TO"], ["Parkinson's disease", "people", "TARGET"], ["autism-like behaviors", "offspring", "TARGET"], ["gut microbiota", "attention deficit hyperactivity disorder", "IS LINKED TO"], ["Oxidative stress", "Parkinson's disease", "AFFECT"], ["gut microbiota", "alterations of behavior", "IS LINKED TO"], ["age-associated neurodegenerative diseases", "population", "TARGET"], ["lipopolysaccharide", "gut microbiota", "IMPACT"], ["gut dysbiosis", "neurological diseases", "AFFECT"], ["fecal microbiota", "antibiotic-treated rats", "LOCATED IN"], ["depression", "stress-related psychiatric disorders", "IS A"], ["saturated fat", "mental health concerns", "INFLUENCE"], ["PD", "neurological diseases", "IS A"], ["bipolar disorder", "Actinobacteria", "CHANGE ABUNDANCE"], ["Dysbiosis", "neurodegenerative diseases", "AFFECT"], ["mental disorders", "IBD", "AFFECT"], ["Gamma-aminobutyric acid", "Alzheimer's and Parkinson's disease", "INFLUENCE"], ["Mn", "sex-selective toxicity", "INFLUENCE"], ["essential tremor", "healthy controls", "TARGET"], ["gut microbiota", "behavioural issues", "IS LINKED TO"], ["PM2.5", "mental disorders", "INFLUENCE"], ["\u03b1-synuclein", "PD-associated inflammation", "INFLUENCE"], ["Infant colic", "carer distress", "AFFECT"], ["phenotypes", "Chrna7 KO mice", "TARGET"], ["gut microbiome", "IBD", "IS LINKED TO"], ["polyunsaturated fatty acids", "MDD", "INFLUENCE"], ["Bacterial extracellular vesicles", "Alzheimer's", "INFLUENCE"], ["iRBD", "synucleinopathies", "AFFECT"], ["PmUre\u03b2", "PD", "INFLUENCE"], ["acetylcholine", "nerve", "LOCATED IN"], ["gut frailty", "frailty", "AFFECT"], ["microbiota", "Parkinson's disease", "IS LINKED TO"], ["probiotics", "psychiatric symptoms", "INFLUENCE"], ["MDD", "Mood disorders", "IS A"], ["cytokines", "DLB", "INFLUENCE"], ["plazomicin", "pro-inflammatory", "INTERACT"], ["Dioscin", "oxidative stress", "INFLUENCE"], ["motor symptoms", "rotenone-challenged mice", "TARGET"], ["anxiety- and depression-like behavior", "CUMS-donor group", "TARGET"], ["COVID-19 clinical manifestations", "shortness of breath", "AFFECT"], ["gut microbes", "autism", "INFLUENCE"], ["short-chain fatty acids", "PD", "INFLUENCE"], ["SCZ", "patients", "TARGET"], ["Gut microbiota dysbiosis", "bipolar disorder", "AFFECT"], ["circadian misalignment", "psychiatric disorders", "AFFECT"], ["Cognitive decline", "neurodegenerative disorders", "AFFECT"], ["gut microbiota dysbiosis", "AD pathogenesis", "AFFECT"], ["obesity", "neurological, psychiatric and metabolic disorders", "IS A"], ["exogenous melatonin", "neural damage", "INFLUENCE"], ["Gastrointestinal (GI) disturbances", "Parkinson's disease", "AFFECT"], ["\u03b1-synuclein", "gut inflammation", "INFLUENCE"], ["gut-microbiota", "anxiety", "IS LINKED TO"], ["gut microbiota", "geriatric syndromes", "IS LINKED TO"], ["patients", "double-blind, randomized controlled trial", "USED BY"], ["alterations in gut microbiota composition", "PD", "AFFECT"], ["AIS patients", "16S rRNA gene sequencing", "USED BY"], ["Bacteroides", "motor impairment", "INFLUENCE"], ["PD", "chronic and progressive neurodegenerative disorder", "IS A"], ["\u03b1-synuclein", "motor symptoms", "INFLUENCE"], ["alterations in gut microbiota composition", "autism", "AFFECT"], ["splenomegaly", "Mice", "TARGET"], ["gut microbiota", "chemotherapy induced long-term gut dysbiosis", "IS LINKED TO"], ["human probiotics", "elderly", "ADMINISTERED"], ["dioscin", "neuroinflammation", "INFLUENCE"], ["depression", "stress", "AFFECT"], ["Gut dysbacteriosis", "intestinal and extraintestinal diseases", "AFFECT"], ["Gut microbiome", "mood disorders", "IS LINKED TO"], ["Rh4", "intestinal flora", "IMPACT"], ["dysbiosis of", "neurodegenerative illnesses", "AFFECT"], ["PD", "gut dysbiosis", "AFFECT"], ["gut microbiota", "sequencing technology", "USED BY"], ["Heightened circulating inflammation", "depression", "AFFECT"], ["Tryptophan metabolites", "inflammation", "INFLUENCE"], ["COVID-19 infection", "microbial dysbiosis", "AFFECT"], ["IBS", "neurodegenerative and neuropsychiatric diseases", "AFFECT"], ["probiotic", "Multiple Sclerosis", "INFLUENCE"], ["fecal microbiota", "colonic inflammation", "IS LINKED TO"], ["GM", "individuals", "LOCATED IN"], ["AN", "Clostridium species", "CHANGE ABUNDANCE"], ["Ginsenoside Rh4", "depression-like behaviors", "INFLUENCE"], ["sulforaphane", "patients", "ADMINISTERED"], ["Gut Microbiota", "Parkinson's Disease", "IS LINKED TO"], ["dysbiosis", "brain", "STRIKE"], ["probiotic mixture", "Bifidobacterium longum", "IMPACT"], ["gut microbiome", "anxious distress", "IS LINKED TO"], ["Gut microbiota", "Parkinson's disease dementia", "IS LINKED TO"], ["individuals", "16S rRNA gene amplicon sequencing", "USED BY"], ["GABA", "gut microbiota", "IMPACT"], ["GI dysfunction", "parkinsonian syndromes", "AFFECT"], ["dysregulated brain transcript response", "mice", "TARGET"], ["\u03b1-synuclein", "disruptions in cellular processes", "INFLUENCE"], ["Microbiota abnormalities", "mood disorders", "AFFECT"], ["IBDs", "neurobiological imbalances", "AFFECT"], ["glucosamine", "insomnia group", "LOCATED IN"], ["MPTP-Induced Nigrostriatal Degeneration", "Recipient Mice", "TARGET"], ["dysbiosis", "stroke", "AFFECT"], ["Calprotectin", "Parkinsonian disease", "CHANGE EFFECT"], ["PD", "chronic inflammatory diseases", "IS A"], ["clozapine monotherapy", "gut microbiota", "IMPACT"], ["psychiatric illnesses", "patients", "TARGET"], ["gut microbiota", "neuroinflammatory response", "IS LINKED TO"], ["gut dysfunction", "peripheral inflammatory response", "AFFECT"], ["iRBD", "PD", "AFFECT"], ["isobutyric acid", "MPTP + H-BCAA mice", "LOCATED IN"], ["depression", "people", "TARGET"], ["gut microbiota", "central nervous system (CNS) degenerative pathologies", "IS LINKED TO"], ["antibiotic rifaximin", "traveler's diarrhea", "CHANGE EFFECT"], ["stress", "mental diseases", "AFFECT"], ["neurodevelopmental impairment", "Autism Spectrum Disorder", "AFFECT"], ["gut microbiota", "16S rRNA analysis", "USED BY"], ["gastrointestinal microbiota", "Parkinson's disease", "IS LINKED TO"], ["gut dysbiosis", "psychiatric illnesses", "AFFECT"], ["gut microbiota disorder", "Neurodegenerative diseases", "AFFECT"], ["\u03b1-synuclein aggregates", "gut", "LOCATED IN"], ["motor alterations", "PD", "AFFECT"], ["Central inflammation", "neurodegenerative disease", "AFFECT"], ["Microbiota", "Irritable Bowel Syndrome", "IS LINKED TO"], ["PD", "depression", "AFFECT"], ["gut inflammation", "Alzheimer's and Parkinson's diseases", "AFFECT"], ["Gut microbiome", "Parkinson's disease", "IS LINKED TO"], ["chronic unpredictable mild stress", "mice", "TARGET"], ["MDE", "participants", "TARGET"], ["\u03b1S oligomers", "\u03b1-synucleinopathies", "INFLUENCE"], ["healthy gut microbiota", "autism spectrum disorder", "IS LINKED TO"], ["BEVs", "BEVs", "INTERACT"], ["gut microbiome", "motor and non-motor symptoms", "IS LINKED TO"], ["altered gut microbiota", "PD", "IS LINKED TO"], ["neurological symptoms", "COVID-19 patients", "TARGET"], ["PM2.5", "central nervous system damage", "INFLUENCE"], ["probiotics <i>Pediococcus pentosaceus", "PD", "INFLUENCE"], ["amyotrophic lateral sclerosis", "Neurodegenerative diseases", "IS A"], ["Gut microbiota-derived short chain fatty acids", "Neurodegenerative diseases", "INFLUENCE"], ["ulcerative colitis", "mice", "TARGET"], ["Sika Deer Velvet Antler Peptide", "Oxidative Damage", "INFLUENCE"], ["Parkinson disease", "patients", "TARGET"], ["seafood", "mood disorders", "INFLUENCE"], ["probiotic", "microbiotas", "IMPACT"], ["\u03b1S", "\u03b1-synucleinopathies", "INFLUENCE"], ["nuts", "mood disorders", "INFLUENCE"], ["fecal microbiota", "mice", "LOCATED IN"], ["infections", "gut microbiota", "CHANGE ABUNDANCE"], ["gastrointestinal involvement", "Parkinson's Disease", "AFFECT"], ["fucoidan", "MPTP-induced motor deficits", "INFLUENCE"], ["carnitine", "cognitive decline", "INFLUENCE"], ["fruits", "gut microbiota", "IMPACT"], ["Gut bacterial profiles", "Parkinson's disease", "IS LINKED TO"], ["Allantoin", "dopaminergic neuronal damage", "INFLUENCE"], ["hypercaloric diet", "gut microbiota", "IMPACT"], ["alterations of intestinal epithelial barrier", "PD", "AFFECT"], ["Fecal zonulin", "PD motor and non-motor symptoms", "INFLUENCE"], ["probiotics", "individuals", "ADMINISTERED"], ["fronto-temporal lobe dementia", "neurological diseases", "IS A"], ["salivary microbiome", "anxiety", "IS LINKED TO"], ["butyrate triglyceride", "constipation", "INFLUENCE"], ["Parkinson's disease", "Propionicicella", "CHANGE ABUNDANCE"], ["ET", "PD group", "TARGET"], ["ADHD", "patients", "TARGET"], ["intestinal gut microbiota", "IBD", "IS LINKED TO"], ["neurodegeneration", "IBD and non-IBD patients", "TARGET"], ["gut microbiome dysbiosis", "Parkinson's disease", "AFFECT"], ["PD", "MPTP-induced Parkinson's disease mice", "TARGET"], ["stress", "neurological diseases", "IS A"], ["Dysbiosis of the gut microbiota", "Parkinson's syndrome", "AFFECT"], ["Gastrointestinal symptoms", "Parkinson's disease", "AFFECT"], ["gut microbiota", "fMRI", "USED BY"], ["brains", "mice", "LOCATED IN"], ["Skin Microbiome", "Chronic Disease Epidemic", "IS LINKED TO"], ["probiotics", "anxiety", "INFLUENCE"], ["fermented foods", "anxiety", "INFLUENCE"], ["culprit proteins", "Alzheimer's", "INFLUENCE"], ["depression symptoms", "microbiota of infants", "CHANGE ABUNDANCE"], ["Alzheimer's", "neuropsychiatric and neurodegenerative disorders", "IS A"], ["Gut microbiota alteration", "psychiatric disorders", "AFFECT"], ["dysbiosis", "people", "TARGET"], ["insulin resistance", "Parkinson's disease", "AFFECT"], ["PD patients", "ELISA method", "USED BY"], ["morphine-treated rats", "16S rRNA sequencing", "USED BY"], ["gut microbiota", "cancer", "IS LINKED TO"], ["psychobiotics", "mental disorders", "INFLUENCE"], ["FC", "gastrointestinal disorder", "IS A"], ["neurological disorders", "patients", "TARGET"], ["gut microbiota", "HCs", "LOCATED IN"], ["probiotics", "mood disorders", "INFLUENCE"], ["delayed gastric emptying", "autonomic issues", "IS A"], ["Butyrate", "PD", "INFLUENCE"], ["xylooligosaccharides", "gut microbiota", "IMPACT"], ["Gut microbiome", "Alzheimer's disease", "IS LINKED TO"], ["gut dysbiosis", "multiple sclerosis", "AFFECT"], ["Chinese materia medica", "gut dysbiosis", "CHANGE EFFECT"], ["anxiety- and depression-like behaviors", "mice", "TARGET"], ["PD", "substantia nigra", "STRIKE"], ["neurodegeneration", "Amyotrophic Lateral Sclerosis", "AFFECT"], ["gut microbiome", "SCZ", "IS LINKED TO"], ["5-HT4 Receptor", "Gut Microbiota", "IMPACT"], ["Ketogenic diet", "gut microbiota", "IMPACT"], ["gut microbiota", "LH susceptible rats", "LOCATED IN"], ["depression", "nursing students", "TARGET"], ["Gut microbiota-derived short-chain fatty acids", "anxiety-like behaviors", "INFLUENCE"], ["Parkinson's disease", "PD model mice", "TARGET"], ["motor and non-motor symptoms", "PD", "AFFECT"], ["circadian disruption", "mental illness", "AFFECT"], ["LPS", "PD", "INFLUENCE"], ["gastrointestinal microbiota", "mood disorders", "IS LINKED TO"], ["inflammation", "Parkinson's disease", "AFFECT"], ["next-generation probiotics", "neurodegenerative and viral diseases", "INFLUENCE"], ["gut microbiota", "depression", "IS LINKED TO"], ["glyphosate", "depression- and anxiety-like behavior", "INFLUENCE"], ["Valeric acid", "Parkinson's", "INFLUENCE"], ["LBD", "vulnerable persons", "TARGET"], ["CUMS", "Helicobacter", "CHANGE ABUNDANCE"], ["Gut microbiota", "anxiety", "IS LINKED TO"], ["gut microbiota", "Illumina MiSequencing", "USED BY"], ["gut microbiota", "sporadic form of Parkinson's disease", "IS LINKED TO"], ["depression", "individuals", "TARGET"], ["hepatic ischemia/reperfusion injury", "mice", "TARGET"], ["HFHS diet", "adolescent rats", "ADMINISTERED"], ["Autism", "neurodevelopmental disorders", "IS A"], ["Neuroinflammation", "toxin stimulation", "AFFECT"], ["Parkinson's disease", "Parkinson's Disease", "AFFECT"], ["Gut microbiota-derived propionate", "osteocalcin", "INTERACT"], ["neurodegeneration", "psychiatric disorders", "AFFECT"], ["DSS", "anxiety", "INFLUENCE"], ["IL-10", "colon tissue", "LOCATED IN"], ["Parkinson's", "neurological disorders", "IS A"], ["PD", "tremor", "AFFECT"], ["probiotics", "gastrointestinal disruption", "INFLUENCE"], ["microbiome", "psychiatric and neurodegenerative disorders", "IS LINKED TO"], ["gut microbiota dysregulation", "PD", "AFFECT"], ["BU", "Parkinson's disease", "INFLUENCE"], ["inflammation-derived oxidative damage", "Parkinson's disease", "AFFECT"], ["A\u03b2", "prefrontal cortex", "LOCATED IN"], ["3,4-Methylenedioxymethamphetamine", "post-traumatic stress disorder", "CHANGE EFFECT"], ["PARK7/DJ-1", "GBA diseases", "INFLUENCE"], ["gut microbiota", "Aging", "IS LINKED TO"], ["Parkinson's disease", "Parkinson's patients", "TARGET"], ["healthy controls", "16S V3 to V4 rRNA sequencing", "USED BY"], ["Inflammation", "neurodegenerative diseases", "AFFECT"], ["acid", "PD", "INFLUENCE"], ["intestinal microbiota", "individuals", "LOCATED IN"], ["ADHD", "medication-naive children and adolescents", "TARGET"], ["cancer", "age-associated diseases", "IS A"], ["microbiota disturbances", "stress", "AFFECT"], ["Gut microbiota-derived short chain fatty acids", "age-related neurodegenerative disorders", "INFLUENCE"], ["gut dysbiosis", "MA-induced CPP", "AFFECT"], ["MPTP-induced abnormalities", "gut microbiota", "CHANGE ABUNDANCE"], ["systemic inflammation", "PD patients", "TARGET"], ["Microbiome Metabolites", "Gut Dysbiosis", "INFLUENCE"], ["Growth factors", "LBD", "INFLUENCE"], ["non-motor symptoms", "PD", "AFFECT"], ["AFO-202 strain-produced beta glucan", "ASD", "INFLUENCE"], ["gut microbes", "diabetes", "INFLUENCE"], ["BAP fibrils", "brains", "LOCATED IN"], ["gut microbiomes", "patients", "LOCATED IN"], ["Gut microbiota", "16S rRNA gene sequencing", "USED BY"], ["sugar", "obesity", "INFLUENCE"], ["non-motor symptoms of PD", "PD patients", "TARGET"], ["leaky gut", "PD patients", "TARGET"], ["intestinal microbiota dysbiosis", "Alzheimer's", "AFFECT"], ["microbes", "PD patients", "LOCATED IN"], ["Microbial dysbiosis", "Akkermansia", "CHANGE ABUNDANCE"], ["Bacteroides and butyrate-producing bacteria", "FC patients", "LOCATED IN"], ["dysbiosis-induced depression-like behavior", "rats", "TARGET"], ["Parkinson's disease", "Mice", "TARGET"], ["COVID-19 disease", "humans", "TARGET"], ["gut microbiota", "brain disorders", "IS LINKED TO"], ["stroke", "host brain disorders", "IS A"], ["placebo", "Patients", "ADMINISTERED"], ["IBD", "Parkinson disease", "AFFECT"], ["severe infections", "depression", "AFFECT"], ["FLZ", "rotenone-challenged mice", "ADMINISTERED"], ["Fatigue", "Alzheimer's", "AFFECT"], ["Malfunction", "inflammatory processes", "AFFECT"], ["Parkinson's disease", "chronic progressive neurodegenerative disease", "IS A"], ["fecal microbiota", "16S rRNA gene sequencing", "USED BY"], ["reduced butyrate-production", "PD pathophysiology", "AFFECT"], ["neurodegeneration", "gut", "STRIKE"], ["Alzheimer's disease", "neurodegenerative disorders", "IS A"], ["Depression", "patients", "TARGET"], ["Gastrointestinal disorders", "Lewy body diseases", "AFFECT"], ["nootropic Ayurvedic herbs", "fecal microbiota", "IMPACT"], ["Standard oral iron supplementation", "gastrointestinal side effects", "INFLUENCE"], ["gut flora", "neurological and psychological conditions", "IS LINKED TO"], ["constipation", "PD patients", "TARGET"], ["oral agents", "gut microbiota", "IMPACT"]]